site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 2 A 42 0 0 5 0 24 0 0 0 2 0 0 0 4 11 0 7 6 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 3 V 33 0 0 0 13 0 0 4 0 3 0 0 0 0 0 3 7 36 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: V->I:LB/B:-: -; 4 M 17 0 0 0 0 0 0 0 0 12 52 0 6 0 0 0 7 6 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 5 A 70 0 0 0 0 2 0 0 0 12 2 0 1 0 2 0 0 10 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: A->P:LB/B:-: -; 6 P 0 0 0 0 0 0 0 0 0 0 0 0 85 0 0 15 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 7 R 11 6 0 0 0 6 0 0 0 10 0 0 15 0 52 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 8 T 19 0 0 0 0 0 0 10 0 11 3 0 0 0 0 3 53 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 9 L 0 0 0 0 11 0 0 18 0 58 0 0 0 0 0 0 0 14 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 10 L 0 0 0 0 21 0 0 3 0 70 0 0 0 0 0 0 0 7 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: L->V:LB/B:-: -; 11 L 0 0 0 0 0 0 0 5 0 78 0 0 16 0 0 0 0 2 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 12 L 0 0 0 0 3 0 0 8 0 65 6 0 6 0 12 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 13 L 0 0 0 0 2 0 0 0 0 84 0 0 0 0 0 0 0 13 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 14 S 41 0 0 0 0 0 9 6 5 7 0 0 0 0 0 30 3 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: S->L:LB/B:-: -; 15 G 23 0 0 0 0 49 4 15 0 0 0 0 0 0 6 0 0 3 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 16 A 35 0 0 0 3 2 0 8 0 10 0 0 11 0 0 15 7 9 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 17 L 11 0 2 0 8 0 0 0 0 50 0 2 10 4 0 8 0 6 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 18 A 48 0 0 0 0 4 0 1 0 0 4 0 7 0 7 5 3 12 0 9 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 19 L 5 0 0 0 18 0 0 0 0 44 3 0 12 3 4 5 2 3 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 20 T 7 0 0 4 0 0 0 0 7 18 0 0 0 9 0 0 51 2 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 21 Q 0 0 1 25 7 4 1 0 0 2 0 0 9 44 5 0 0 0 0 0 SIGNAL::SIGNAL: 22 T 4 0 7 4 0 0 0 0 0 0 0 0 6 0 4 6 58 9 0 0 SIGNAL::SIGNAL: 23 W 1 3 3 1 0 6 2 1 1 2 0 2 4 8 11 1 1 8 47 0 SIGNAL::SIGNAL: W->R:LB/B:-: -; 24 A e 92.2 6o9c_A ZN EDO 57 0 1 1 0 10 0 1 1 1 0 0 6 0 1 7 2 12 0 0 SIGNAL::SIGNAL: 25 G e 36.9 6o9c_A Human T Cell Receptor Mel8, Beta Chain[245 aa] CD:NI:IOD:NA GOL:IPA:EDO 7 0 9 10 0 57 0 0 0 0 0 0 0 6 7 2 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 26 S e 42.2 6o9c_A CL GOL:EDO:SO4:IMD:PGE:ACT 4 0 0 3 0 0 0 0 0 0 7 2 17 1 3 46 15 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 27 H E b 10.5 6o9c_A CD:NI:IOD:MG:NA:ZN GOL:EDO:SO4:IMD:PGE:ACT 0 0 0 8 0 0 83 0 0 0 0 0 2 0 0 0 0 0 0 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 28 S E b 3.9 6o9c_A NA EDO:GOL:SO4:PGE 6 4 0 0 0 0 0 0 0 0 0 0 2 0 0 66 14 6 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 29 M E b 1.9 6o9c_A CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TAT_HTL1C:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:Q692E0_CVHSA:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:Q9QAC5_HBV:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:RASK_HUMAN:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:TAX PEPTIDE[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:SELF-PEPTIDE P1049[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:Immunogenic peptide[9 aa]:Melanoma peptide L7A[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:CMV peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:Spike protein S2[9 aa]:8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:Spike protein S2' [10 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p.. FMT:GLY:EDO 0 0 0 0 0 0 0 0 0 82 12 0 0 6 0 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 30 R E e 35.2 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[98 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[90 aa] NA:IOD 1PG:GOL:FMT:SO4:EDO:IPA:PG4:PEG:P6G:PGE:ACT 0 10 0 0 0 0 2 2 2 6 4 0 0 7 59 2 4 0 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 31 Y E b 4.3 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] MET:LEU NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. FMT:GLY:EDO 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 95 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular" 32 F E e 39.2 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] CL:NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. 1PG:GOL:SO4:EDO:IPA:PG4:IMD:PEG:MES:ACT:P6G:FMT:PGE:NO3 0 0 17 0 33 6 10 5 0 12 0 11 0 0 0 0 6 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 33 F E b 3.3 6o9c_A B2MG_HUMAN:TAT_HTL1C:ENV_HV1B8:POL_HV1MA:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:NCAP_CVHSA:B2MG_PANTR:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:FETA_HUMAN:POLG_HCVJ1:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:INS_HUMAN:Q9WPU2_9HIV1:TAX_HTL1F:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:R4P6M5_9INFA:R4X2K3_9INFA:TERT_HUMAN:A14_VACCW:E9P5U1_9INFA:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:PHX2B_HUMAN:MAGA8_HUMAN:RASK_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:BETA-2 MICROGLOBULIN[100 aa]:TAX PEPTIDE[9 aa]:BETA 2-MICROGLOBULIN[100 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (HLA-A*0201)[100 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:BETA-2 MICROGLOBULIN[99 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BETA 2-MICROGLOBULIN[99 aa]:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:BETA-2-MICROGLOBULIN[100 aa]:9 RESIDUE PEPTIDE[9 aa]:beta-2-microglobulin[100 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:Beta-2-microglobulin[100 aa]:self-peptide P1049[9 aa]:Beta-2-microglobulin[93 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:Beta-2-microglobulin[99 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:octapeptide from Melan-A/MART-1[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:BETA-2-MICROGLOBULIN[98 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:Beta-2-microglobulin[98 aa]:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Alpha-fetoprotein[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[10 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:Insulin[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Telomerase reverse transcriptase[9 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:Beta-2-microglobulin[97 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:BETA-2-MICROGLOBULIN[99 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:Beta-2-microglobulin[96 aa]:Matrix protein 1[9 aa]:Beta-2-microglobulin[92 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:Protein Nef[8 aa]:Protein Nef[10 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:NS5[9 aa]:Gag protein[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:G1/S-specific cyclin-D2[10 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:MTB[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Beta-2-microglobulin[101 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Spike protein S1[9 aa]:Spike protein S2[9 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Beta-2-microglobulin[90 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VLNDILSRL [9 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:Nucleoprotein peptide[9 aa]:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] LEU CL:NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. EDO 0 0 1 2 23 0 6 6 0 18 0 0 0 2 6 6 1 7 0 22 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" F->S:LB/B:rs2075684: -;F->T:LB/B:-: -;F->Y:LB/B:rs2075684: -; 34 T E e 32.5 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. ACT 3 0 0 0 0 0 0 4 0 6 14 0 0 0 8 0 66 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 35 S E b 0.8 6o9c_A NA GOL:EDO 41 6 0 0 0 25 0 4 0 0 0 0 0 0 0 8 2 12 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 36 V E e 27.3 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4:PEG:1PE 6 3 0 0 0 0 2 22 0 25 4 0 0 0 0 0 0 37 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 37 S b 18.8 6o9c_A GOL:EDO:SO4:PEG:FMT 1 0 0 0 6 0 4 0 0 0 0 0 6 0 0 75 6 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 38 R b 18.6 6o9c_A B2MG_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:Beta-2-microglobulin[99 aa]:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[100 aa]:Heavy chain[216 aa] NA:CL:BR:CA:3NI:IOD GOL:EDO:IPA:SO4:ACY:PEG:PG4:PGE:1PE 0 0 12 6 9 0 0 0 6 13 0 4 4 3 35 4 0 0 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 39 P T e 37.2 6o9c_A Light chain[216 aa]:Light chain[215 aa] NA:CL:CA GOL:SO4:ACY:PEG:EDO:1PE 6 0 12 7 0 0 2 0 6 2 0 0 61 2 2 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 40 G T e 103.6 6o9c_A B2MG_HUMAN:KI3L1_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:Heavy chain[216 aa]:Light chain[216 aa]:Light chain[215 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 .. NA:CL:BR:CA:3NI SO4:GOL:ACY:EDO:PEG:1PE 8 0 10 0 0 48 0 3 0 3 0 6 0 0 5 11 0 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 41 R S e 68.4 6o9c_A B2MG_HUMAN:KI3L1_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa]:Heavy chain[216 aa]:Beta-2-microglobulin[103 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:Beta-2-microglobulin[101 aa] NA:CL:CA:3NI SO4:GOL:EDO:ACY:PEG:1PE 2 0 0 5 1 0 7 2 4 16 0 0 13 0 23 13 11 0 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->S:LB/B:rs1059423: -; 42 G S e 71.4 6o9c_A B2MG_HUMAN:KI3L1_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:Heavy chain[216 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 .. CA:NA:IOD GOL:SO4:EDO:PEG:1PE 0 0 3 9 0 58 0 0 0 1 0 0 4 0 1 14 0 7 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 43 E S e 68.3 6o9c_A B2MG_HUMAN:Q2YDB4_HUMAN:KI3L1_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:Hypothetical protein[242 aa]:D30 TCR beta chain[244 aa]:Heavy chain[216 aa]:T-cell receptor beta chain[235 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:TIL1383i (h3T) T cell receptor beta chain[247 aa]:IgG, Fab Light Chain V2[214 aa] MG:NA:IOD Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa] GOL:EDO:SO4:PEG 0 0 1 29 4 0 7 2 4 18 0 0 0 14 0 0 6 7 6 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 44 P b 15.5 6o9c_A NA:IOD GOL:EDO:SO4:PEG 0 0 0 0 0 0 0 0 0 0 6 0 72 3 0 13 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 45 R E e 32.4 6o9c_A B2MG_HUMAN:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin[96 aa] CL:NA:CA:MG SO4:GOL:EDO:IPA:PG4:EPE:PEG:SCN:PGE:1PE:PO4 9 0 0 6 2 6 0 0 0 5 0 0 0 11 43 5 6 0 9 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 46 F E b 2.4 6o9c_A TERT_HUMAN:Q9YYU8_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:Q9YXL6_9INFA:NEF_HV1ND:PHX2B_HUMAN:SPIKE_SARS2:Telomerase reverse transcriptase[9 aa]:10-mer peptide from Protein Nef[10 aa]:Protein Nef[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:8-Mer peptide from Protein Nef[8 aa]:Protein Nef[8 aa]:HIV-1 Nef138-10 peptide[10 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:9-mer peptide from the HCoV spike protein[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:Spike protein S1[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa] NA GOL:EDO 0 3 0 0 60 0 0 0 0 12 0 0 0 0 0 0 6 3 10 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 47 I E e 35.7 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa] NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:SO4:EDO:PG4:ACT:PEG:EPE 0 9 5 9 0 0 0 30 0 21 1 0 0 7 0 2 6 2 7 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 48 A E b 2.7 6o9c_A Q9YYU8_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:Q9YXL6_9INFA:NEF_HV1ND:PHX2B_HUMAN:RDRP_I97A1:SPIKE_SARS2:10-mer peptide from Protein Nef[10 aa]:Protein Nef[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:8-Mer peptide from Protein Nef[8 aa]:Protein Nef[8 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:H7-25-F[5 aa]:HIV-1 Nef138-10 peptide[10 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:CMV peptide[9 aa]:Spike protein S1[9 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa] 33 0 0 7 0 5 0 6 0 2 0 0 0 0 0 20 9 18 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 49 V E e 21.3 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa]:4-mer lipopeptide[5 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. ACT 1 0 0 5 0 0 0 0 0 14 1 0 0 3 2 11 6 54 2 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 50 G E b 1.2 6o9c_A 4 0 0 1 0 77 0 4 0 0 0 0 0 0 4 3 0 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 51 Y E e 31.7 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] CL:NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:PGE:EDO:SO4:PEG:IPA:PG4:MES:NO3 0 0 0 0 3 0 5 6 0 3 0 0 0 8 0 2 0 0 26 47 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 52 V E b 0.0 6o9c_A 0 0 0 0 10 0 0 0 0 39 0 0 0 0 0 0 0 51 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 53 D T b 13.6 6o9c_A CL:K:NA GOL:PGE:SO4:EDO:PEG:IPA:IMD:ACT:FMT:NO3 0 0 78 0 0 15 0 0 0 0 0 6 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 54 D T e 38.3 6o9c_A CD:CL:K GOL:PGE:7PE:SO4:EDO:PEG:IPA:PG4:IMD:MES:ACT:FMT:NO3 2 0 55 10 0 13 0 0 0 0 0 5 7 3 0 5 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 55 T E e 20.8 6o9c_A GOL:FMT:PG4:EDO 0 0 0 12 0 0 5 0 9 20 0 0 0 27 3 0 24 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" T->S:LB/B:-: -; 56 Q E e 32.7 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:7PE:EDO:PG4:PEG 3 0 0 4 0 0 6 0 0 12 0 3 19 49 0 0 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 57 F E b 0.0 6o9c_A Q80817_9DELA:NCAP_SARS2:TAX protein[9 aa]:Nucleoprotein[9 aa] NA 0 0 0 0 68 0 0 15 0 4 0 0 0 0 0 0 4 0 0 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 58 V E b 0.0 6o9c_A 4-mer lipopeptide[5 aa] NA 0 0 0 0 12 0 14 0 0 35 0 0 0 0 0 0 5 31 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 59 R E e 22.5 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. 7PE:GOL:EDO:SO4:EPE:PEG:1PE 1 0 0 0 1 14 17 0 2 0 1 0 2 1 37 11 13 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->Q:LB/B:-: -; 60 F E b 2.4 6o9c_A CMV peptide[9 aa] NA EDO:GOL 0 2 0 0 24 0 0 0 0 0 3 0 0 0 0 0 0 0 15 56 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 61 D E b 11.1 6o9c_A B2MG_HUMAN:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[101 aa] NA GOL:SO4:EDO:PG4:EPE:PEG:1PE 0 0 57 3 0 0 0 0 2 0 0 28 0 0 0 10 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 62 S T e 21.9 6o9c_A B2MG_HUMAN:BETA-2 MICROGLOBULIN[100 aa] GOL:EDO:SO4 1 3 0 3 0 5 5 0 3 1 0 9 0 0 5 61 0 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 63 D T e 56.2 6o9c_A B2MG_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:Heavy chain[216 aa]:Beta-2-microglobulin[100 aa] EDO:SO4:EPE:1PE 2 1 52 9 1 2 1 1 2 4 1 6 1 6 1 3 4 2 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 64 A S b 18.8 6o9c_A Heavy chain[216 aa] NA GOL:EDO:SO4:EPE:PEG 26 9 3 2 1 5 1 2 10 3 1 1 5 1 6 19 2 2 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 65 A S e 94.6 6o9c_A B2MG_HUMAN:Heavy chain[216 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[100 aa] Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[273 aa] GOL:EDO:SO4:EPE:PEG 27 3 2 11 1 23 0 1 3 8 0 1 2 1 3 6 1 6 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 66 S S e 43.0 6o9c_A NA GOL:EDO:PG4:EPE:SO4:PEG 1 1 3 1 0 1 0 2 3 1 0 14 1 0 7 37 27 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 67 Q e 38.3 6o9c_A Heavy chain[216 aa]:T-cell receptor beta chain[235 aa] NA Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa] SO4:GOL:EDO 15 0 6 1 0 7 0 1 6 1 0 3 20 8 18 6 5 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" Q->R:LB/B:rs4155911: -; 68 R S e 33.2 6o9c_A Immunoglobulin light chain H2[214 aa]:10LH single chain fragment variable (scFv)[227 aa].. TAM IOD:NA Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[273 aa] GOL:EPE:EDO:PG4:SO4:PEG 1 0 0 7 5 1 0 10 10 2 0 0 0 8 46 2 7 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->K:LB/B:-: -; 69 M b 5.3 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:POL_HV1MA:POL_HV1Z2:MAGA3_HUMAN:PME17_HUMAN:NCAP_CVHSA:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:N4BP2_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:INS_HUMAN:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:R4P6M5_9INFA:R4X2K3_9INFA:TERT_HUMAN:A14_VACCW:AMPD2_HUMAN:Q9YYU3_9HIV1:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:octapeptide from Melan-A/MART-1[9 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from NEDD4-binding protein 2[10 ..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[10 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Telomerase reverse transcriptase[9 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:KLV peptide[10 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:H7-25-F[5 aa]:H7-25-F[7 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:peptide[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[9 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Nucleoprotein peptide[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VLNDILSRL [9 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:PB1 peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] MET:LEU NA GOL:EDO:PG4:SO4:PEG 27 0 1 3 10 2 0 4 5 5 14 0 0 2 0 2 4 13 0 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 70 E E e 20.1 6o9c_A T cell receptor, alpha chain[110 aa] NA GOL:EDO:PG4:EPE:SO4:PEG 1 0 6 46 0 1 0 1 12 4 0 9 1 2 1 5 6 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 71 P E e 27.9 6o9c_A BTB GOL:EDO:PG4:SO4:MES:EPE 1 0 0 1 5 6 3 0 1 2 0 0 70 1 0 7 1 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 72 R e 42.3 6o9c_A B2MG_HUMAN:B2MG_PANTR:E3GL_ADE06:Q8BEL5_ADE04:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:BETA 2-MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:Beta-2-microglobulin[101 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, alpha chain[110 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] BTB NA GOL:SO4:7PE:PEG:EDO:MES:EPE 0 6 0 0 0 0 0 0 4 13 5 0 0 5 37 2 10 8 5 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 73 A S b 8.0 6o9c_A T cell receptor, alpha chain[108 aa]:T cell receptor, alpha chain[110 aa] BTB IOD GOL:PEG:SO4:EDO:MES:EPE 38 0 0 5 0 21 0 8 14 0 0 0 0 0 0 6 5 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 74 P H e 69.0 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:I6LEL9_HUMAN:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, alpha chain[110 aa]:KIR3DL1[280 aa] IOD GOL:PEG:SO4:EDO:EPE 9 4 0 2 0 0 3 0 5 3 0 0 49 7 8 6 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 75 W H b 5.6 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa] IOD:CL:MG GOL:ACT:PEG:EDO 4 0 0 0 0 0 0 0 0 9 0 0 0 0 3 0 0 0 80 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 76 I H b 0.0 6o9c_A 6 0 1 4 4 6 0 19 1 1 25 1 1 1 2 12 1 16 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 77 E H e 63.8 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:I6LEL9_HUMAN:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, alpha chain[110 aa]:KIR3DL1[280 aa] BTB PEG:SO4:EDO:GOL:MES:EPE 12 0 2 47 0 3 2 1 16 2 0 0 1 9 1 2 1 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 78 Q T e 69.4 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:I6LEL9_HUMAN:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:KIR3DL1[280 aa] EDO:ACT:GOL:PEG 3 0 3 2 0 10 6 1 7 1 0 19 1 28 5 7 1 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 79 E S e 20.6 6o9c_A Q9YYU3_9HIV1:Q8BEL5_ADE04:A6 alpha chain[200 aa]:8-Mer peptide from Protein Nef[8 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa] 1PG:EDO:PEG:GOL 1 0 1 30 0 5 2 1 7 15 0 5 1 9 2 1 3 13 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 80 G e 21.4 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa] EDO:PG4:GOL:PEG 13 0 1 4 1 42 0 1 1 6 0 1 1 1 5 11 1 10 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" G->E:LB/B:-: -;G->R:LB/B:rs1059449: -; 81 P H e 76.0 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[103 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR beta chain[241 aa] Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[274 aa] GOL:EDO:PG4:PEG:FMT 8 0 4 1 1 1 0 1 4 2 6 5 35 3 2 20 4 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 82 E H e 68.3 6o9c_A NCAP_CVHSA:WT1_HUMAN:A0A087WSZ9_HUMAN:K7N5N2_HUMAN:K7N5M3_HUMAN:TVAL2_HUMAN:TCA_HUMAN:TVA22_HUMAN:T CELL RECEPTOR ALPHA[115 aa]:HUMAN T-CELL RECEPTOR[200 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:A6 TCR alpha chain[200 aa]:Antibody heavy chain[220 aa]:WT126 peptide[9 aa]:DMF5 alpha chain[199 aa]:C1-28 TCR alpha chain[198 aa]:T36-5 TCR alpha chain[199 aa]:A6 alpha chain[200 aa]:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Alpha Chain[197 aa]:ESK1[212 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:1E6 TCR Alpha Chain[199 aa]:1E6 TCR Alpha Chain[189 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:HCV1406 TCR alpha chain[207 aa]:T-cell receptor alpha variable 30,T-cell receptor,..:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:T cell receptor alpha chain[191 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:302TIL TCR alpha chain[189 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:Alpha chain of engineered high affinity T-cell rec..:SILv44 T cell receptor alpha chain[197 aa]:SILv44 T cell receptor alpha chain[196 aa]:T4H2 T cell receptor alpha chain[201 aa]:Immunoglobulin light chain H2[214 aa]:Heavy chain of Fab fragment 11D06[215 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:Fab heavy chain[212 aa]:Fab heavy chain[218 aa]:T cell receptor, alpha chain[185 aa]:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR alpha chain[257 aa]:REGN6972 Fab heavy chain[214 aa] Q5S3G3_HUMAN:HLA class I histocompatibility antigen[274 aa] 1PG:GOL:EDO:PG4:SO4:PEG:FMT:EPE 2 0 9 37 1 2 1 1 10 2 3 1 1 10 1 2 7 2 9 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 83 Y H b 4.3 6o9c_A TAT_HTL1C:POL_HV1MA:POL_HV1Z2:ERBB2_HUMAN:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:O11822_9HIV1:MAR1_HUMAN:ENV_HV1MA:POL_HV1B1:MAGA1_HUMAN:HMHA1_HUMAN:WT1_HUMAN:Q692E0_CVHSA:Q1WDM0_9INFA:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YJW5_HBV:LMP2_EBVB9:Q9YYU3_9HIV1:Q9YYU8_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:ENV_HV1LW:Q9QAC5_HBV:A14_VACCW:E9P5U1_9INFA:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:CCND2_HUMAN:Q9WGX1_9HIV1:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:NCAP_INBAC:RASN_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:NCAP_I46A1:RDRP_I97A1:MAGA4_HUMAN:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:T CELL RECEPTOR ALPHA[190 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:Human T-cell lymphotropic virus type 1 Tax peptide..:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:GAG PROTEIN[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:P1049[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:Tel1p peptide[9 aa]:WT126 peptide[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Solute carrier organic anion..:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[10 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:10-mer peptide from Protein Nef[10 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:A6 alpha chain[200 aa]:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma motif[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:peptide from Virion membrane protein A14[9 aa]:Nucleoprotein[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:8-Mer peptide from Protein Nef[8 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide Y10L[10 aa]:Protein Nef[8 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:NS5[9 aa]:GTS1 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Polyprotein[9 aa]:Synemin[9 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:T4H2 T cell receptor alpha chain[201 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Insulin-like growth factor-binding protein-like 1 ..:Nucleoprotein peptide[9 aa]:Spike protein S2[9 aa]:Spike protein S1[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Fab heavy chain[212 aa]:Fab heavy chain[218 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Spike protein S1 peptide[9 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:PN45545 TCR alpha chain[257 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:REGN6972 Fab heavy chain[214 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] PE8 NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p.. 1PG:GOL:EDO:PG4:SO4 4 0 7 1 4 1 5 1 1 6 2 1 1 1 1 1 14 4 0 42 MOD_RES:/note="Sulfotyrosine":TOPO_DOM:/note="Extracellular":MOD_RES:/note="Sulfotyrosine":TOPO_DOM:/note="Extracellular" 84 W H b 12.7 6o9c_A Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[273 aa] GOL:EDO:PG4:SO4:PEG 1 5 1 1 1 1 0 1 1 7 0 1 1 1 1 5 1 1 68 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 85 D H e 38.3 6o9c_A TVA22_HUMAN:K7N5M3_HUMAN:Antibody heavy chain[220 aa]:T36-5 TCR beta chain[241 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:SILv44 T cell receptor alpha chain[197 aa]:Immunoglobulin light chain H2[214 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45428 TCR beta chain[287 aa]:TD08 TCR beta chain[235 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR beta chain[241 aa] TAM IOD Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[274 aa] GOL:SO4:EPE:EDO:FMT 7 0 28 30 1 6 0 1 3 7 0 5 1 1 1 6 3 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 86 Q H e 54.1 6o9c_A NEF_HV1Z6:MAG1_HUMAN:NCAP_CVHSA:Q6PIZ8_HUMAN:MYPR_HUMAN:Q9YV12_9HIV1:Q9YYU8_9HIV1:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:A0A0B4J279_HUMAN:TCA_HUMAN:TITIN_HUMAN:A0A075B6T6_HUMAN:NEF_HV1ND:A0A087WSZ9_HUMAN:K7N5N2_HUMAN:K7N5M3_HUMAN:TVAL2_HUMAN:CCND2_HUMAN:TVA22_HUMAN:PK3CA_HUMAN:NS1_INBSJ:SPIKE_SARS2:NCAP_I46A1:RDRP_I97A1:T CELL RECEPTOR ALPHA[190 aa]:Negative factor[10 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:T-cell Receptor, alpha chain[193 aa]:AHIII TCR ALPHA CHAIN[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:Antibody heavy chain[220 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:DMF5 alpha chain[199 aa]:DMF4 alpha chain[194 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:1E6 TCR Alpha Chain[200 aa]:1E6 TCR Alpha Chain[201 aa]:1E6 TCR Alpha Chain[199 aa]:C1-28 TCR alpha chain[198 aa]:10-mer peptide from Protein Nef[10 aa]:H27-14 TCR alpha chain[194 aa]:H27-14 TCR alpha chain[204 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR alpha chain[204 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Alpha Chain[197 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Mel5 TCR chain alpha[194 aa]:ESK1[212 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:Titin[9 aa]:1E6 TCR Alpha Chain[189 aa]:1E6 TCR Alpha Chain[191 aa]:A6-TCR Valpha[108 aa]:Human TCR Light Chain[204 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Protein Nef[10 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:T-cell receptor alpha variable 30,T-cell receptor,..:H7-25-F[7 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:G1/S-specific cyclin-D2[10 aa]:Mel5 TCR, alpha chain[194 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:peptide[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:302TIL TCR alpha chain[189 aa]:influenza A NP145-156 peptide[7 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:T-cell receptor alpha chain[166 aa]:a7b2 ALPHA CHAIN[192 aa]:a7b2 ALPHA CHAIN[191 aa]:Alpha chain of engineered high affinity T-cell rec..:T-cell receptor alpha chain[189 aa]:SILv44 T cell receptor alpha chain[197 aa]:T4H2 T cell receptor alpha chain[201 aa]:Immunoglobulin light chain H2[214 aa]:Heavy chain of Fab fragment 11D06[215 aa]:9-mer peptide from the HCoV spike protein[9 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:Mel5 Human TCR, alpha chain[198 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:T-cell receptor alpha chain[200 aa]:Fab heavy chain[212 aa]:Fab heavy chain[218 aa]:T cell receptor, alpha chain[185 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S1 peptide[9 aa]:Nucleoprotein peptide[9 aa]:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:10LH single chain fragment variable (scFv)[227 aa]..:HIV-1 RT[9 aa]:PN45545 TCR alpha chain[257 aa]:CMV peptide[9 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:TD08 TCR alpha chain[183 aa]:TD08 TCR beta chain[235 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR alpha chain[203 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:H25-11 TCR alpha chain[203 aa]:TCR alpha chain[198 aa]:TCR alpha chain[194 aa]:T-cell receptor alpha chain[182 aa]:T-cell receptor beta chain[239 aa]:TCR alpha chain[175 aa]:TCR beta chain[237 aa] PE8 GOL:SO4:EDO 0 0 0 7 0 8 1 0 20 1 0 9 0 13 35 0 3 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" Q->E:LB/B:-: -;Q->G:LB/B:-: -;Q->L:LB/B:-: -;Q->R:LB/B:-: -; 87 E H b 15.6 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:TVAL2_HUMAN:TCA_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:DMF5 alpha chain[199 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:C7 TCR alpha chain[185 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Light Chain[204 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:T-cell receptor alpha chain[189 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:PN45545 TCR alpha chain[257 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] MET:LEU:PE8 NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:EDO:GLY 0 0 2 49 0 5 0 0 0 5 0 5 0 14 0 6 1 9 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" E->N:LB/B:-: -;E->Q:LB/B:-: -; 88 T H b 1.3 6o9c_A CL GOL:EDO 3 0 0 0 0 0 0 0 6 3 0 5 0 0 6 10 61 3 4 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 89 R H e 63.2 6o9c_A POL_HV1MA:TCB_HUMAN:TCA_HUMAN:PME17_HUMAN:O11822_9HIV1:Q6PIZ8_HUMAN:Q6NS87_HUMAN:A2NVQ1_HUMAN:Q2YDB4_HUMAN:PP65_HCMVA:POL_HV1B1:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:Q9YYH6_9HIV1:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q9DIT6_9HEPC:A0A585_HUMAN:TRBC1_HUMAN:AMPD2_HUMAN:A0A578_HUMAN:K7N5M4_HUMAN:A0A087WZ08_HUMAN:A0A075B6T6_HUMAN:A0A0B4J277_HUMAN:K7N5M3_HUMAN:W8FN10_9FLAV:K7N5N2_HUMAN:A0A5B3_HUMAN:A0A0C4ZKA8_HUMAN:W8EGN4_9HIV1:W0GUW4_9HIV1:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:A0A087WSZ9_HUMAN:Q6PJ56_HUMAN:TVAL2_HUMAN:RTA_EBVG:TVA22_HUMAN:TVBK2_HUMAN:P53_HUMAN:NCAP_SARS2:R1AB_SARS2:SPIKE_SARS2:MAGA8_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:T CELL RECEPTOR ALPHA[115 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:T CELL RECEPTOR ALPHA[190 aa]:T CELL RECEPTOR BETA[242 aa]:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:T-cell Receptor alpha chain[194 aa]:T-cell Receptor beta chain[237 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:HUMAN T-CELL RECEPTOR[200 aa]:gag peptide[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:HYB3 HEAVY CHAIN[223 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:GAG PROTEIN[9 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor beta chain[241 aa]:T-cell receptor alpha chain[206 aa]:A6-Tcr[200 aa]:AHIII TCR BETA CHAIN[237 aa]:TCR ALPHA[194 aa]:TCR BETA[237 aa]:T-Cell Receptor, Alpha Chain[194 aa]:Hypothetical protein[241 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Alpha Chain[195 aa]:T-Cell Receptor, Beta Chain[242 aa]:AHIII TCR ALPHA CHAIN[194 aa]:HIV P17[9 aa]:65 KDA PHOSPHOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:A6 TCR alpha chain[200 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:Antibody light chain[206 aa]:Antibody heavy chain[220 aa]:Antibody light chain[212 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:Antibody light chain[211 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:T-cell Receptor, Beta Chain[244 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:10-meric peptide from Hemagglutinin[10 aa]:10-meric peptide from Genome polyprotein[10 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:T-CELL RECEPTOR, BETA CHAIN[245 aa]:DMF5 alpha chain[199 aa]:DMF5 beta chain[242 aa]:DMF4 alpha chain[195 aa]:DMF4 alpha chain[194 aa]:DMF4 beta chain[243 aa]:A6 alpha chain[200 aa]:1E6 TCR Alpha Chain[200 aa]:1E6 TCR Alpha Chain[201 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Alpha Chain[199 aa]:1E6 TCR Beta Chain[244 aa]:1E6 TCR Beta Chain[245 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:C1-28 TCR alpha chain[198 aa]:T36-5 TCR beta chain[241 aa]:JKF6 alpha chain[201 aa]:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Beta Chain[245 aa]:High Affinity TCR Alpha Chain[197 aa]:V_segment translation product, T-cell receptor bet..:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Mel5 TCR chain alpha[194 aa]:Mel5 TCR chain beta[244 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:ESK1[212 aa]:Protein TRBV5-1,Human nkt tcr beta chain[241 aa]:1E6 TCR Alpha Chain[189 aa]:1E6 TCR Alpha Chain[191 aa]:1E6 TCR Alpha Chain[197 aa]:1E6 TCR Beta Chain[247 aa]:Marker peptide[10 aa]:C7 TCR alpha chain[192 aa]:C7 TCR alpha chain[187 aa]:C25 beta[246 aa]:C25 beta[245 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:T-cell receptor beta-2 chain C region[239 aa]:T-cell receptor beta-2 chain C region[241 aa]:T-cell receptor beta-2 chain C region[238 aa]:A6-TCR Valpha[110 aa]:A6-TCR Valpha[108 aa]:Peptide G9L[9 aa]:Human TCR Light Chain[204 aa]:Human TCR Heavy Chain[244 aa]:Peptide G11N[10 aa]:M1-G4E, GILEFVFTL[9 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TCRbeta chain[241 aa]:TCRalpha chain[201 aa]:TCRbeta chain[239 aa]:TCRalpha chain[203 aa]:HCV1406 TCR alpha chain[207 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:NS5[9 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:T-cell receptor beta variable 19,TRB protein[243 a..:T-cell receptor Alpha chain[201 aa]:Human T-cell receptor beta chain[242 aa]:T-cell receptor Alpha chain[200 aa]:Human T-cell receptor beta chain[241 aa]:HUman T-cell receptor Alpha chain[200 aa]:Human T-cell receptor Beta chain[239 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell receptor alpha chain[200 aa]:Human T-cell Receptor beta chain[242 aa]:Human T-cell Receptor beta chain[241 aa]:Gag protein[9 aa]:TCR F50 alpha chain[202 aa]:T-cell receptor alpha variable 30,T-cell receptor,..:D30 TCR beta chain[244 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:T cell receptor alpha chain[191 aa]:T cell receptor alpha chain[190 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 TCR beta chain[242 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR alpha chain[195 aa]:DMF5 TCR beta chain[241 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:TRA@ protein[198 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:Mel5 TCR, alpha chain[194 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Replication and transcription activator[9 aa]:302TIL TCR alpha chain[189 aa]:302TIL TCR alpha chain[202 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:T cell receptor beta variable 11-2,Human nkt tcr b..:T-cell receptor beta chain[244 aa]:T-cell receptor alpha chain[166 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:a7b2 ALPHA CHAIN[192 aa]:DMF4 Beta CHAIN[242 aa]:a7b2 ALPHA CHAIN[191 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:Alpha chain of engineered high affinity T-cell rec..:Beta chain of high affinity engineered T-cell rece..:T-cell receptor alpha chain[189 aa]:T-cell receptor beta chain[242 aa]:SILv44 T cell receptor alpha chain[197 aa]:SILv44 T cell receptor beta chain[241 aa]:SILv44 T cell receptor alpha chain[196 aa]:T4H2 T cell receptor alpha chain[201 aa]:T4H2 T cell receptor beta chain[240 aa]:T4H2 T cell receptor beta chain[239 aa]:T-cell receptor 1a2, alfa chain[193 aa]:peptide from p53 tumor suppressor[9 aa]:T-cell receptor 1a2, alfa chain[196 aa]:Cellular tumor antigen p53 peptide[9 aa]:T-cell receptor 12-6, alfa chain[183 aa]:T-cell receptor 38-10, alfa chain[188 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin light chain H2[214 aa]:Heavy chain of Fab fragment 11D06[215 aa]:Light chain of Fab fragment 11D06[212 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:Nucleoprotein[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Spike protein S1 peptide[10 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:TRAV12-1 TCR-alpha[199 aa]:TRBV19 TCR beta[239 aa]:TRAV12-1 TCR-alpha[198 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor alpha chain[243 aa]:T-cell receptor beta chain[285 aa]:Mel5 Human TCR, alpha chain[198 aa]:Mel5 Human TCR, beta chain[244 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:T-cell receptor alpha chain[200 aa]:Fab heavy chain[212 aa]:Fab light chain[211 aa]:Fab heavy chain[218 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:T cell receptor, alpha chain[185 aa]:T cell receptor, beta chain[237 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Light Chain V2[214 aa]:Light chain[211 aa]:Heavy chain[214 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR alpha chain[257 aa]:PN45545 TCR beta chain[287 aa]:PN45428 TCR beta chain[287 aa]:REGN6972 Fab light chain[214 aa]:REGN6972 Fab heavy chain[214 aa]:Melanoma-associated antigen 4 peptide[9 aa]:H2aM31345N Fab heavy chain[207 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:TD08 TCR beta chain[235 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR beta chain[241 aa]:TCR alpha chain[198 aa]:TCR beta chain[240 aa]:TCR beta chain[242 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor beta chain[236 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR alpha chain[176 aa]:TCR beta chain[238 aa] TAM CL:IOD GOL:SO4:EDO:EPE:P4G:ACT:PEG 7 0 2 16 5 7 0 0 3 1 2 2 0 29 10 0 15 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->G:LB/B:rs1994744: -; 90 N H e 58.8 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:TCA_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:Q6PIZ8_HUMAN:MAR1_HUMAN:A2NVQ1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:H2RG00_PANTR:K7N5M9_HUMAN:A14_VACCW:AMPD2_HUMAN:A0A578_HUMAN:K7N5M4_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:K7N5M3_HUMAN:A0A075B6T6_HUMAN:M1_I34A1:NEF_HV1ND:Q80817_9DELA:A0A0B4J277_HUMAN:W8FN10_9FLAV:K7N5N2_HUMAN:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:A0A087WSZ9_HUMAN:TVAL2_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:TVA22_HUMAN:TVBK2_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:T CELL RECEPTOR ALPHA[115 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:T-cell Receptor alpha chain[194 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:Tax Peptide V7R[9 aa]:PROTEIN (human T-Cell receptor)[200 aa]:TAX PEPTIDE Y8A[9 aa]:HUMAN T-CELL RECEPTOR[200 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:HYB3 HEAVY CHAIN[223 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor alpha chain[206 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[200 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:AHIII TCR ALPHA CHAIN[194 aa]:P1049[9 aa]:TCR ALPHA[194 aa]:T-Cell Receptor, Alpha Chain[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:T-Cell Receptor, Alpha Chain[195 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR alpha chain[200 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:Antibody heavy chain[220 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 alpha chain[199 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:DMF4 alpha chain[195 aa]:DMF4 beta chain[243 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:A6 alpha chain[200 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:1E6 TCR Alpha Chain[200 aa]:1E6 TCR Alpha Chain[201 aa]:1E6 TCR Alpha Chain[199 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:C1-28 TCR alpha chain[198 aa]:H27-14 TCR alpha chain[194 aa]:H27-14 TCR alpha chain[204 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR beta chain[241 aa]:T36-5 TCR alpha chain[204 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 alpha chain[201 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Alpha Chain[196 aa]:Melanoma peptide L7A[10 aa]:High Affinity TCR Alpha Chain[197 aa]:High Affinity TCR Beta Chain[245 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain alpha[194 aa]:Mel5 TCR chain beta[244 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:ESK1[212 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Protein TRBV5-1,Human nkt tcr beta chain[241 aa]:Titin[9 aa]:Marker peptide[10 aa]:1E6 TCR Alpha Chain[189 aa]:1E6 TCR Alpha Chain[191 aa]:1E6 TCR Alpha Chain[197 aa]:C7 TCR alpha chain[185 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C7 TCR alpha chain[192 aa]:C7 TCR alpha chain[187 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:Melanoma derived Mart-1 peptide[10 aa]:A6-TCR Valpha[110 aa]:A6-TCR Valpha[108 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Light Chain[204 aa]:PF6 TCR alpha chain[191 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:TCRalpha chain[200 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:HCV1406 TCR alpha chain[207 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:Gag protein[9 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:T-cell receptor alpha variable 30,T-cell receptor,..:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:NS3 peptide[10 aa]:T cell receptor alpha chain[191 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:T cell receptor alpha chain[190 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:DMF5 TCR alpha chain[189 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR alpha chain[195 aa]:ALK[10 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:302TIL TCR alpha chain[189 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:302TIL TCR alpha chain[202 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:T cell receptor beta variable 11-2,Human nkt tcr b..:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:T-cell receptor alpha chain[166 aa]:T-cell receptor alpha chain[188 aa]:a7b2 ALPHA CHAIN[192 aa]:a7b2 ALPHA CHAIN[191 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Alpha chain of engineered high affinity T-cell rec..:Beta chain of high affinity engineered T-cell rece..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:T-cell receptor alpha chain[189 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:SILv44 T cell receptor alpha chain[197 aa]:Melanocyte protein PMEL[9 aa]:SILv44 T cell receptor alpha chain[196 aa]:T4H2 T cell receptor alpha chain[201 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:Heavy chain of Fab fragment 11D06[215 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pRLQ3 T cell receptor alpha chain[200 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:TRAV12-1 TCR-alpha[199 aa]:TRAV12-1 TCR-alpha[198 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:TCR alpha[191 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TCR alpha[181 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor alpha chain[243 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, alpha chain[198 aa]:Mel5 Human TCR, beta chain[244 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:T-cell receptor alpha chain[200 aa]:Fab heavy chain[212 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Fab heavy chain[218 aa]:Tyrosinase peptide[9 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:T cell receptor, alpha chain[185 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:IgG, Fab Light Chain V2[214 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Light chain[211 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:10LH single chain fragment variable (scFv)[227 aa]..:HIV-1 RT[9 aa]:PN45545 TCR alpha chain[257 aa]:Melanoma-associated antigen 4[10 aa]:PN45428 TCR beta chain[287 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:TD08 TCR alpha chain[183 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR alpha chain[203 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:H25-11 TCR alpha chain[203 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:TCR alpha chain[198 aa]:TCR beta chain[240 aa]:TCR alpha chain[194 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:T-cell receptor alpha chain[183 aa]:KRAS-G12V nonamer peptide[9 aa]:T-cell receptor alpha chain[182 aa]:T-cell receptor beta chain[239 aa]:TCR alpha chain[175 aa]:TCR beta chain[237 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa] MET:LEU:PE8 NA:MG Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:SO4:EDO:PG4:ACY:GLY:P4G:PEG 6 0 17 3 0 0 0 12 14 11 3 14 0 0 2 12 4 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" N->K:LB/B:rs1994744: -; 91 V H b 3.3 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:POL_HV1Z2:MAGA3_HUMAN:PME17_HUMAN:MAG1_HUMAN:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:R4P6M5_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:MAGAA_HUMAN:TYRO_HUMAN:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA4_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:octapeptide from Melan-A/MART-1[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[10 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Insulin[10 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Matrix protein 1[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:NS5[9 aa]:Gag protein[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS3 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Nucleoprotein peptide[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S1 peptide[9 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa] MET:LEU CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. EDO 13 1 5 0 6 3 0 6 0 42 1 0 0 6 0 3 1 3 9 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" V->M:LB/B:-: -; 92 K H e 43.9 6o9c_A TCB_HUMAN:TCA_HUMAN:Q6NS87_HUMAN:Q2YDB4_HUMAN:A0A087WZ08_HUMAN:Q6PJ56_HUMAN:T CELL RECEPTOR ALPHA[115 aa]:T-cell Receptor beta chain[237 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:HUMAN T-CELL RECEPTOR[200 aa]:HYB3 HEAVY CHAIN[223 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor beta chain[241 aa]:A6-Tcr[200 aa]:AHIII TCR BETA CHAIN[237 aa]:TCR BETA[237 aa]:Hypothetical protein[241 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Beta Chain[242 aa]:A6 TCR alpha chain[200 aa]:Antibody light chain[212 aa]:Antibody light chain[211 aa]:T-cell Receptor, Beta Chain[244 aa]:DMF4 beta chain[243 aa]:A6 alpha chain[200 aa]:C1-28 TCR alpha chain[198 aa]:H27-14 TCR beta chain[242 aa]:T36-5 TCR beta chain[241 aa]:High Affinity TCR Beta Chain[245 aa]:Mel5 TCR chain beta[244 aa]:C25 beta[246 aa]:C25 beta[245 aa]:T-cell receptor beta-2 chain C region[239 aa]:T-cell receptor beta-2 chain C region[241 aa]:T-cell receptor beta-2 chain C region[242 aa]:JM22 TCR beta chain[240 aa]:Human T-cell receptor beta chain[242 aa]:Human T-cell receptor Beta chain[240 aa]:D30 TCR beta chain[244 aa]:V-delta chain of T cell receptor[207 aa]:TRA@ protein[198 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:Beta chain of high affinity engineered T-cell rece..:T4H2 T cell receptor beta chain[240 aa]:T-cell receptor 1a2, alfa chain[193 aa]:T-cell receptor 1a2, alfa chain[196 aa]:T-cell receptor 12-6, alfa chain[183 aa]:Immunoglobulin light chain H2[214 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor beta chain[285 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Fab light chain[211 aa]:T cell receptor, beta chain[237 aa]:IgG, Fab Light Chain V2[214 aa]:REGN6972 Fab light chain[214 aa]:TD08 TCR beta chain[235 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR beta chain[241 aa]:TCR beta chain[237 aa] CL GOL:SO4:PEG:EDO 0 0 0 7 6 0 0 0 42 2 0 0 3 10 19 6 6 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 93 A H e 41.1 6o9c_A CORA_HBVIL:TCB_HUMAN:TCA_HUMAN:NEF_HV1Z6:PME17_HUMAN:NCAP_CVHSA:O11822_9HIV1:Q6PIZ8_HUMAN:Q6NS87_HUMAN:A2NVQ1_HUMAN:Q2YDB4_HUMAN:CO024_HUMAN:MYPR_HUMAN:N4BP2_HUMAN:VME1_CVHSA:CTG1B_HUMAN:Q1WDM0_9INFA:Q9DIT6_9HEPC:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:Q9YYU8_9HIV1:INS_HUMAN:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:H2RG00_PANTR:K7N5M9_HUMAN:A14_VACCW:LSP1_HUMAN:AMPD2_HUMAN:A0A578_HUMAN:K7N5M4_HUMAN:A0A087WZ08_HUMAN:E9P5U1_9INFA:A0A075B6T6_HUMAN:A0A0K0K1A5_HUMAN:M1_I34A1:A0A0B4J277_HUMAN:K7N5M3_HUMAN:K7N5N2_HUMAN:W0GUW4_9HIV1:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:A0A5B3_HUMAN:A0A0C4ZKA8_HUMAN:Q6PJ56_HUMAN:A0A1B0GXE1_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:TVBK2_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:PK3CA_HUMAN:R1AB_SARS2:PHX2B_HUMAN:SPIKE_SARS2:RASN_HUMAN:NCAP_INBSI:M1_INBAC:I27RA_HUMAN:NCAP_I46A1:NCAP_SARS2:MAGA4_HUMAN:T CELL RECEPTOR ALPHA[115 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:T CELL RECEPTOR ALPHA[190 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:9 RESIDUE PEPTIDE[9 aa]:self-peptide P1049[9 aa]:T-cell Receptor alpha chain[194 aa]:T-cell Receptor beta chain[237 aa]:GILGFVFTL[9 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:PROTEIN (human T-Cell receptor)[243 aa]:HUMAN T-CELL RECEPTOR[200 aa]:HUMAN T-CELL RECEPTOR[243 aa]:Negative factor[10 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:HYB3 HEAVY CHAIN[223 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:GAG PROTEIN[9 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor beta chain[241 aa]:T-cell receptor alpha chain[206 aa]:A6-Tcr[200 aa]:A6-Tcr[243 aa]:SELF-PEPTIDE P1049[9 aa]:AHIII TCR BETA CHAIN[237 aa]:P1049[9 aa]:TCR ALPHA[194 aa]:T-Cell Receptor, Alpha Chain[194 aa]:Hypothetical protein[241 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Alpha Chain[195 aa]:T-Cell Receptor, Beta Chain[242 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:AHIII TCR ALPHA CHAIN[194 aa]:FLU MATRIX PEPTIDE[9 aa]:JM22 TCR BETA CHAIN[240 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:MYELIN PROTEOLIPID PROTEIN[9 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:A6 TCR alpha chain[200 aa]:A6 TCR beta chain[245 aa]:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:Antibody light chain[206 aa]:Antibody heavy chain[220 aa]:NYESO-1 peptide[9 aa]:Antibody light chain[212 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:TRBV6-5 protein[245 aa]:Antibody light chain[211 aa]:Membrane protein[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:10-meric peptide from Genome polyprotein[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:DMF5 beta chain[242 aa]:DMF4 alpha chain[195 aa]:DMF4 beta chain[242 aa]:DMF4 alpha chain[194 aa]:DMF4 beta chain[243 aa]:A6 alpha chain[200 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:C1-28 TCR alpha chain[198 aa]:H27-14 TCR alpha chain[194 aa]:H27-14 TCR beta chain[242 aa]:H27-14 TCR alpha chain[204 aa]:T36-5 TCR beta chain[241 aa]:JKF6 alpha chain[201 aa]:A6 beta chain[245 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:High Affinity TCR Beta Chain[245 aa]:Core protein[9 aa]:Nucleocapsid protein[11 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:peptide from Virion membrane protein A14[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Mel5 TCR chain beta[244 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:Protein TRBV5-1,Human nkt tcr beta chain[241 aa]:Marker peptide[10 aa]:C7 TCR alpha chain[185 aa]:C7 TCR alpha chain[192 aa]:C7 TCR alpha chain[187 aa]:C25 beta[246 aa]:C25 beta[245 aa]:T-cell receptor beta-2 chain C region[239 aa]:T-cell receptor beta-2 chain C region[241 aa]:Matrix protein 1[9 aa]:T-cell receptor beta-2 chain C region[242 aa]:T-cell receptor beta-2 chain C region[238 aa]:A6-TCR Valpha[110 aa]:A6-TCR Vbeta[115 aa]:A6-TCR Valpha[108 aa]:A6-TCR Vbeta[114 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Light Chain[204 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR beta chain[237 aa]:Epstein Barr Virus, Latent membrane protein-2 epit..:M1-F5L, GILGLVFTL[9 aa]:JM22 TCR beta chain[240 aa]:M1-G4E, GILEFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TCRbeta chain[241 aa]:Influenza M1(58-66) peptide[9 aa]:TCRbeta chain[239 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:MVWGPDPLYV[10 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:T-cell receptor Alpha chain[201 aa]:Human T-cell receptor beta chain[242 aa]:T-cell receptor Alpha chain[200 aa]:Human T-cell receptor beta chain[241 aa]:HUman T-cell receptor Alpha chain[200 aa]:Human T-cell receptor Beta chain[239 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell receptor alpha chain[200 aa]:Human T-cell Receptor beta chain[242 aa]:Gag protein[9 aa]:Human T-cell Receptor beta chain[241 aa]:T-cell receptor beta variable 19,TRB protein[243 a..:TCR F50 alpha chain[202 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:D30 TCR beta chain[244 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:H7-25[11 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor beta chain[241 aa]:T cell receptor beta chain[242 aa]:T cell receptor beta chain[239 aa]:DMF5 TCR beta chain[242 aa]:DMF5 TCR beta chain[241 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:TRA@ protein[198 aa]:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:G1/S-specific cyclin-D2[10 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:MTB[9 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:302TIL TCR alpha chain[189 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:T cell receptor beta variable 11-2,Human nkt tcr b..:Cancer/testis antigen 1[9 aa]:T-cell receptor beta chain[244 aa]:T-cell receptor alpha chain[166 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor alpha chain[194 aa]:T-cell receptor beta chain[239 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:Beta chain of high affinity engineered T-cell rece..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:T-cell receptor beta chain[242 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:SILv44 T cell receptor alpha chain[197 aa]:SILv44 T cell receptor beta chain[241 aa]:Melanocyte protein PMEL[9 aa]:SILv44 T cell receptor alpha chain[196 aa]:T-cell receptor 1a2, alfa chain[193 aa]:T-cell receptor 1a2, alfa chain[196 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:T-cell receptor 12-6, alfa chain[183 aa]:TCR 12-6, beta chain[244 aa]:T-cell receptor 38-10, alfa chain[188 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:Light chain of Fab fragment 11D06[212 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S2[9 aa]:Spike protein S1[9 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:TCR alpha[191 aa]:TCR beta[246 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TCR alpha[181 aa]:TCR beta[245 aa]:TCR alpha[163 aa]:TCR beta[244 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor beta chain[285 aa]:Mel5 Human TCR, beta chain[244 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:T-cell receptor alpha chain[200 aa]:Fab light chain[211 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:T cell receptor, beta chain[237 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:IgG, Fab Light Chain V2[214 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S1 peptide[9 aa]:Light chain[211 aa]:Nucleoprotein peptide[9 aa]:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:NY-ESO-1 peptide[9 aa]:Melanoma-associated antigen 4[10 aa]:REGN6972 Fab light chain[214 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:TD08 TCR beta chain[235 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR beta chain[241 aa]:TCR beta chain[240 aa]:TCR alpha chain[194 aa]:TCR beta chain[242 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor beta chain[236 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa]:TCR beta chain[238 aa] IOD GOL:PEG:EDO 19 0 10 22 0 21 4 3 4 0 0 9 0 0 2 5 1 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 94 Q H b 14.8 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:KPCD2_HUMAN:LSP1_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:Q6PJ56_HUMAN:A0A1B0GXE1_HUMAN:K7N5M4_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:DMF5 beta chain[242 aa]:MART-1(27-35) peptide[10 aa]:DMF4 beta chain[242 aa]:DMF4 beta chain[243 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:T36-5 TCR beta chain[241 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 beta chain[241 aa]:JKF6 beta chain[240 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Beta Chain[245 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain beta[244 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR beta chain[241 aa]:ALK[10 aa]:TRA@ protein[198 aa]:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Beta chain of high affinity engineered T-cell rece..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, beta chain[244 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:TCR alpha chain[194 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:T-cell receptor beta chain[236 aa]:KRAS-G12V nonamer peptide[9 aa]:T-cell receptor beta chain[239 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR beta chain[238 aa] MET CL:NA:MG Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO 0 0 1 10 1 0 4 0 8 3 8 15 0 20 6 1 3 9 11 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" Q->H:LB/B:rs7830686: -; 95 S H e 25.0 6o9c_A Q2YDB4_HUMAN:T-cell receptor, beta chain[243 aa]:Hypothetical protein[242 aa] NA GOL:SO4:PEG:EDO 19 0 6 34 8 9 0 0 0 0 0 6 0 5 0 1 9 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 96 Q H e 72.4 6o9c_A TAT_HTL1C:TCB_HUMAN:TCA_HUMAN:NEF_HV1Z6:Q6NS87_HUMAN:Q2YDB4_HUMAN:TAX_HTL1F:A0A585_HUMAN:TRBC1_HUMAN:KI2S2_HUMAN:LSP1_HUMAN:A0A087WZ08_HUMAN:A0A0K0K1A5_HUMAN:K7N5M4_HUMAN:A0A5B3_HUMAN:A0A0C4ZKA8_HUMAN:Q6PJ56_HUMAN:A0A1B0GXE1_HUMAN:TVBK2_HUMAN:HHAT_HUMAN:P53_HUMAN:I27RA_HUMAN:TAX PEPTIDE[9 aa]:T CELL RECEPTOR BETA[209 aa]:T CELL RECEPTOR BETA[242 aa]:T-cell Receptor beta chain[237 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:TAX PEPTIDE P6A[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:PROTEIN (human T-Cell receptor)[243 aa]:HUMAN T-CELL RECEPTOR[200 aa]:HUMAN T-CELL RECEPTOR[243 aa]:Negative factor[10 aa]:HYB3 HEAVY CHAIN[223 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor beta chain[241 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[200 aa]:A6-Tcr[243 aa]:AHIII TCR BETA CHAIN[237 aa]:TCR BETA[237 aa]:Hypothetical protein[241 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Beta Chain[242 aa]:JM22 TCR BETA CHAIN[240 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR alpha chain[200 aa]:A6 TCR beta chain[245 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:Antibody light chain[206 aa]:Antibody light chain[212 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:TRBV6-5 protein[245 aa]:Antibody light chain[211 aa]:T-cell Receptor, Beta Chain[244 aa]:Tax peptide[9 aa]:T-CELL RECEPTOR, BETA CHAIN[245 aa]:HuD peptide[9 aa]:DMF5 beta chain[242 aa]:DMF4 beta chain[242 aa]:DMF4 beta chain[243 aa]:TAX(Y5F) peptide[9 aa]:A6 alpha chain[200 aa]:A6 beta chain[245 aa]:1E6 TCR Beta Chain[244 aa]:1E6 TCR Beta Chain[245 aa]:H27-14 TCR beta chain[242 aa]:T36-5 TCR beta chain[241 aa]:Protein Tax-1[9 aa]:JKF6 beta chain[241 aa]:JKF6 beta chain[240 aa]:High Affinity TCR Beta Chain[245 aa]:V_segment translation product, T-cell receptor bet..:Killer cell immunoglobulin-like receptor 2DS2[190 ..:Lymphocyte-specific protein 1[12 aa]:Mel5 TCR chain beta[244 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Beta Chain[247 aa]:C7 TCR alpha chain[185 aa]:C7 TCR beta chain[226 aa]:C7 TCR alpha chain[192 aa]:C7 TCR alpha chain[187 aa]:C7 TCR beta chain[235 aa]:C7 TCR beta chain[238 aa]:C25 beta[246 aa]:C25 beta[245 aa]:T-cell receptor beta-2 chain C region[239 aa]:T-cell receptor beta-2 chain C region[241 aa]:T-cell receptor beta-2 chain C region[242 aa]:T-cell receptor beta-2 chain C region[238 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR beta chain[237 aa]:JM22 TCR beta chain[240 aa]:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TCRbeta chain[241 aa]:TCRbeta chain[239 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:Protein TRBV6-5,Human nkt tcr beta chain[240 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:T-cell receptor beta variable 19,TRB protein[243 a..:Human T-cell receptor beta chain[242 aa]:Human T-cell receptor beta chain[241 aa]:Human T-cell receptor Beta chain[239 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell Receptor beta chain[242 aa]:Human T-cell Receptor beta chain[241 aa]:TCR F50 alpha chain[202 aa]:TCR F50 beta chain[240 aa]:D30 TCR beta chain[244 aa]:T cell receptor beta chain[241 aa]:T cell receptor beta chain[242 aa]:T cell receptor beta chain[239 aa]:DMF5 TCR beta chain[242 aa]:DMF5 TCR beta chain[241 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:TRA@ protein[198 aa]:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:302TIL TCR beta chain[245 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:302TIL TCR beta chain[244 aa]:T cell receptor beta variable 11-2,Human nkt tcr b..:T-cell receptor beta chain[244 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:Beta chain of high affinity engineered T-cell rece..:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:SILv44 T cell receptor beta chain[241 aa]:T4H2 T cell receptor beta chain[240 aa]:T4H2 T cell receptor beta chain[239 aa]:T-cell receptor 1a2, alfa chain[193 aa]:T-cell receptor 1a2, alfa chain[196 aa]:Cellular tumor antigen p53 peptide[9 aa]:T-cell receptor 12-6, alfa chain[183 aa]:TCR 12-6, beta chain[244 aa]:Immunoglobulin light chain H2[214 aa]:T cell receptor, beta chain[247 aa]:pYLQ7 T cell receptor beta chain[240 aa]:TRBV19 TCR beta[239 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:TCR beta[246 aa]:TCR beta[245 aa]:TCR alpha[163 aa]:TCR beta[244 aa]:TCR alpha[179 aa]:T-cell receptor (TRBV/TRBC)[240 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain (TRBV/TRBC)[238 aa]:T-cell receptor beta chain[285 aa]:Mel5 Human TCR, beta chain[244 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:T-cell receptor beta chain[238 aa]:Fab light chain[211 aa]:TIL1383i (h3T) T cell receptor beta chain[247 aa]:T cell receptor, beta chain[237 aa]:YLQ-SG3 TCR beta chain (TRBV7-9)[239 aa]:IgG, Fab Light Chain V2[214 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Light chain[211 aa]:T-cell receptor beta chain[242 aa]:10LH single chain fragment variable (scFv)[227 aa]..:REGN6972 Fab light chain[214 aa]:H2aM31345N Fab heavy chain[207 aa]:H2aM31345N Fab light chain[214 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:TD08 TCR beta chain[235 aa]:H25-11 TCR beta chain[241 aa]:TCR beta chain[240 aa]:TCR beta chain[242 aa]:T-cell receptor beta chain[236 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR beta chain[238 aa] MG GOL:SO4:PEG:EDO 0 0 3 25 0 0 3 3 6 1 3 0 6 41 6 0 0 0 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 97 T H e 40.9 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:TCB_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:Q6NS87_HUMAN:MAR1_HUMAN:Q2YDB4_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:KPCD2_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:LSP1_HUMAN:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:A0A087WZ08_HUMAN:A0A0K0K1A5_HUMAN:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:Q6PJ56_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:TVBK2_HUMAN:K7N5M4_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:PROTEIN (human T-Cell receptor)[243 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:HYB3 HEAVY CHAIN[223 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor beta chain[241 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[243 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:Hypothetical protein[241 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Beta Chain[242 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:JM22 TCR BETA CHAIN[240 aa]:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR beta chain[245 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:Antibody light chain[206 aa]:Antibody light chain[212 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:Antibody light chain[211 aa]:T-cell Receptor, Beta Chain[244 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 beta chain[242 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:DMF4 beta chain[242 aa]:DMF4 beta chain[243 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:A6 beta chain[245 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:H27-14 TCR beta chain[242 aa]:T36-5 TCR beta chain[241 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:JKF6 beta chain[241 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 beta chain[240 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Beta Chain[245 aa]:Melanoma peptide L7A[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain beta[244 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:C7 TCR alpha chain[185 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C7 TCR alpha chain[187 aa]:C25 beta[246 aa]:C25 beta[245 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:T-cell receptor beta-2 chain C region[241 aa]:T-cell receptor beta-2 chain C region[242 aa]:Melanoma derived Mart-1 peptide[10 aa]:A6-TCR Vbeta[115 aa]:A6-TCR Vbeta[114 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR beta chain[239 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:JM22 TCR beta chain[240 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:TCRbeta chain[241 aa]:Influenza M1(58-66) peptide[9 aa]:TCRbeta chain[239 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:D30 TCR beta chain[244 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25[11 aa]:T cell receptor beta chain[241 aa]:NS3 peptide[10 aa]:T cell receptor beta chain[242 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:T cell receptor beta chain[239 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR beta chain[241 aa]:ALK[10 aa]:TRA@ protein[198 aa]:G1/S-specific cyclin-D2[10 aa]:Mel5 TCR, beta chain[244 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:T cell receptor beta variable 11-2,Human nkt tcr b..:Cancer/testis antigen 1[9 aa]:T-cell receptor beta chain[244 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Beta chain of high affinity engineered T-cell rece..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:SILv44 T cell receptor beta chain[241 aa]:Melanocyte protein PMEL[9 aa]:T-cell receptor 1a2, alfa chain[193 aa]:peptide from p53 tumor suppressor[9 aa]:T-cell receptor 1a2, alfa chain[196 aa]:Cellular tumor antigen p53 peptide[9 aa]:TCR 12-6, beta chain[244 aa]:Immunoglobulin light chain H2[214 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pYLQ7 T cell receptor beta chain[240 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:TCR beta[246 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TCR beta[245 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:TCR beta[244 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, beta chain[244 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:TIL1383i (h3T) T cell receptor beta chain[247 aa]:6-11 T cell receptor alpha chain[200 aa]:T cell receptor, beta chain[237 aa]:YLQ-SG3 TCR beta chain (TRBV7-9)[239 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Heavy Chain V2[216 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Light chain[211 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:T-cell receptor beta chain[242 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:10LH single chain fragment variable (scFv)[227 aa]..:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:H2aM31345N Fab heavy chain[207 aa]:TLF: TLFDEPPPL[9 aa]:TD08 TCR beta chain[235 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR beta chain[240 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:H25-11 TCR beta chain[241 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:TCR beta chain[240 aa]:TCR alpha chain[194 aa]:TCR beta chain[242 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:T-cell receptor beta chain[236 aa]:KRAS-G12V nonamer peptide[9 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR beta chain[238 aa] NA:MG Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4 2 0 3 0 2 0 0 11 2 12 8 1 0 10 6 9 19 14 1 0 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular" T->I:LB/B:rs1994744: -; 98 D H b 0.0 6o9c_A Q9YXL6_9INFA:IBPL1_HUMAN:RASN_HUMAN:RDRP_I97A1:SPIKE_SARS2:NY-ESO-1 peptide analogue S9S[9 aa]:citrulline variant HA-1 peptide[9 aa]:RNA-directed RNA polymerase catalytic subunit[8 aa..:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:Peptide G11N[10 aa]:G9V[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:MTB[9 aa]:influenza A NP145-156 peptide[7 aa]:Insulin-like growth factor-binding protein-like 1 ..:KRAS G12D peptide (VVVGADGVGK)[10 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:PB1 peptide[8 aa]:NY-ESO-1 peptide[9 aa]:CMV peptide[9 aa]:Spike protein S2' [10 aa] ARG MG SO4:EDO 0 0 9 14 33 0 0 0 0 23 0 6 0 0 0 1 0 0 0 10 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" D->H:LB/B:-: -;D->N:LB/B:-: -; 99 R H e 50.6 6o9c_A TCB_HUMAN:Q2YDB4_HUMAN:KI2S2_HUMAN:A0A087WZ08_HUMAN:Q6PJ56_HUMAN:A0A1B0GXE1_HUMAN:K7N5M4_HUMAN:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:HYB3 HEAVY CHAIN[223 aa]:T-cell receptor, beta chain[243 aa]:Hypothetical protein[241 aa]:Hypothetical protein[242 aa]:JM22 TCR BETA CHAIN[240 aa]:Antibody light chain[212 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:Antibody light chain[211 aa]:T-cell Receptor, Beta Chain[244 aa]:T-CELL RECEPTOR, BETA CHAIN[245 aa]:DMF4 beta chain[242 aa]:1E6 TCR Beta Chain[245 aa]:H27-14 TCR beta chain[242 aa]:High Affinity TCR Beta Chain[245 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:Mel5 TCR chain beta[244 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Beta Chain[247 aa]:1E6 TCR Beta Chain[244 aa]:C7 TCR beta chain[238 aa]:C25 beta[246 aa]:C25 beta[245 aa]:T-cell receptor beta-2 chain C region[242 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR beta chain[237 aa]:JM22 TCR beta chain[240 aa]:TCRbeta chain[241 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:Human T-cell receptor beta chain[242 aa]:Human T-cell receptor beta chain[241 aa]:Human T-cell Receptor beta chain[242 aa]:T cell receptor beta chain[241 aa]:T cell receptor beta chain[242 aa]:T cell receptor beta chain[239 aa]:TRA@ protein[198 aa]:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:302TIL TCR beta chain[245 aa]:302TIL TCR beta chain[244 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:Beta chain of high affinity engineered T-cell rece..:SILv44 T cell receptor beta chain[241 aa]:TCR 12-6, beta chain[244 aa]:TCR repeptor 38-10, beta chain[242 aa]:Immunoglobulin light chain H2[214 aa]:T cell receptor, beta chain[247 aa]:TRBV19 TCR beta[239 aa]:TCR beta[246 aa]:TCR beta[245 aa]:TCR beta[244 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain[285 aa]:Mel5 Human TCR, beta chain[244 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Fab light chain[211 aa]:TIL1383i (h3T) T cell receptor beta chain[247 aa]:6-11 T cell receptor beta chain[243 aa]:T cell receptor, beta chain[237 aa]:IgG, Fab Light Chain V2[214 aa]:T-cell receptor beta chain[242 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa] NA GOL:SO4:EDO:PEG 0 0 0 5 0 0 1 4 10 19 3 0 0 1 48 0 2 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 100 V H e 57.3 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:MAGA4_HUMAN:TCB_HUMAN:POL_HV1Z2:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:Q2YDB4_HUMAN:Q6NS87_HUMAN:PP65_HCMVA:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:NCAP_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:POLG_HCVJ1:Q9YJW5_HBV:Q9YV12_9HIV1:Q9YYU8_9HIV1:Q9Q5D4_9HIV1:TAX_HTL1F:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:R4X2K3_9INFA:A0A585_HUMAN:TRBC1_HUMAN:KI2S2_HUMAN:KPCD2_HUMAN:AMPD2_HUMAN:A0A087WZ08_HUMAN:M1_I34A1:Q80817_9DELA:A0A5B3_HUMAN:A0A0C4ZKA8_HUMAN:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:K7N5M4_HUMAN:Q6PJ56_HUMAN:A0A1B0GXE1_HUMAN:CCND2_HUMAN:RETR2_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:KI3L1_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:PHX2B_HUMAN:TAX PEPTIDE[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:GILGFVFTL[9 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:HYB3 HEAVY CHAIN[223 aa]:Trans-activating transcriptional regulatory peptid..:SYNTHETIC PEPTIDE[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:T-cell receptor, beta chain[243 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:Hypothetical protein[241 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Beta Chain[242 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:JM22 TCR BETA CHAIN[240 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:Antibody light chain[211 aa]:CANCER/MART-1[10 aa]:T-cell Receptor, Beta Chain[244 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:10-meric peptide from Melanoma antigen recognized ..:Wilms tumor protein[9 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 beta chain[242 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:DMF4 beta chain[242 aa]:DMF4 beta chain[243 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:1E6 TCR Beta Chain[244 aa]:1E6 TCR Beta Chain[245 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:H27-14 TCR beta chain[242 aa]:T36-5 TCR beta chain[241 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 beta chain[241 aa]:JKF6 beta chain[240 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:High Affinity TCR Beta Chain[245 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:Nucleoprotein[11 aa]:V_segment translation product, T-cell receptor bet..:Killer cell immunoglobulin-like receptor 2DS2[190 ..:Serine/threonine-protein kinase D2[9 aa]:AMP deaminase 2[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain beta[244 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:Marker peptide[10 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Beta Chain[247 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C7 TCR beta chain[226 aa]:C7 TCR beta chain[235 aa]:C7 TCR beta chain[238 aa]:C25 beta[246 aa]:C25 beta[245 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:T-cell receptor beta-2 chain C region[238 aa]:Melanoma derived Mart-1 peptide[10 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR beta chain[239 aa]:Matrix protein 1[9 aa]:M1-F5L, GILGLVFTL[9 aa]:JM22 TCR beta chain[240 aa]:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TAX protein[9 aa]:TCRbeta chain[241 aa]:TCRbeta chain[239 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:T-cell receptor beta variable 19,TRB protein[243 a..:Gag protein[9 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:D30 TCR beta chain[244 aa]:H7-25-F[5 aa]:T cell receptor beta chain[241 aa]:T cell receptor beta chain[242 aa]:T cell receptor beta chain[239 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:TRA@ protein[198 aa]:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:G1/S-specific cyclin-D2[10 aa]:Mel5 TCR, beta chain[244 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Reticulophagy regulator 2[9 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:Replication and transcription activator[9 aa]:Melanoma antigen variant[9 aa]:302TIL TCR beta chain[245 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:302TIL TCR beta chain[244 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Beta chain of high affinity engineered T-cell rece..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:SILv44 T cell receptor beta chain[241 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:TCR 12-6, beta chain[244 aa]:TCR repeptor 38-10, beta chain[242 aa]:Immunoglobulin light chain H2[214 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:Nucleoprotein[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Spike protein S1[9 aa]:pRLQ3 T cell receptor beta chain[243 aa]:pYLQ7 T cell receptor beta chain[240 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:TCR beta[246 aa]:TCR beta[245 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:TCR beta[244 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain (TRBV/TRBC)[238 aa]:T-cell receptor beta chain[285 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, beta chain[244 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:T-cell receptor beta chain[238 aa]:Fab light chain[211 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:TIL1383i (h3T) T cell receptor beta chain[247 aa]:6-11 T cell receptor beta chain[243 aa]:YLQ-SG3 TCR beta chain (TRBV7-9)[239 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:IgG, Fab Light Chain V2[214 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:10LH single chain fragment variable (scFv)[227 aa]..:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:H2aM31345N Fab heavy chain[207 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:Spike protein S2[9 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:H25-11 TCR beta chain[241 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:TCR beta chain[240 aa]:TCR beta chain[242 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:TCR beta chain[239 aa] 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. GOL:EDO:SO4 4 0 4 14 0 3 0 9 0 11 3 0 0 0 3 1 1 46 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" V->A:LB/B:-: -;V->E:LB/B:rs1071742: -; 101 D H e 32.7 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG:MET NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. ALA:SO4:GOL:GLY:EDO:ACT 4 0 30 17 7 4 0 0 0 0 4 13 0 0 0 7 8 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" D->N:LB/B:rs1136688: -;D->S:LB/B:-: -; 102 L H b 5.6 6o9c_A CL:IOD GOL:SO4:EDO:PEG:FMT 0 0 0 0 9 0 0 12 0 65 3 0 0 0 5 0 0 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 103 G H e 41.7 6o9c_A KI2S2_HUMAN:KI3L1_HUMAN:HYB3 LIGHT CHAIN[210 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:T-cell receptor beta chain[235 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:Human T-cell Receptor 4C6, beta Chain[240 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:IgG, Fab Heavy Chain V2[216 aa] NA:CL 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. GOL:SO4:EDO:ACT:PEG 10 0 4 8 6 7 0 3 9 6 0 2 0 8 22 2 0 5 6 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 104 T H e 26.6 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:KI2S2_HUMAN:A14_VACCW:AMPD2_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11803_9HIV1:W0GUW4_9HIV1:CCND2_HUMAN:TPSN_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:KI3L1_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:HYB3 LIGHT CHAIN[210 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:Antibody light chain[211 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:G9V[9 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Tapasin[364 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:TCR repeptor 38-10, beta chain[242 aa]:Immunoglobulin heavy chain H2[223 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pRLQ3 T cell receptor beta chain[243 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Tapasin[348 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Heavy Chain V2[216 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG:MET CL 1A24_HUMAN:Q53Z42_HUMAN:HLA class I histocompatibility antigen, A-24 alpha..:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:PGE:EDO:SO4:ACT:PEG 2 0 8 8 6 0 4 10 1 0 2 6 0 1 5 0 35 0 0 10 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 105 L H b 5.1 6o9c_A CORA_HBVIL:M1_IAPUE:POL_HV1MA:TAT_HTL1C:MAGA4_HUMAN:POL_HV1Z2:ERBB2_HUMAN:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:INS_HUMAN:TAX_HTL1F:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:TERT_HUMAN:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:TAX PEPTIDE[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:65 KDA PHOSPHOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:Latent membrane protein 2[9 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Telomerase reverse transcriptase[9 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Spike protein S1[9 aa]:Spike protein S2[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Heavy Chain V2[216 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:Nucleoprotein peptide[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG 13 0 0 2 0 0 0 23 0 49 3 0 0 3 0 0 5 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 106 R H e 30.4 6o9c_A KI2S2_HUMAN:HYB3 LIGHT CHAIN[210 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:6-11 T cell receptor beta chain[243 aa]:IgG, Fab Heavy Chain V2[216 aa] CL GOL:SO4:EDO:ACT:PEG:FMT 2 0 0 15 2 0 0 3 10 24 9 0 0 11 11 0 4 9 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 107 G H e 57.1 6o9c_A TPSN_HUMAN:KI3L1_HUMAN:T-cell receptor, beta chain[243 aa]:Tapasin[364 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:IgG, Fab Heavy Chain V2[216 aa] NA 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. SO4:PGE:GOL:PEG 8 0 9 5 0 38 1 0 6 0 0 4 0 2 14 2 3 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 108 Y H e 26.1 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:TPSN_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:KI3L1_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:HYB3 LIGHT CHAIN[210 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:T-cell receptor, beta chain[243 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:Tapasin[364 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Tapasin[348 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Heavy Chain V2[216 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG CL 1A24_HUMAN:Q53Z42_HUMAN:HLA class I histocompatibility antigen, A-24 alpha..:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:PGE:SO4:MES:EDO:ACT:PEG 0 0 0 0 16 0 10 3 0 5 4 6 0 12 3 0 0 2 0 37 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular" 109 Y T e 28.7 6o9c_A IOD 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:EDO:MES:SO4:PG4:PEG 5 0 4 5 0 2 3 14 6 5 4 0 0 2 6 0 0 0 0 41 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 110 N T e 90.3 6o9c_A CALR_HUMAN:T-cell receptor, beta chain[243 aa]:Calreticulin[364 aa]:IgG, Fab Heavy Chain V2[216 aa] NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. GOL:SO4:MES:EDO 4 0 7 1 0 2 4 0 5 0 0 53 2 0 11 10 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":MUTAGEN:/note="N->Q: Impairs the recruitment of HLA-A*02 in the peptide-loading complex.":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":MUTAGEN:/note="N->Q: Impairs the recruitment of HLA-A*02 in the peptide-loading complex.":TOPO_DOM:/note="Extracellular" 111 Q e 31.6 6o9c_A B2MG_HUMAN:BETA 2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[101 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:EPE:EDO:SO4:PEG:P4G:PG4 0 0 9 11 3 2 10 0 2 8 0 0 4 38 2 0 0 4 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 112 S e 48.4 6o9c_A CALR_HUMAN:Calreticulin[365 aa]:Light chain[216 aa]:Light chain[215 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:EPE:SO4:EDO:P4G:PEG 1 0 2 2 0 4 0 3 9 1 0 0 0 5 2 48 14 8 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 113 E T e 71.4 6o9c_A KI3L1_HUMAN:HYB3 LIGHT CHAIN[210 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:IgG, Fab Heavy Chain V2[216 aa] GOL:SO4:EDO:1PE 5 0 6 30 1 5 0 1 15 2 0 6 12 10 1 1 1 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 114 A T e 61.6 6o9c_A B2MG_HUMAN:Light chain[216 aa]:Light chain[215 aa]:Beta-2-microglobulin[100 aa] SO4:GOL:PEG:EDO 13 0 18 6 4 15 0 4 13 4 0 2 1 1 1 6 6 3 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" A->D:LB/B:rs1136692: -; 115 G S e 36.9 6o9c_A B2MG_HUMAN:Beta-2-microglobulin[103 aa] GOL:EDO:PEG:SO4 1 0 2 10 5 57 3 1 1 1 0 1 1 4 3 1 2 1 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 116 S e 53.1 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA-2 MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[99 aa]:Heavy chain[216 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa]:Beta-2-microglobulin[98 aa] GOL:EDO:IPA:SO4:PEG 5 0 0 0 2 1 0 0 0 13 0 0 24 0 0 42 4 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 117 H b 12.0 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] CL GOL:EPE:IPA:SO4:EDO:PEG:FMT 1 0 0 0 5 5 54 5 0 10 0 6 0 0 0 1 0 0 0 10 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 118 T E e 22.1 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA-2 MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:Beta-2-microglobulin[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA 2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[101 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA:CL GOL:EDO 3 0 4 4 0 0 0 6 0 0 0 0 0 0 0 5 57 21 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 119 I E b 4.1 6o9c_A NEF_HV1Z6:MAG1_HUMAN:MAGA1_HUMAN:Q9YYU8_9HIV1:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:Q9YXL3_9INFA:Q9YXL6_9INFA:TITIN_HUMAN:NEF_HV1ND:CCND2_HUMAN:CTNB1_HUMAN:PK3CA_HUMAN:SPIKE_SARS2:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:NCAP_INBSI:NCAP_I46A1:RDRP_I97A1:RASK_HUMAN:Negative factor[10 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:nonameric peptide from Melanoma-associated antigen..:10-mer peptide from Protein Nef[10 aa]:Nef73 peptide from Protein Nef[10 aa]:Protein Nef[10 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:8-Mer peptide from Protein Nef[8 aa]:Titin[9 aa]:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:HIV-1 Nef138-10 peptide[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Catenin beta-1[9 aa]:influenza A NP145-156 peptide[7 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Spike protein S1 peptide[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:Nucleoprotein peptide[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:CMV peptide[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:Spike protein S1[9 aa]:Spike protein S2' [10 aa]:KRAS-G12V nonamer peptide[9 aa] ARG NA EDO 0 0 0 0 7 0 0 29 0 46 1 0 0 0 1 0 0 12 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" I->L:LB/B:rs1071743: -;I->V:LB/B:-: -; 120 Q E e 40.3 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. 0 0 0 0 0 0 0 0 0 0 0 0 0 95 0 0 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 121 I E b 2.9 6o9c_A B2MG_HUMAN:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:TAT_HTL1C:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:PME17_HUMAN:MAG1_HUMAN:B2MG_PANTR:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:NCAP_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:Q9YJW5_HBV:LMP2_EBVB9:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9YXL6_9INFA:O75767_HUMAN:Q9QAC5_HBV:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NS1_INBSJ:I27RA_HUMAN:MAGA4_HUMAN:MAGA8_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (HLA-A*0201)[100 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:BETA-2 MICROGLOBULIN[99 aa]:TAX PEPTIDE[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:BETA-2-MICROGLOBULIN[100 aa]:9 RESIDUE PEPTIDE[9 aa]:beta-2-microglobulin[100 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:nonameric peptide ligand from the MART-1/Melan-A[9..:Beta-2-microglobulin[100 aa]:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:Beta-2-microglobulin[93 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:BETA-2-MICROGLOBULIN[98 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:Beta-2-microglobulin[98 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:Latent membrane protein 2[9 aa]:Insulin[10 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Beta-2-microglobulin[92 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:G9V[9 aa]:Peptide Y10L[10 aa]:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:Protein Nef[10 aa]:M1-G4E, GILEFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:Beta-2-microglobulin[96 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:MTB[9 aa]:NP44[9 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:Beta-2-microglobulin[101 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:EAAGIGILTV[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:Beta-2-microglobulin[103 aa]:9-mer peptide from the HCoV spike protein[9 aa]:Beta-2-microglobulin[106 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Beta-2-microglobulin[90 aa]:Tyrosinase peptide[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S1 peptide[9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:peptide KRAS-G12V-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa] NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4:PGE 13 0 4 4 6 16 0 7 0 2 4 0 0 0 8 1 1 19 13 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" I->M:LB/B:rs1136695: -;I->R:LB/B:-: -; 122 M E b 12.1 6o9c_A B2MG_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:BETA-2 MICROGLOBULIN[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA 2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[98 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[90 aa] IOD:MG 1PG:FMT:GOL:EDO:IPA:SO4:PEG:PG4:P6G:PGE 2 0 0 2 2 0 0 16 9 8 27 0 0 2 14 8 10 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 123 Y E b 10.0 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] MET:LEU CL:NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. EDO:GOL 19 0 0 1 6 10 6 4 0 16 8 1 2 0 4 3 0 0 0 21 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" Y->F:LB/B:rs1136697: -; 124 G E b 0.0 6o9c_A 0 0 1 9 2 74 0 0 0 0 2 0 0 0 0 8 0 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 125 C E b 0.0 6o9c_A 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":TOPO_DOM:/note="Extracellular" 126 D E b 11.1 6o9c_A Human T Cell Receptor Mel8, Beta Chain[245 aa] EDO:SO4:PGE:ACT 0 0 18 61 0 1 7 0 1 0 0 5 0 0 2 0 0 0 0 6 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 127 V E b 0.0 6o9c_A EDO:SO4 0 2 0 0 13 0 2 8 0 41 8 0 0 4 0 0 4 19 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 128 G b 4.8 6o9c_A Human T Cell Receptor Mel8, Beta Chain[245 aa] GOL:EDO:SO4 3 0 1 8 3 20 21 2 4 5 0 6 1 5 1 2 10 1 1 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 129 S T e 79.7 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:PA2.1 Fab Heavy Chain[215 aa] TAM CL GOL:IPA:EDO:SO4:EPE:ACT:PGE 9 0 0 14 1 0 5 2 0 2 0 12 14 0 3 30 5 0 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" S->P:LB/B:rs1136700: -; 130 D T e 70.4 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:PA2.1 Fab Heavy Chain[215 aa] GOL:EPE:SO4:EDO:ACT 1 0 34 6 1 18 7 0 1 1 0 10 9 0 3 6 1 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 131 G S b 17.9 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:PA2.1 Fab Heavy Chain[215 aa] TAM NA GOL:SO4:EDO:EPE:ACT:PGE 0 0 0 4 0 63 0 0 0 0 0 13 0 2 2 2 12 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" G->W:LB/B:rs1136702: -; 132 R e 50.6 6o9c_A IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:PA2.1 Fab Heavy Chain[215 aa]:PA2.1 Fab Light Chain[218 aa]:PA2.1 Fab Light Chain[217 aa] CL:NA GOL:SO4:EPE:EDO 5 0 0 10 0 1 5 2 6 0 0 7 1 7 23 27 4 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 133 F E e 34.9 6o9c_A TVA22_HUMAN:K7N5M3_HUMAN:T cell receptor alpha variable 22,Human nkt tcr al..:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:PA2.1 Fab Heavy Chain[215 aa]:PA2.1 Fab Light Chain[217 aa]:PA2.1 Fab Light Chain[218 aa] PE8 CL:NA GOL:SO4:EDO:PEG 10 0 1 1 26 4 3 4 1 14 0 1 3 1 9 11 6 2 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" F->L:LB/B:rs1059488: -; 134 L E e 28.1 6o9c_A Human T Cell Receptor Mel8, Beta Chain[245 aa]:PA2.1 Fab Light Chain[217 aa]:PA2.1 Fab Light Chain[218 aa] GOL:SO4:PEG:EDO 1 0 0 0 2 0 0 10 0 28 0 0 3 1 1 11 17 22 2 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 135 R E e 39.5 6o9c_A B2MG_HUMAN:Beta-2-microglobulin[100 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa] CL:NA GOL:SO4:PEG:PG4:EDO:ACT 4 0 2 11 0 3 0 0 6 0 0 4 6 2 48 7 3 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 136 G E b 9.5 6o9c_A GOL:EDO 5 0 0 0 6 51 0 0 0 3 0 2 0 0 6 15 3 0 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 137 Y E b 11.7 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[100 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin[98 aa] 1PG:GOL:FMT:PG4:EDO:PEG:P6G 5 0 0 0 32 0 1 0 0 6 1 0 0 0 0 11 3 9 0 30 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 138 R E b 12.3 6o9c_A CORA_HBVIL:M1_IAPUE:POL_HV1Z2:NEF_HV1Z6:MAG1_HUMAN:NCAP_CVHSA:CRTC_HUMAN:MAR1_HUMAN:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:N4BP2_HUMAN:VME1_CVHSA:Q6SW59_HCMV:POLG_HCVJ1:Q9YYU8_9HIV1:Q9YJW5_HBV:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9YXL6_9INFA:Q9YXY3_9HIV1:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:W8FN10_9FLAV:RETR2_HUMAN:SYNEM_HUMAN:CTNB1_HUMAN:HHAT_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:NCAP_INBAC:RASN_HUMAN:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:PHX2B_HUMAN:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:9 RESIDUE PEPTIDE[9 aa]:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:Negative factor[10 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from NEDD4-binding protein 2[10 ..:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:Tel1p peptide[9 aa]:Membrane protein[9 aa]:Nucleoprotein peptide[9 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:10-meric peptide from Melanoma antigen recognized ..:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:Mart-1(27-35) peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Insulin[10 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:9-mer peptide from Pol protein[9 aa]:Immunogenic peptide[9 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:8-Mer peptide from Protein Nef[8 aa]:Marker peptide[10 aa]:Matrix protein 1[9 aa]:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:Protein Nef[10 aa]:M1-G4E, GILEFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS3 peptide[10 aa]:GTS1 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:peptide[9 aa]:MTB[9 aa]:NP44[9 aa]:NRAS Q61K peptide[10 aa]:Catenin beta-1[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S1 peptide[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:HIV-1 RT[9 aa]:Spike protein S2[9 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG CL GOL:EDO:SO4:PGE 7 1 3 14 5 2 2 2 3 22 2 3 1 3 4 2 2 4 16 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->E:LB/B:-: -;R->H:LB/B:-: -;R->Q:LB/B:-: -; 139 Q E e 53.1 6o9c_A B2MG_HUMAN:CD8A_HUMAN:B2MG_PANTR:TPSN_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:T-CELL CORECEPTOR CD8[114 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Tapasin[348 aa]:Beta-2-microglobulin[90 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. 1PG:FMT:GOL:EDO:SO4:PG4:PEG:P6G:PGE 1 0 1 1 1 5 16 1 7 1 2 1 1 35 22 1 1 3 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 140 D E b 8.6 6o9c_A B2MG_HUMAN:TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:B2MG_PANTR:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:BETA-2 MICROGLOBULIN[100 aa]:TAX PEPTIDE[9 aa]:BETA 2-MICROGLOBULIN[100 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:BETA-2-MICROGLOBULIN[100 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:beta-2-microglobulin[100 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:Beta-2-microglobulin[100 aa]:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:Beta-2-microglobulin[93 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:TAX PEPTIDE P6A[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:Beta-2-microglobulin[99 aa]:gag peptide[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:BETA-2-MICROGLOBULIN[98 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:Beta-2-microglobulin[98 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:Beta-2-microglobulin[97 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:BETA-2-MICROGLOBULIN[99 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:Beta-2-microglobulin[96 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Beta-2-microglobulin[101 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Nucleoprotein peptide[9 aa]:Spike protein S2[9 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Beta-2-microglobulin[90 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:NY-ESO-1 peptide[9 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG:MET NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. SO4:EDO:GOL 5 0 4 6 21 7 5 2 1 8 3 1 1 0 1 2 1 11 0 22 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" D->H:LB/B:-: -;D->Y:LB/B:-: -; 141 A E b 16.1 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. 53 0 0 3 4 15 0 12 0 2 0 0 0 0 0 5 0 2 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 142 Y E b 3.9 6o9c_A PB2 peptide from influenza, TYQWIIRNW[9 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa] NA:CL GOL:EDO:SO4:PEG:PG4 0 0 0 0 21 0 2 2 0 11 0 0 0 0 0 0 0 3 3 57 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 143 D T e 38.3 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:IPA:EDO:SO4:PEG 0 0 41 7 0 6 0 0 1 0 0 34 0 10 0 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 144 G T e 71.4 6o9c_A B2MG_HUMAN:B2MG_PANTR:TPSN_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Tapasin[348 aa]:Beta-2-microglobulin[90 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. EDO 0 0 0 0 0 75 0 0 0 4 0 0 0 6 11 0 0 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 145 K E e 74.1 6o9c_A B2MG_HUMAN:B2MG_PANTR:TPSN_HUMAN:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Tapasin[348 aa]:Beta-2-microglobulin[97 aa] 1A02_HUMAN:Q53Z42_HUMAN:HLA class I histocompatibility antigen, A-2 alpha ..:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4:PEG:PG4 1 2 0 33 0 2 0 0 14 18 2 0 1 15 8 4 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 146 D E e 82.1 6o9c_A B2MG_HUMAN:CD8A_HUMAN:B2MG_PANTR:TPSN_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:T-CELL CORECEPTOR CD8[114 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Tapasin[348 aa]:Beta-2-microglobulin[90 aa] NA 1A02_HUMAN:Q53Z42_HUMAN:HLA class I histocompatibility antigen, A-2 alpha ..:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4:PG4:PEG 0 0 46 27 0 0 3 2 3 3 0 9 0 1 0 0 4 0 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 147 Y E b 3.5 6o9c_A ENV_HV1B8:M1_IAPUE:POL_HV1Z2:MAGA3_HUMAN:NEF_HV1Z6:MAG1_HUMAN:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CO024_HUMAN:ENV_HV1MA:MYPR_HUMAN:LSP1_HUMAN:N4BP2_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:NCAP_CVHSA:CTG1B_HUMAN:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:MAR1_HUMAN:SO2A1_HUMAN:Q9YYU8_9HIV1:LMP2_EBVB9:Q9YV12_9HIV1:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:Q9QAC5_HBV:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:SYNEM_HUMAN:RTA_EBVG:HHAT_HUMAN:PMEL_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:SPIKE_SARS2:RASN_HUMAN:MAGAA_HUMAN:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA4_HUMAN:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:self-peptide P1049[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:GAG PEPTIDE[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:Telomerase reverse transcriptase[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:decameric peptide from Lymphocyte-specific protein..:decameric peptide from NEDD4-binding protein 2[10 ..:HIV-1 peptide[10 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:Tel1p peptide[9 aa]:WT126 peptide[9 aa]:Nucleoprotein peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:Immunogenic peptide[9 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:12-mer peptide F12K[12 aa]:Matrix protein 1[9 aa]:Peptide G9L[9 aa]:Peptide Y9L[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:peptide[9 aa]:NP44[9 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:MM90[10 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 7[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S2[9 aa]:Spike protein S1[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:IgG, Fab Heavy Chain V2[216 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S1 peptide[9 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:NY-ESO-1 peptide[9 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa] MET NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. EDO:SO4:PG4:GOL 0 0 1 0 46 0 4 2 0 10 0 3 0 0 0 1 0 7 0 27 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 148 I E b 1.8 6o9c_A NA SO4:EDO:PG4:GOL 3 0 0 0 0 1 0 17 0 48 10 0 0 0 2 0 2 16 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 149 A E e 27.7 6o9c_A TPSN_HUMAN:Tapasin[348 aa] NA SO4:EDO:PG4:GOL 16 0 0 10 0 0 1 3 2 6 0 2 0 0 24 31 5 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 150 L E b 8.4 6o9c_A GOL:EDO 0 0 0 0 61 0 0 8 0 21 0 0 0 3 0 0 0 2 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 151 N e 27.3 6o9c_A TPSN_HUMAN:Tapasin[348 aa] CL GOL:EDO:MES:SO4 0 3 36 2 0 0 0 0 9 0 0 30 0 14 2 0 2 0 2 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" N->K:LB/B:rs1059509: -; 152 E T e 80.4 6o9c_A CD8A_HUMAN:TPSN_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Tapasin[348 aa] CL:IOD GOL:EDO:SO4:PEG 0 0 3 18 0 9 2 0 9 5 0 15 6 4 1 28 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 153 D T e 40.7 6o9c_A Human T Cell Receptor Mel8, Beta Chain[245 aa] IOD GOL:EDO:SO4:MES:PEG 2 1 42 12 0 1 5 2 9 3 0 8 0 0 2 5 6 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 154 L S b 1.7 6o9c_A TAM SO4:EDO 1 2 1 1 1 4 0 6 3 26 2 5 1 3 1 1 19 21 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 155 R S e 69.6 6o9c_A K7N5M3_HUMAN:TPSN_HUMAN:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Tapasin[348 aa] TAM GOL:SO4:EDO:MES 1 0 1 2 1 26 0 1 9 12 3 1 8 2 20 3 7 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 156 S e 28.9 6o9c_A TPSN_HUMAN:Tapasin[364 aa]:Tapasin[348 aa] SO4:GOL:MES 7 3 2 20 0 0 0 1 3 5 5 4 3 0 0 30 15 2 0 0 MUTAGEN:/note="S->C: Impairs the maturation of a peptide-receptive HLA-A*02-B2M complex.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="S->C: Impairs the maturation of a peptide-receptive HLA-A*02-B2M complex.":TOPO_DOM:/note="Extracellular" 157 W E b 2.8 6o9c_A NEF_HV1Z6:CTNB1_HUMAN:PK3CA_HUMAN:Negative factor[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:Catenin beta-1[9 aa]:Mutant PIK3CA peptide[9 aa] NA:MG:CL GOL:SO4:EDO 2 1 0 0 14 0 1 0 0 0 0 0 4 2 0 3 0 0 63 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 158 T E e 48.7 6o9c_A TPSN_HUMAN:Tapasin[348 aa] NA:CL:MG 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. GOL:SO4:EDO:PG4 2 0 2 9 0 2 1 2 2 4 1 0 6 4 18 6 33 8 0 0 MUTAGEN:/note="T->K: Impairs binding to TAP1-TAP2 transporter, resulting in impaired presentation of intracellular peptides." ECO:0000269|PubMed:8805302":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="T->K: Impairs binding to TAP1-TAP2 transporter, resulting in impaired presentation of intracellular peptides." ECO:0000269|PubMed:8805302":TOPO_DOM:/note="Extracellular" 159 A E b 17.0 6o9c_A TPSN_HUMAN:Tapasin[348 aa] CL:MG:NA GOL:SO4:EDO:PG4 55 2 0 3 0 12 0 0 0 2 2 0 9 0 0 3 7 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 160 A S e 50.0 6o9c_A TPSN_HUMAN:Tapasin[364 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Tapasin[348 aa] NA 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. EDO:SO4:PG4:GOL:PEG 24 2 8 2 1 10 0 0 0 6 2 1 6 3 0 3 0 33 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 161 D S e 38.3 6o9c_A Human T Cell Receptor Mel8, Beta Chain[245 aa] IOD 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. GOL:EDO:MES:SO4:PG4:PEG 0 0 29 6 0 5 6 1 0 0 1 7 10 1 0 3 24 1 5 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 162 M H e 83.1 6o9c_A TPSN_HUMAN:T-cell receptor, beta chain[243 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Tapasin[348 aa] IOD 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. FMT:GOL:MES:EDO:PG4:SO4 2 0 2 20 1 3 0 3 4 7 7 3 21 0 7 4 8 4 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 163 A H b 11.6 6o9c_A CCND2_HUMAN:TPSN_HUMAN:SPIKE_SARS2:G1/S-specific cyclin-D2[10 aa]:Tapasin[364 aa]:Spike protein S2' [10 aa] IOD GOL:SO4:MES:EDO:PG4 34 0 0 10 1 11 0 0 0 23 0 0 6 0 5 2 2 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 164 A H b 0.0 6o9c_A EDO 38 1 0 2 1 25 0 7 2 0 3 2 4 7 0 1 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 165 Q H e 32.1 6o9c_A TPSN_HUMAN:T-cell receptor, beta chain[243 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Tapasin[348 aa] 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. GOL:SO4:EDO:MES:PEG 2 0 2 5 0 3 5 1 9 5 0 6 5 23 23 6 2 1 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 166 I H e 34.5 6o9c_A KI2S2_HUMAN:CCND2_HUMAN:TPSN_HUMAN:KI3L1_HUMAN:SPIKE_SARS2:HYB3 LIGHT CHAIN[210 aa]:T-cell receptor, beta chain[243 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:G1/S-specific cyclin-D2[10 aa]:Tapasin[364 aa]:Killer cell immunoglobulin-like receptor 3DL1[275 ..:Tapasin[348 aa]:IgG, Fab Heavy Chain V2[216 aa]:Spike protein S2' [10 aa] 1A24_HUMAN:Q53Z42_HUMAN:HLA class I histocompatibility antigen, A-24 alpha..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:PGE:SO4:EDO:MES 4 0 0 0 6 3 0 22 7 4 2 3 19 5 4 2 5 9 6 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" I->T:LB/B:rs1059516: -; 167 T H b 9.7 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:TPSN_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Tapasin[364 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG:MET Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:ACT 5 8 11 1 2 0 0 7 1 9 6 2 0 1 2 10 23 9 3 0 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular" 168 K H b 17.5 6o9c_A CL:MG:NA GOL:SO4:EDO 25 4 1 4 0 2 0 0 31 1 0 8 0 11 5 2 4 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" K->Q:LB/B:-: -; 169 R H e 58.1 6o9c_A KI2S2_HUMAN:KI3L1_HUMAN:TPSN_HUMAN:HYB3 LIGHT CHAIN[210 aa]:T-cell receptor, beta chain[243 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:pRLQ3 T cell receptor beta chain[243 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Tapasin[348 aa]:IgG, Fab Heavy Chain V2[216 aa] CD:NI 1A24_HUMAN:HLA class I histocompatibility antigen, A-24 alpha.. GOL:SO4:EDO:MES:PEG 5 0 6 21 3 0 4 1 9 10 2 2 0 9 17 2 2 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->H:LB/B:rs1059520: -; 170 K H e 55.7 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:Q6NS87_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A0A585_HUMAN:TRBC1_HUMAN:KI2S2_HUMAN:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:A0A087WZ08_HUMAN:E9P5U1_9INFA:A0A0K0K1A5_HUMAN:M1_I34A1:NEF_HV1ND:Q80817_9DELA:K7N5M4_HUMAN:W8FN10_9FLAV:A0A5B3_HUMAN:A0A0C4ZKA8_HUMAN:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:A0A1B0GXE1_HUMAN:CCND2_HUMAN:TPSN_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:KI3L1_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:T-cell Receptor beta chain[237 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:HYB3 LIGHT CHAIN[210 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor beta chain[241 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[243 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:AHIII TCR BETA CHAIN[237 aa]:P1049[9 aa]:TCR BETA[237 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:Antibody light chain[211 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:BSLF2/BMLF1 protein[9 aa]:T-CELL RECEPTOR, BETA CHAIN[245 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:A6 TCR beta chain[245 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:TAX(Y5F) peptide[9 aa]:A6 beta chain[245 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:H27-14 TCR beta chain[242 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 beta chain[241 aa]:JKF6 beta chain[240 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:V_segment translation product, T-cell receptor bet..:Killer cell immunoglobulin-like receptor 2DS2[190 ..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:C7 TCR beta chain[226 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C7 TCR beta chain[235 aa]:C7 TCR beta chain[238 aa]:C25 beta[246 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:T-cell receptor beta-2 chain C region[241 aa]:Matrix protein 1[9 aa]:T-cell receptor beta-2 chain C region[242 aa]:T-cell receptor beta-2 chain C region[238 aa]:Melanoma derived Mart-1 peptide[10 aa]:A6-TCR Vbeta[115 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Heavy Chain[244 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:JM22 TCR beta chain[240 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:TCRbeta chain[239 aa]:KLV peptide[10 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRBV6-5,Human nkt tcr beta chain[240 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:NS5[9 aa]:T-cell receptor beta variable 19,TRB protein[243 a..:Gag protein[9 aa]:Human T-cell receptor beta chain[241 aa]:Human T-cell receptor Beta chain[239 aa]:Human T-cell Receptor beta chain[242 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:T cell receptor beta chain[241 aa]:NS3 peptide[10 aa]:T cell receptor beta chain[242 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:T cell receptor beta chain[239 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:G1/S-specific cyclin-D2[10 aa]:Tapasin[364 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:SILv44 T cell receptor beta chain[241 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:TCR repeptor 38-10, beta chain[242 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pRLQ3 T cell receptor beta chain[243 aa]:TRBV19 TCR beta[239 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:T-cell receptor (TRBV/TRBC)[240 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain (TRBV/TRBC)[238 aa]:T-cell receptor beta chain[285 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:T-cell receptor beta chain[238 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:TIL1383i (h3T) T cell receptor beta chain[247 aa]:6-11 T cell receptor beta chain[243 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Heavy Chain V2[216 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Light chain[211 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:H2aM31345N Fab light chain[214 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:TD08 TCR beta chain[235 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR beta chain[240 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:TCR beta chain[240 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG IOD:CL 1A24_HUMAN:Q53Z42_HUMAN:HLA class I histocompatibility antigen, A-24 alpha..:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4:ACT:PEG 3 0 6 6 5 0 0 6 31 12 0 3 0 5 2 4 1 5 3 9 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular" 171 W H b 18.3 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A0A585_HUMAN:TRBC1_HUMAN:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:A0A0K0K1A5_HUMAN:K7N5M4_HUMAN:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:T-cell Receptor beta chain[237 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:AHIII TCR BETA CHAIN[237 aa]:P1049[9 aa]:TCR BETA[237 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:H27-14 TCR beta chain[242 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:V_segment translation product, T-cell receptor bet..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C7 TCR beta chain[235 aa]:C25 beta[246 aa]:C25 beta[245 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Heavy Chain[244 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRBV6-5,Human nkt tcr beta chain[240 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:Human T-cell receptor beta chain[242 aa]:Human T-cell receptor Beta chain[239 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell Receptor beta chain[242 aa]:Human T-cell Receptor beta chain[241 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:DMF4 Beta CHAIN[242 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pRLQ3 T cell receptor beta chain[243 aa]:TRBV19 TCR beta[239 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:T-cell receptor (TRBV/TRBC)[240 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain (TRBV/TRBC)[238 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:T-cell receptor beta chain[238 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:4-mer lipopeptide[5 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] ARG:MET IOD:NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. ALA:GOL:SO4:EDO:GLY:PGE 0 4 0 0 7 0 0 4 3 8 1 3 0 2 0 3 0 0 57 6 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 172 E H e 49.2 6o9c_A TPSN_HUMAN:Tapasin[348 aa] CD:NA:CL GOL:EDO 2 0 1 39 2 2 0 0 7 0 3 28 0 10 2 0 2 0 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 173 A H e 64.3 6o9c_A TCB_HUMAN:Q6PIZ8_HUMAN:KI2S2_HUMAN:KI3L1_HUMAN:T CELL RECEPTOR BETA[209 aa]:T-cell Receptor beta chain[237 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:A6-Tcr[243 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:AHIII TCR BETA CHAIN[237 aa]:JM22 TCR BETA CHAIN[240 aa]:A6 TCR beta chain[245 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:1E6 TCR Beta Chain[246 aa]:A6 beta chain[245 aa]:Killer cell immunoglobulin-like receptor 2DS2[190 ..:C7 TCR beta chain[226 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR beta chain[237 aa]:JM22 TCR beta chain[240 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:T cell receptor beta chain[241 aa]:T cell receptor beta chain[239 aa]:TCR repeptor 38-10, beta chain[242 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:pRLQ3 T cell receptor beta chain[243 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:6-11 T cell receptor beta chain[243 aa]:6-11 T cell receptor alpha chain[200 aa]:IgG, Fab Heavy Chain V2[216 aa]:Light chain[211 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:T-cell receptor beta chain[236 aa]:T-cell receptor beta chain[239 aa]:TCR beta chain[239 aa]:TCR beta chain[238 aa] GOL:EDO:SO4:PEG 14 2 4 3 0 3 1 0 9 6 0 8 4 7 3 16 5 4 0 9 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" A->T:LB/B:rs1059526: -; 174 A T e 54.5 6o9c_A CORA_HBVIL:POL_HV1MA:TCB_HUMAN:POL_HV1Z2:NEF_HV1Z6:PME17_HUMAN:NCAP_CVHSA:Q6PIZ8_HUMAN:Q6NS87_HUMAN:MAR1_HUMAN:Q2YDB4_HUMAN:A2NVQ1_HUMAN:LSP1_HUMAN:POF1B_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9DIT6_9HEPC:Q9YJW5_HBV:Q9YV12_9HIV1:Q9Q5D4_9HIV1:Q9YXL3_9INFA:TAX_HTL1F:Q9QAC5_HBV:R4X2K3_9INFA:A0A585_HUMAN:TRBC1_HUMAN:KI2S2_HUMAN:A14_VACCW:A0A578_HUMAN:K7N5M4_HUMAN:A0A087WZ08_HUMAN:A0A0K0K1A5_HUMAN:W8FN10_9FLAV:RETR2_HUMAN:TVBK2_HUMAN:PMEL_HUMAN:P53_HUMAN:KI3L1_HUMAN:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:RASN_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:RASK_HUMAN:T CELL RECEPTOR BETA[209 aa]:T CELL RECEPTOR BETA[242 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:T-cell Receptor beta chain[237 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:T-CELL RECEPTOR, BETA CHAIN[243 aa]:PROTEIN (human T-Cell receptor)[243 aa]:HUMAN T-CELL RECEPTOR[243 aa]:Negative factor[10 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor beta chain[241 aa]:T-cell receptor alpha chain[206 aa]:A6-Tcr[243 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:AHIII TCR BETA CHAIN[237 aa]:TCR BETA[237 aa]:Hypothetical protein[241 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Alpha Chain[195 aa]:T-Cell Receptor, Beta Chain[242 aa]:JM22 TCR BETA CHAIN[240 aa]:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:A6 TCR beta chain[245 aa]:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:Antibody heavy chain[220 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:Tel1p peptide[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:T-CELL RECEPTOR, BETA CHAIN[245 aa]:10mer peptide from Pre-core-protein[10 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 beta chain[242 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:A6 beta chain[245 aa]:RT313 peptide[9 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Beta Chain[244 aa]:1E6 TCR Beta Chain[245 aa]:C1-28 TCR beta chain[243 aa]:H27-14 TCR beta chain[242 aa]:T36-5 TCR beta chain[241 aa]:Protein Nef[10 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 beta chain[241 aa]:JKF6 beta chain[240 aa]:PA polymerase subunit[10 aa]:Protein Tax-1[9 aa]:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleoprotein[11 aa]:V_segment translation product, T-cell receptor bet..:Killer cell immunoglobulin-like receptor 2DS2[190 ..:peptide from Virion membrane protein A14[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:Protein TRBV5-1,Human nkt tcr beta chain[241 aa]:Marker peptide[10 aa]:1E6 TCR Beta Chain[247 aa]:C7 TCR beta chain[226 aa]:C7 TCR beta chain[235 aa]:C7 TCR beta chain[238 aa]:C25 alpha[198 aa]:C25 beta[246 aa]:C25 beta[245 aa]:T-cell receptor beta-2 chain C region[239 aa]:T-cell receptor beta-2 chain C region[241 aa]:T-cell receptor beta-2 chain C region[242 aa]:T-cell receptor beta-2 chain C region[238 aa]:Melanoma derived Mart-1 peptide[10 aa]:A6-TCR Vbeta[114 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR beta chain[237 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:JM22 TCR beta chain[240 aa]:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TCRbeta chain[241 aa]:TCRbeta chain[239 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:Protein TRBV6-5,Human nkt tcr beta chain[240 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Human T-cell receptor beta chain[242 aa]:Human T-cell receptor beta chain[241 aa]:Human T-cell receptor Beta chain[239 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell Receptor beta chain[242 aa]:Human T-cell Receptor beta chain[241 aa]:TCR F50 alpha chain[202 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:D30 TCR beta chain[244 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:V-beta chain of T cell receptor[245 aa]:T cell receptor beta chain[241 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:T cell receptor beta chain[239 aa]:DMF5 TCR beta chain[242 aa]:DMF5 TCR beta chain[241 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Reticulophagy regulator 2[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:T cell receptor beta variable 11-2,Human nkt tcr b..:T-cell receptor beta chain[244 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:DMF4 Beta CHAIN[242 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239)[10 aa]:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:SILv44 T cell receptor beta chain[241 aa]:Melanocyte protein PMEL[9 aa]:TCR receptor 1a2, beta chain[240 aa]:peptide from p53 tumor suppressor[9 aa]:TCR receptor 1a2, beta chain[241 aa]:Cellular tumor antigen p53 peptide[9 aa]:T-cell receptor 12-6, alfa chain[183 aa]:T-cell receptor 38-10, alfa chain[188 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:Light chain of Fab fragment 11D06[212 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:pRLQ3 T cell receptor alpha chain[200 aa]:pRLQ3 T cell receptor beta chain[243 aa]:TRAV12-1 TCR-alpha[199 aa]:TRBV19 TCR beta[239 aa]:TRAV12-1 TCR-alpha[198 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:TCR alpha[191 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TCR alpha[181 aa]:T-cell receptor (TRBV/TRBC)[240 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain (TRBV/TRBC)[238 aa]:T-cell receptor beta chain[285 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:T-cell receptor beta chain[238 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:6-11 T cell receptor beta chain[243 aa]:6-11 T cell receptor alpha chain[200 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:IgG, Fab Heavy Chain V2[216 aa]:Light chain[211 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:T-cell receptor beta chain[242 aa]:10LH single chain fragment variable (scFv)[227 aa]..:HIV-1 RT[9 aa]:CMV peptide[9 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:TD08 TCR beta chain[235 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR beta chain[241 aa]:peptide KRAS-G12V-9[9 aa]:TCR beta chain[240 aa]:TCR beta chain[242 aa]:KRAS-G12wt-9[9 aa]:Spike protein S1[9 aa]:T-cell receptor beta chain[236 aa]:KRAS-G12V nonamer peptide[9 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR beta chain[238 aa] GOL:SO4:EDO:PGE:PEG 22 0 6 5 0 0 3 5 6 7 0 5 0 26 3 2 2 5 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" A->V:LB/B:-: -; 175 H T e 56.5 6o9c_A TCB_HUMAN:Q6PIZ8_HUMAN:A2NVQ1_HUMAN:Q2YDB4_HUMAN:A0A585_HUMAN:TRBC1_HUMAN:KI2S2_HUMAN:A0A0B4J279_HUMAN:TCA_HUMAN:K7N5M3_HUMAN:A0A087WZ08_HUMAN:TVBK2_HUMAN:K7N5M4_HUMAN:KI3L1_HUMAN:PDIA3_HUMAN:M1_INBAC:T CELL RECEPTOR BETA[209 aa]:T-cell Receptor alpha chain[194 aa]:T-cell Receptor beta chain[237 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[200 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:T-CELL RECEPTOR, BETA CHAIN[243 aa]:PROTEIN (human T-Cell receptor)[243 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor alpha chain[206 aa]:A6-Tcr[243 aa]:AHIII TCR ALPHA CHAIN[194 aa]:TCR ALPHA[194 aa]:T-Cell Receptor, Alpha Chain[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:T-Cell Receptor, Alpha Chain[195 aa]:AHIII TCR BETA CHAIN[237 aa]:JM22 TCR ALPHA CHAIN[199 aa]:JM22 TCR BETA CHAIN[240 aa]:A6 TCR beta chain[245 aa]:Antibody heavy chain[220 aa]:Tel1p peptide[9 aa]:TRBV6-5 protein[245 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:A6 beta chain[245 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Beta Chain[244 aa]:C1-28 TCR alpha chain[198 aa]:T36-5 TCR alpha chain[199 aa]:V_segment translation product, T-cell receptor bet..:Killer cell immunoglobulin-like receptor 2DS2[190 ..:Mel5 TCR chain alpha[194 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:1E6 TCR Beta Chain[245 aa]:1E6 TCR Beta Chain[247 aa]:C25 alpha[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[201 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:T-cell receptor beta-2 chain C region[241 aa]:T-cell receptor beta-2 chain C region[242 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:T-cell receptor beta-2 chain C region[238 aa]:PF6 TCR alpha chain[190 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR alpha chain[191 aa]:PF6 TCR beta chain[237 aa]:JM22 TCR alpha chain[195 aa]:JM22 TCR beta chain[240 aa]:TCRbeta chain[241 aa]:TCRbeta chain[239 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:TCR F50 alpha chain[202 aa]:D30 TCR beta chain[244 aa]:T cell receptor beta chain[241 aa]:T cell receptor beta chain[239 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:T cell receptor beta variable 11-2,Human nkt tcr b..:T-cell receptor alpha chain[197 aa]:T-cell receptor alpha chain[198 aa]:T-cell receptor alpha chain[166 aa]:T-cell receptor alpha chain[194 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor alpha chain[189 aa]:T-cell receptor beta chain[240 aa]:a7b2 ALPHA CHAIN[192 aa]:DMF4 Beta CHAIN[242 aa]:a7b2 ALPHA CHAIN[191 aa]:T-cell receptor 1a2, alfa chain[193 aa]:T-cell receptor 12-6, alfa chain[183 aa]:T-cell receptor 38-10, alfa chain[188 aa]:Killer cell immunoglobulin-like receptor 3DL1[290 ..:Killer cell immunoglobulin-like receptor 3DL1[275 ..:pRLQ3 T cell receptor alpha chain[200 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:TRAV12-1 TCR-alpha[199 aa]:TRAV12-1 TCR-alpha[198 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:T-cell receptor alpha chain[243 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Protein disulfide-isomerase A3[459 aa]:Fab heavy chain[212 aa]:Fab heavy chain[218 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:6-11 T cell receptor beta chain[243 aa]:6-11 T cell receptor alpha chain[200 aa]:T cell receptor, alpha chain[185 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Light chain[211 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45428 TCR alpha chain[251 aa]:H2aM31345N Fab heavy chain[207 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:TD08 TCR beta chain[235 aa]:TD08 TCR alpha chain[203 aa]:TD08 TCR beta chain[240 aa]:H25-11 TCR alpha chain[203 aa]:H25-11 TCR beta chain[241 aa]:TCR beta chain[240 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor beta chain[236 aa]:T-cell receptor alpha chain[182 aa]:T-cell receptor beta chain[239 aa]:TCR alpha chain[175 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa] MG:CD:NA:CO:3NI:ZN:CL GOL:EDO:SO4 2 1 6 2 2 13 8 2 17 2 3 4 14 2 8 7 0 1 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" H->R:LB/B:-: -; 176 E H e 33.7 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:TCB_HUMAN:POL_HV1Z2:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:NCAP_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:TERT_HUMAN:A0A585_HUMAN:TRBC1_HUMAN:A14_VACCW:AMPD2_HUMAN:A0A087WZ08_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:A0A0K0K1A5_HUMAN:K7N5M4_HUMAN:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:Q9WGX1_9HIV1:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:T-cell Receptor beta chain[237 aa]:GILGFVFTL[9 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:Negative factor[10 aa]:NY-ESO-1 peptide[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:Trans-activating transcriptional regulatory peptid..:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:AHIII TCR BETA CHAIN[237 aa]:P1049[9 aa]:TCR BETA[237 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:JM22 TCR BETA CHAIN[240 aa]:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:T-CELL RECEPTOR, BETA CHAIN[245 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Beta Chain[244 aa]:1E6 TCR Beta Chain[245 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:H27-14 TCR beta chain[242 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:A6 beta chain[245 aa]:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Telomerase reverse transcriptase[9 aa]:V_segment translation product, T-cell receptor bet..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:8-Mer peptide from Protein Nef[8 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Marker peptide[10 aa]:1E6 TCR Beta Chain[247 aa]:C7 TCR beta chain[226 aa]:C7 TCR beta chain[235 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C7 TCR beta chain[238 aa]:C25 beta[246 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:T-cell receptor beta-2 chain C region[239 aa]:T-cell receptor beta-2 chain C region[241 aa]:Matrix protein 1[9 aa]:T-cell receptor beta-2 chain C region[238 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:Peptide antigen YLAPGPVTA[9 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR beta chain[237 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:JM22 TCR beta chain[240 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:TCRbeta chain[241 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRBV6-5,Human nkt tcr beta chain[240 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:Human T-cell receptor beta chain[242 aa]:Human T-cell receptor beta chain[241 aa]:Human T-cell receptor Beta chain[239 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell Receptor beta chain[242 aa]:Human T-cell Receptor beta chain[241 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-MET-TYR-LYS[4 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:DMF4 Beta CHAIN[242 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:T-cell receptor 38-10, alfa chain[188 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[9 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, alpha chain[187 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:TRBV19 TCR beta[239 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:T-cell receptor (TRBV/TRBC)[240 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor beta chain[285 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:T cell receptor, alpha chain[185 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:10LH single chain fragment variable (scFv)[227 aa]..:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:TD08 TCR beta chain[235 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR beta chain[240 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:H25-11 TCR beta chain[241 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:SO4:EDO:PGE 4 0 14 31 2 5 0 9 7 1 0 0 0 4 7 0 5 2 1 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" E->A:LB/B:-: -;E->R:LB/B:-: -;E->V:LB/B:rs9256983: -;E->W:LB/B:-: -; 177 A H b 1.8 6o9c_A PK3CA_HUMAN:Mutant PIK3CA peptide[9 aa] TAM MG:NA:CL GOL:SO4:EDO 31 4 0 0 0 4 0 10 4 16 4 1 1 0 0 1 8 11 1 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 178 E H e 50.8 6o9c_A TCA_HUMAN:Q6PIZ8_HUMAN:A2NVQ1_HUMAN:H2RG00_PANTR:K7N5M9_HUMAN:A0A0B4J279_HUMAN:K7N5M3_HUMAN:A0A075B6T6_HUMAN:A0A0B4J277_HUMAN:TVA22_HUMAN:T-cell Receptor alpha chain[194 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[200 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:T-CELL RECEPTOR, BETA CHAIN[243 aa]:PROTEIN (human T-Cell receptor)[243 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor alpha chain[206 aa]:AHIII TCR ALPHA CHAIN[194 aa]:TCR ALPHA[194 aa]:T-Cell Receptor, Alpha Chain[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:JM22 TCR ALPHA CHAIN[199 aa]:A6 TCR alpha chain[200 aa]:A6 TCR beta chain[245 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:DMF4 alpha chain[195 aa]:DMF4 alpha chain[194 aa]:A6 beta chain[245 aa]:C1-28 TCR alpha chain[198 aa]:H27-14 TCR alpha chain[204 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR alpha chain[204 aa]:JKF6 alpha chain[201 aa]:A6 alpha chain[200 aa]:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Alpha Chain[197 aa]:DMF5 alpha chain[199 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:Mel5 TCR chain alpha[194 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:1E6 TCR Alpha Chain[191 aa]:C7 TCR alpha chain[185 aa]:C7 TCR alpha chain[187 aa]:C25 alpha[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:A6-TCR Valpha[110 aa]:A6-TCR Valpha[108 aa]:Human TCR Light Chain[204 aa]:PF6 TCR alpha chain[190 aa]:JM22 TCR alpha chain[195 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:TCRalpha chain[200 aa]:TCRbeta chain[241 aa]:TCRbeta chain[239 aa]:HCV1406 TCR alpha chain[207 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:TCR F50 alpha chain[202 aa]:D30 TCR beta chain[244 aa]:T cell receptor alpha chain[192 aa]:T cell receptor alpha chain[191 aa]:T cell receptor alpha chain[190 aa]:DMF5 TCR alpha chain[195 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:Mel5 TCR, alpha chain[194 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:302TIL TCR alpha chain[189 aa]:302TIL TCR alpha chain[202 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:T-cell receptor alpha chain[198 aa]:T-cell receptor alpha chain[166 aa]:T-cell receptor alpha chain[194 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor alpha chain[189 aa]:T-cell receptor beta chain[240 aa]:a7b2 ALPHA CHAIN[192 aa]:DMF4 Beta CHAIN[242 aa]:a7b2 ALPHA CHAIN[191 aa]:Alpha chain of engineered high affinity T-cell rec..:SILv44 T cell receptor alpha chain[197 aa]:T4H2 T cell receptor alpha chain[201 aa]:T-cell receptor 1a2, alfa chain[193 aa]:T-cell receptor 1a2, alfa chain[196 aa]:T-cell receptor 12-6, alfa chain[183 aa]:T-cell receptor 38-10, alfa chain[188 aa]:T cell receptor, alpha chain[187 aa]:pRLQ3 T cell receptor alpha chain[200 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:TRAV12-1 TCR-alpha[199 aa]:TRAV12-1 TCR-alpha[198 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor alpha chain[243 aa]:Mel5 Human TCR, alpha chain[198 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:T-cell receptor alpha chain[200 aa]:Fab heavy chain[212 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:6-11 T cell receptor alpha chain[200 aa]:T cell receptor, alpha chain[185 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:Light chain[211 aa]:PN45428 TCR alpha chain[251 aa]:H2aM31345N Fab heavy chain[207 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:TD08 TCR alpha chain[183 aa]:TD08 TCR alpha chain[203 aa]:H25-11 TCR alpha chain[203 aa]:TCR alpha chain[198 aa]:TCR beta chain[240 aa]:TCR alpha chain[194 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa] TAM MG:CD:CO:3NI:ZN:NA GOL:SO4:EDO 6 0 13 53 0 0 1 0 4 1 0 1 0 11 3 0 6 0 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 179 Q H e 69.4 6o9c_A TAT_HTL1C:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:TCB_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:TCA_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:Q6PIZ8_HUMAN:MAR1_HUMAN:A2NVQ1_HUMAN:Q2YDB4_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:Q9YYU8_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:H2RG00_PANTR:K7N5M9_HUMAN:A0A585_HUMAN:TRBC1_HUMAN:A14_VACCW:AMPD2_HUMAN:A0A0B4J279_HUMAN:A0A578_HUMAN:K7N5M4_HUMAN:K7N5M3_HUMAN:A0A087WZ08_HUMAN:E9P5U1_9INFA:A0A075B6T6_HUMAN:M1_I34A1:NEF_HV1ND:Q80817_9DELA:A0A0B4J277_HUMAN:A0A0K0K1A5_HUMAN:W8FN10_9FLAV:K7N5N2_HUMAN:A0A5B3_HUMAN:A0A0C4ZKA8_HUMAN:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:A0A1B0GXE1_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:TVA22_HUMAN:TVBK2_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:T CELL RECEPTOR ALPHA[115 aa]:T CELL RECEPTOR BETA[209 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:T CELL RECEPTOR ALPHA[190 aa]:T CELL RECEPTOR BETA[242 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:T-cell Receptor alpha chain[194 aa]:T-cell Receptor beta chain[237 aa]:GILGFVFTL[9 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[200 aa]:T-CELL RECEPTOR BETA CHAIN C REGION[241 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:T-CELL RECEPTOR, BETA CHAIN[243 aa]:Tax Peptide V7R[9 aa]:PROTEIN (human T-Cell receptor)[200 aa]:PROTEIN (human T-Cell receptor)[243 aa]:TAX PEPTIDE Y8A[9 aa]:HUMAN T-CELL RECEPTOR[200 aa]:HUMAN T-CELL RECEPTOR[243 aa]:Negative factor[10 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:HYB3 HEAVY CHAIN[223 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:T-cell Receptor, alpha chain[193 aa]:T-cell receptor, beta chain[243 aa]:T-cell receptor alpha chain[205 aa]:T-cell receptor alpha chain[206 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[200 aa]:A6-Tcr[243 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:AHIII TCR ALPHA CHAIN[194 aa]:P1049[9 aa]:TCR ALPHA[194 aa]:TCR BETA[237 aa]:T-Cell Receptor, Alpha Chain[194 aa]:Hypothetical protein[241 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:Hypothetical protein[242 aa]:T-Cell Receptor, Alpha Chain[195 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:AHIII TCR BETA CHAIN[237 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:JM22 TCR ALPHA CHAIN[199 aa]:JM22 TCR BETA CHAIN[240 aa]:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:65 KDA PHOSPHOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR alpha chain[200 aa]:A6 TCR beta chain[245 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:Antibody light chain[206 aa]:Antibody heavy chain[220 aa]:Antibody light chain[212 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:RA14 TCR beta chain (TRBV6-5, TRBD1, TRBJ1-2)[243 ..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:Tel1p peptide[9 aa]:TRBV6-5 protein[245 aa]:CANCER/MART-1[10 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:T-cell Receptor, Beta Chain[244 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:T-CELL RECEPTOR, BETA CHAIN[245 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 alpha chain[199 aa]:DMF5 beta chain[242 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:DMF4 alpha chain[195 aa]:DMF4 beta chain[242 aa]:DMF4 alpha chain[194 aa]:DMF4 beta chain[243 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:A6 alpha chain[200 aa]:A6 beta chain[245 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:1E6 TCR Beta Chain[246 aa]:1E6 TCR Alpha Chain[201 aa]:1E6 TCR Alpha Chain[199 aa]:1E6 TCR Beta Chain[244 aa]:1E6 TCR Beta Chain[245 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:10-mer peptide from Protein Nef[10 aa]:H27-14 TCR alpha chain[194 aa]:H27-14 TCR beta chain[242 aa]:H27-14 TCR alpha chain[204 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR beta chain[241 aa]:T36-5 TCR alpha chain[204 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 alpha chain[201 aa]:JKF6 beta chain[241 aa]:JKF6 beta chain[240 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Beta Chain[245 aa]:Melanoma peptide L7A[10 aa]:High Affinity TCR Alpha Chain[197 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:V_segment translation product, T-cell receptor bet..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain alpha[194 aa]:Mel5 TCR chain beta[244 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:ESK1[212 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:Protein TRBV5-1,Human nkt tcr beta chain[241 aa]:Marker peptide[10 aa]:1E6 TCR Alpha Chain[197 aa]:1E6 TCR Beta Chain[247 aa]:C7 TCR alpha chain[185 aa]:C7 TCR beta chain[226 aa]:C7 TCR alpha chain[192 aa]:C7 TCR alpha chain[187 aa]:C7 TCR beta chain[238 aa]:C25 alpha[198 aa]:C25 beta[246 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C25 beta[245 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:TCR alpha chain,Human nkt tcr alpha chain[201 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:T-cell receptor beta-2 chain C region[241 aa]:Matrix protein 1[9 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:T-cell receptor beta-2 chain C region[238 aa]:Melanoma derived Mart-1 peptide[10 aa]:A6-TCR Valpha[110 aa]:A6-TCR Valpha[108 aa]:Peptide G9L[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Human TCR Light Chain[204 aa]:Human TCR Heavy Chain[244 aa]:PF6 TCR alpha chain[190 aa]:PF6 TCR beta chain[239 aa]:PF6 TCR alpha chain[191 aa]:PF6 TCR beta chain[237 aa]:Peptide Y9L[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:JM22 TCR alpha chain[195 aa]:JM22 TCR beta chain[240 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:Human T-cell Receptor, Class I, Heavy beta Chain[2..:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:TCRalpha chain[200 aa]:TCRbeta chain[241 aa]:Influenza M1(58-66) peptide[9 aa]:TCRalpha chain[201 aa]:TCRbeta chain[239 aa]:TCRalpha chain[203 aa]:KLV peptide[10 aa]:HCV1406 TCR alpha chain[207 aa]:HCV1406 TCR beta chain[240 aa]:HCV1406 TCR beta chain[241 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:Protein TRBV6-5,Human nkt tcr beta chain[240 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:NS5[9 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:T-cell receptor beta variable 19,TRB protein[243 a..:Gag protein[9 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:Human T-cell receptor beta chain[241 aa]:HUman T-cell receptor Alpha chain[200 aa]:Human T-cell receptor Beta chain[239 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor Beta chain[240 aa]:Human T-cell receptor alpha chain[200 aa]:Human T-cell Receptor beta chain[242 aa]:Human T-cell Receptor beta chain[241 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:TCR F50 alpha chain[202 aa]:TCR F50 beta chain[240 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:D30 TCR beta chain[244 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25[11 aa]:V-delta chain of T cell receptor[207 aa]:V-beta chain of T cell receptor[245 aa]:T cell receptor alpha chain[192 aa]:T cell receptor beta chain[241 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 TCR beta chain[242 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR alpha chain[195 aa]:DMF5 TCR beta chain[241 aa]:ALK[10 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 beta chain,DMF5 beta chain[240 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:DMF5 T-cell Receptor Beta Chain fusion[242 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Mel5 TCR, alpha chain[194 aa]:Mel5 TCR, beta chain[244 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:High Affinity Mel5 TCR, beta chain[244 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:Replication and transcription activator[9 aa]:MM92[9 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:302TIL TCR alpha chain[189 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:302TIL TCR alpha chain[202 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:T cell receptor beta variable 11-2,Human nkt tcr b..:T-cell receptor alpha chain[197 aa]:T-cell receptor alpha chain[198 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:T-cell receptor alpha chain[166 aa]:T-cell receptor beta chain[235 aa]:T-cell receptor beta chain[239 aa]:T-cell receptor beta chain[237 aa]:T-cell receptor beta chain[240 aa]:a7b2 ALPHA CHAIN[192 aa]:DMF4 Beta CHAIN[242 aa]:a7b2 ALPHA CHAIN[191 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Alpha chain of engineered high affinity T-cell rec..:Beta chain of high affinity engineered T-cell rece..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:SILv44 T cell receptor beta chain[241 aa]:Melanocyte protein PMEL[9 aa]:T4H2 T cell receptor alpha chain[201 aa]:T4H2 T cell receptor beta chain[240 aa]:T4H2 T cell receptor beta chain[239 aa]:T-cell receptor 1a2, alfa chain[193 aa]:peptide from p53 tumor suppressor[9 aa]:T-cell receptor 1a2, alfa chain[196 aa]:Cellular tumor antigen p53 peptide[9 aa]:T-cell receptor 12-6, alfa chain[183 aa]:TCR 12-6, beta chain[244 aa]:T-cell receptor 38-10, alfa chain[188 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[221 aa]:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:Light chain of Fab fragment 11D06[212 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[9 aa]:mutant PIK3CA peptide[9 aa]:T cell receptor, alpha chain[187 aa]:T cell receptor, beta chain[247 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pRLQ3 T cell receptor alpha chain[200 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:pYLQ7 T cell receptor beta chain[240 aa]:TRAV12-1 TCR-alpha[199 aa]:TRBV19 TCR beta[239 aa]:TRAV12-1 TCR-alpha[198 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:4C6 Human T-cell Receptor, beta Chain[240 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human T-cell Receptor 4C6, beta Chain[240 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:Human 4C6 T-cell Receptor, beta Chain[240 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:TCR alpha[191 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TCR alpha[181 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:T-cell receptor (TRBV/TRBC)[240 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:Human T-cell Receptor YLQ36, beta chain[242 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor beta chain (TRBV/TRBC)[238 aa]:T-cell receptor alpha chain[243 aa]:T-cell receptor beta chain[285 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, alpha chain[198 aa]:Mel5 Human TCR, beta chain[244 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Human Mel5 T Cell Receptor, Beta Chain[244 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:Melanoma-associated antigen 10[9 aa]:T-cell receptor alpha chain[200 aa]:T-cell receptor beta chain[238 aa]:Fab heavy chain[212 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Fab heavy chain[218 aa]:Tyrosinase peptide[9 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:6-11 T cell receptor alpha chain[200 aa]:T cell receptor, alpha chain[185 aa]:Mutant PIK3CA peptide[9 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:YLQ-SG3 TCR beta chain (TRBV7-9)[239 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:IgG, Fab Heavy Chain V2[216 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:T-cell receptor alpha chain[199 aa]:10LH single chain fragment variable (scFv)[227 aa]..:HIV-1 RT[9 aa]:PN45545 TCR beta chain[287 aa]:Melanoma-associated antigen 4[10 aa]:PN45428 TCR alpha chain[251 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:H2aM31345N Fab heavy chain[207 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 beta[244 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:SARS-CoV-2 specific private TCR RLQ7 beta[245 aa]:TD08 TCR alpha chain[183 aa]:TD08 TCR beta chain[235 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR alpha chain[203 aa]:TD08 TCR beta chain[240 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:H25-11 TCR alpha chain[203 aa]:H25-11 TCR beta chain[241 aa]:peptide KRAS-G12V-9[9 aa]:TCR alpha chain[198 aa]:TCR beta chain[240 aa]:TCR alpha chain[194 aa]:TCR beta chain[242 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor beta chain[236 aa]:KRAS-G12V nonamer peptide[9 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR beta chain[239 aa]:TCR beta chain[237 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa]:TCR beta chain[238 aa] 3IB NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:IPA:EDO:SO4:P4G:PGE 0 0 3 4 0 2 1 7 5 4 8 2 0 28 15 0 17 0 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 180 L H b 14.6 6o9c_A TAT_HTL1C:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:T36-5 TCR alpha chain[199 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide G11N[10 aa]:G9V[9 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:ALA-MET-TYR-LYS[4 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S1 peptide[9 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] CL GOL:SO4:EDO:P4G:PGE 9 0 3 4 4 0 4 5 12 8 3 4 0 4 8 6 12 13 1 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" L->Q:LB/B:-: -;L->R:LB/B:-: -;L->W:LB/B:rs9260156: -; 181 R H e 33.6 6o9c_A H2RG00_PANTR:K7N5M9_HUMAN:A0A0B4J279_HUMAN:TCA_HUMAN:K7N5M3_HUMAN:A0A075B6T6_HUMAN:TVA22_HUMAN:T-cell Receptor alpha chain[194 aa]:High Affinity TCR Alpha Chain[197 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:Protein TRAV21,T-cell receptor alpha chain C regio..:TCR alpha chain,Human nkt tcr alpha chain[201 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:A6-TCR Valpha[110 aa]:A6-TCR Valpha[108 aa]:TCRalpha chain[201 aa]:TCRalpha chain[203 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:T cell receptor alpha variable 22,Human nkt tcr al..:Alpha chain of engineered high affinity T-cell rec..:pYLQ7 T cell receptor alpha chain[197 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:T-cell receptor alpha chain[243 aa]:TCR alpha chain[198 aa]:TCR alpha chain[194 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor alpha chain[182 aa] TAM GOL:SO4:PEG:EDO 1 0 0 7 7 0 3 1 11 1 0 0 0 8 54 0 0 1 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 182 A H e 51.8 6o9c_A TCA_HUMAN:H2RG00_PANTR:K7N5M9_HUMAN:A0A0B4J279_HUMAN:K7N5M3_HUMAN:A0A075B6T6_HUMAN:A0A0B4J277_HUMAN:K7N5N2_HUMAN:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:A0A087WSZ9_HUMAN:TVA22_HUMAN:NCAP_SARS2:T CELL RECEPTOR ALPHA[115 aa]:T CELL RECEPTOR ALPHA[190 aa]:T-cell Receptor alpha chain[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:HUMAN T-CELL RECEPTOR[200 aa]:A6-Tcr[200 aa]:AHIII TCR ALPHA CHAIN[194 aa]:TCR ALPHA[194 aa]:A6 TCR alpha chain[200 aa]:Antibody heavy chain[220 aa]:RA14 TCR alpha chain (TRAV24, TRAJ49)[199 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:DMF5 alpha chain[199 aa]:DMF4 alpha chain[195 aa]:DMF4 alpha chain[194 aa]:A6 alpha chain[200 aa]:1E6 TCR Alpha Chain[200 aa]:1E6 TCR Alpha Chain[201 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR alpha chain[204 aa]:JKF6 alpha chain[201 aa]:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Alpha Chain[197 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:Mel5 TCR chain alpha[194 aa]:ESK1[212 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:1E6 TCR Alpha Chain[199 aa]:1E6 TCR Alpha Chain[189 aa]:1E6 TCR Alpha Chain[197 aa]:C7 TCR alpha chain[187 aa]:C25 alpha[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[201 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:A6-TCR Valpha[110 aa]:A6-TCR Valpha[108 aa]:PF6 TCR alpha chain[190 aa]:PF6 TCR alpha chain[191 aa]:TCRalpha chain[200 aa]:TCRalpha chain[201 aa]:TCRalpha chain[203 aa]:HCV1406 TCR alpha chain[207 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:T-cell receptor alpha variable 30,T-cell receptor,..:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:T cell receptor alpha chain[191 aa]:T cell receptor alpha chain[190 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 TCR alpha chain[195 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:Mel5 TCR, alpha chain[194 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:302TIL TCR alpha chain[189 aa]:302TIL TCR alpha chain[202 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:T-cell receptor alpha chain[198 aa]:a7b2 ALPHA CHAIN[192 aa]:a7b2 ALPHA CHAIN[191 aa]:Alpha chain of engineered high affinity T-cell rec..:T-cell receptor alpha chain[189 aa]:SILv44 T cell receptor beta chain[241 aa]:T4H2 T cell receptor alpha chain[201 aa]:Heavy chain of Fab fragment 11D06[215 aa]:T cell receptor, alpha chain[187 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:TRAV12-1 TCR-alpha[199 aa]:TRAV12-1 TCR-alpha[198 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:TCR alpha[191 aa]:TCR alpha[181 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor alpha chain[243 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, alpha chain[198 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:T-cell receptor alpha chain[200 aa]:Fab heavy chain[212 aa]:Fab heavy chain[218 aa]:TIL1383i (h3T) T cell receptor alpha chain[189 aa]..:T cell receptor, alpha chain[185 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:T-cell receptor alpha chain[199 aa]:Nucleoprotein[9 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR beta chain[287 aa]:PN45428 TCR alpha chain[251 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:TD08 TCR alpha chain[183 aa]:H25-11 TCR alpha chain[203 aa]:TCR alpha chain[198 aa]:TCR alpha chain[194 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa] GOL:EDO:PEG 47 0 2 1 0 1 5 2 5 1 0 12 0 4 2 4 9 2 2 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" A->V:LB/B:-: -; 183 Y H e 24.3 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:TCA_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:A14_VACCW:AMPD2_HUMAN:A0A0B4J279_HUMAN:TITIN_HUMAN:K7N5M3_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:A0A075B6T6_HUMAN:K7N5N2_HUMAN:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:TVAL2_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:TVA22_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:T CELL RECEPTOR ALPHA[115 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:T-cell Receptor alpha chain[194 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:Tax Peptide V7R[9 aa]:PROTEIN (human T-Cell receptor)[200 aa]:TAX PEPTIDE Y8A[9 aa]:HUMAN T-CELL RECEPTOR[200 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[200 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:TCR ALPHA[194 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:AHIII TCR ALPHA CHAIN[194 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR alpha chain[200 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:Antibody heavy chain[220 aa]:CANCER/MART-1[10 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 alpha chain[199 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:A6 alpha chain[200 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:T36-5 TCR alpha chain[199 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:JKF6 alpha chain[201 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Alpha Chain[196 aa]:Melanoma peptide L7A[10 aa]:High Affinity TCR Alpha Chain[197 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain alpha[194 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:C25 alpha[198 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:TCR alpha chain,Human nkt tcr alpha chain[201 aa]:Matrix protein 1[9 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:PF6 TCR alpha chain[190 aa]:PF6 TCR alpha chain[191 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:Epstein Barr Virus, Latent membrane protein-2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:TCRalpha chain[200 aa]:Influenza M1(58-66) peptide[9 aa]:TCRalpha chain[201 aa]:TCRalpha chain[203 aa]:KLV peptide[10 aa]:HCV1406 TCR alpha chain[207 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:Gag protein[9 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:NS3 peptide[10 aa]:T cell receptor alpha chain[191 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:T cell receptor alpha chain[190 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:DMF5 TCR alpha chain[189 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR alpha chain[195 aa]:ALK[10 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:G1/S-specific cyclin-D2[10 aa]:ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa]:Mel5 TCR, alpha chain[194 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Alpha chain of engineered high affinity T-cell rec..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:T4H2 T cell receptor alpha chain[201 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:T cell receptor, alpha chain[187 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor alpha chain[243 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, alpha chain[198 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:10LH single chain fragment variable (scFv)[227 aa]..:HIV-1 RT[9 aa]:PN45545 TCR beta chain[287 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:8-mer peptide from Protein Nef[8 aa]:TD08 TCR alpha chain[203 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:TCR alpha chain[198 aa]:TCR alpha chain[194 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:T-cell receptor alpha chain[183 aa]:KRAS-G12V nonamer peptide[9 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR alpha chain[176 aa] MET:LEU MG:IOD Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:EDO:GLY:P4G:SO4 14 0 0 14 7 0 0 1 2 17 2 0 0 0 1 1 3 2 3 33 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" 184 L H b 0.0 6o9c_A citrulline variant HA-1 peptide[9 aa] GOL 2 0 0 0 1 0 0 7 0 59 5 0 3 0 0 0 0 22 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 185 D H e 37.7 6o9c_A H2RG00_PANTR:K7N5M9_HUMAN:K7N5M3_HUMAN:TVA22_HUMAN:Uncharacterized protein, T-cell receptor, sp3.4 al..:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:TCRalpha chain[201 aa]:T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G..:T cell receptor alpha variable 22,Human nkt tcr al..:T-cell receptor alpha chain[189 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:T-cell receptor alpha chain[243 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:PA2.1 Fab Heavy Chain[215 aa]:PA2.1 Fab Light Chain[217 aa]:PA2.1 Fab Light Chain[218 aa]:TCR alpha chain[194 aa] PE8 SO4:GOL:PEG:EDO 0 0 33 25 0 2 3 0 4 5 0 7 0 3 3 10 3 0 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" D->E:LB/B:rs1059542: -; 186 G T e 35.7 6o9c_A A0A0B4J279_HUMAN:TCA_HUMAN:A0A087WSZ9_HUMAN:K7N5N2_HUMAN:TVA22_HUMAN:K7N5M3_HUMAN:T CELL RECEPTOR ALPHA[190 aa]:T-cell Receptor alpha chain[194 aa]:AHIII TCR ALPHA CHAIN[194 aa]:TCR ALPHA[194 aa]:C1-28 TCR alpha chain[198 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:T-cell receptor alpha variable 30,T-cell receptor,..:T cell receptor alpha variable 22,Human nkt tcr al..:a7b2 ALPHA CHAIN[192 aa]:T-cell receptor alpha chain[189 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:T-cell receptor alpha chain[198 aa]:PA2.1 Fab Heavy Chain[215 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR alpha chain[257 aa]:PN45428 TCR alpha chain[251 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa].. PE8 SO4:PEG:EDO:GOL 3 0 12 10 2 27 2 0 6 0 4 3 0 0 8 2 21 0 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 187 T H e 45.5 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:TCA_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:CRTC_HUMAN:MAR1_HUMAN:A2NVQ1_HUMAN:Q6PIZ8_HUMAN:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q692E0_CVHSA:Q6SW59_HCMV:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:WT1_HUMAN:Q9YJW5_HBV:LMP2_EBVB9:Q9YYU8_9HIV1:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9QAC5_HBV:R4P6M5_9INFA:R4X2K3_9INFA:H2RG00_PANTR:K7N5M9_HUMAN:A14_VACCW:AMPD2_HUMAN:A0A0B4J279_HUMAN:TITIN_HUMAN:K7N5M3_HUMAN:NEF_HV1ND:Q80817_9DELA:A0A0B4J277_HUMAN:W8FN10_9FLAV:A0A075B6T6_HUMAN:K7N5N2_HUMAN:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:A0A087WSZ9_HUMAN:TVAL2_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:RTA_EBVG:HAUS3_HUMAN:TVA22_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:RASN_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:T CELL RECEPTOR ALPHA[115 aa]:T CELL RECEPTOR ALPHA[190 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:T-cell Receptor alpha chain[194 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:HUMAN T-CELL RECEPTOR[200 aa]:Negative factor[10 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[200 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:AHIII TCR ALPHA CHAIN[194 aa]:TCR ALPHA[194 aa]:T-Cell Receptor, Alpha Chain[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[192 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR alpha chain[200 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:Antibody heavy chain[220 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:DMF5 alpha chain[199 aa]:MART-1(27-35) peptide[10 aa]:DMF4 alpha chain[195 aa]:DMF4 alpha chain[194 aa]:TAX(Y5F) peptide[9 aa]:A6 alpha chain[200 aa]:Latent membrane protein 2[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:1E6 TCR Alpha Chain[200 aa]:1E6 TCR Alpha Chain[201 aa]:1E6 TCR Alpha Chain[199 aa]:10-mer peptide from Protein Nef[10 aa]:C1-28 TCR alpha chain[198 aa]:H27-14 TCR alpha chain[194 aa]:H27-14 TCR alpha chain[204 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR alpha chain[204 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:JKF6 alpha chain[201 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Alpha Chain[197 aa]:Melanoma motif[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Nucleocapsid protein[11 aa]:Nucleoprotein[11 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain alpha[194 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:TCR alpha chain,Human nkt tcr alpha chain[201 aa]:TCR alpha chain,Human nkt tcr alpha chain[196 aa]:TCR alpha chain,Human nkt tcr alpha chain[198 aa]:TCR alpha chain,Human nkt tcr alpha chain[191 aa]:Melanoma derived Mart-1 peptide[10 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:PF6 TCR alpha chain[190 aa]:PF6 TCR alpha chain[191 aa]:Peptide Y9L[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:Human T-cell Receptor, Class I, Light alpha Chain[..:TAX protein[9 aa]:TCRalpha chain[200 aa]:TCRalpha chain[201 aa]:TCRalpha chain[203 aa]:HCV1406 TCR alpha chain[207 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:NA231 influenza epitope[9 aa]:GTS3 peptide[10 aa]:T-cell receptor alpha variable 30,T-cell receptor,..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:V-delta chain of T cell receptor[207 aa]:T cell receptor alpha chain[192 aa]:NS3 peptide[10 aa]:T cell receptor alpha chain[191 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:T cell receptor alpha chain[190 aa]:DMF5 TCR alpha chain[189 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR alpha chain[195 aa]:ALK[10 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:G1/S-specific cyclin-D2[10 aa]:Mel5 TCR, alpha chain[194 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:MM90[10 aa]:Melanoma antigen variant[9 aa]:302TIL TCR alpha chain[189 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:302TIL TCR alpha chain[202 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:a7b2 ALPHA CHAIN[192 aa]:a7b2 ALPHA CHAIN[191 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Alpha chain of engineered high affinity T-cell rec..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:T-cell receptor alpha chain[189 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:SILv44 T cell receptor alpha chain[196 aa]:T4H2 T cell receptor alpha chain[201 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Heavy chain of Fab fragment 11D06[215 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:T cell receptor, alpha chain[187 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:TRAV12-1 TCR-alpha[199 aa]:TRAV12-1 TCR-alpha[198 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:4C6 Human T-cell Receptor, alpha Chain[191 aa]:Human T-cell Receptor 4C6, alpha Chain[194 aa]:Diabetes epitope LWMRLLPLL[9 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:TCR alpha[191 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:TCR alpha[181 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:TCR alpha[163 aa]:TCR alpha[179 aa]:T-cell receptor (TRAV/TRAC)[201 aa]:Human T-cell Receptor YLQ36, alpha chain[199 aa]:T-cell receptor alpha chain (TRAV/TRAC)[200 aa]:T-cell receptor alpha chain[243 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, alpha chain[198 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:T-cell receptor alpha chain[200 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:T cell receptor, alpha chain[185 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR alpha chain[257 aa]:PN45545 TCR beta chain[287 aa]:PN45428 TCR alpha chain[251 aa]:CMV peptide[9 aa]:REGN6972 Fab heavy chain[214 aa]:TLF: TLFDEPPPL[9 aa]:SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa]..:SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa]..:TD08 TCR alpha chain[183 aa]:8-mer peptide from Protein Nef[8 aa]:TD08 TCR alpha chain[203 aa]:H25-11 TCR alpha chain[203 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:TCR alpha chain[198 aa]:TCR alpha chain[194 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:T-cell receptor alpha chain[183 aa]:KRAS-G12V nonamer peptide[9 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR alpha chain[176 aa]:TCR alpha chain[177 aa] PE8 NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p.. SO4:GOL:EDO:IMD:P4G 2 0 13 10 0 2 0 4 2 3 2 4 2 0 0 4 26 16 0 9 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" T->E:LB/B:-: -;T->R:LB/B:-: -; 188 C H b 0.0 6o9c_A 0 95 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 2 0 DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":TOPO_DOM:/note="Extracellular" 189 V H b 2.7 6o9c_A PA2.1 Fab Heavy Chain[215 aa] SO4:GOL:EDO 1 0 1 1 1 1 0 6 10 5 1 3 36 1 7 1 6 15 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 190 E H e 36.2 6o9c_A TCA_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:H2RG00_PANTR:K7N5M9_HUMAN:A0A0B4J279_HUMAN:A0A0B4J277_HUMAN:K7N5M3_HUMAN:A0A075B6T6_HUMAN:A0A075B6X0_HUMAN:A0A1B0GUM0_HUMAN:TVAL2_HUMAN:TVA22_HUMAN:T CELL RECEPTOR ALPHA[115 aa]:T-cell Receptor alpha chain[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:HUMAN T-CELL RECEPTOR[200 aa]:A6-Tcr[200 aa]:AHIII TCR ALPHA CHAIN[194 aa]:TCR ALPHA[194 aa]:A6 TCR alpha chain[200 aa]:Antibody heavy chain[220 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:DMF5 alpha chain[199 aa]:A6 alpha chain[200 aa]:10-mer peptide from Protein Nef[10 aa]:C1-28 TCR alpha chain[198 aa]:T36-5 TCR alpha chain[199 aa]:T36-5 TCR alpha chain[204 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:Mel5 TCR chain alpha[194 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:Protein TRAV21,T-cell receptor alpha chain C regio..:C7 TCR alpha chain[187 aa]:TCRalpha chain[200 aa]:TCRalpha chain[201 aa]:TCRalpha chain[203 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:T-cell receptor Alpha chain[201 aa]:T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[200 aa]:HUman T-cell receptor Alpha chain[201 aa]:Human T-cell receptor alpha chain[200 aa]:T-cell receptor alpha variable 12-2,T-cell recepto..:T cell receptor alpha chain[191 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:Mel5 TCR, alpha chain[194 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:T cell receptor alpha variable 22,Human nkt tcr al..:a7b2 ALPHA CHAIN[192 aa]:T-cell receptor alpha chain[189 aa]:T4H2 T cell receptor alpha chain[201 aa]:Heavy chain of Fab fragment 11D06[215 aa]:pYLQ7 T cell receptor alpha chain[197 aa]:Human 4C6 T-cell Receptor, alpha Chain[192 aa]:T-cell receptor alpha chain[243 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:YLQ-SG3 TCR alpha chain (TRAV12-2)[197 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:PA2.1 Fab Heavy Chain[215 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR alpha chain[257 aa]:REGN6972 Fab heavy chain[214 aa]:TD08 TCR alpha chain[183 aa]:TD08 TCR alpha chain[203 aa]:H25-11 TCR alpha chain[203 aa]:TCR alpha chain[194 aa]:T-cell receptor alpha chain[183 aa]:T-cell receptor alpha chain[182 aa]:TCR alpha chain[175 aa]:TCR alpha chain[177 aa] PE8 NA 1PG:GOL:SO4:EDO:PEG:IMD:ACT:FLC:PG4 8 0 2 22 1 6 13 1 1 3 2 1 1 15 15 3 2 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" E->D:LB/B:rs8795778: -; 191 W H e 25.9 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:TCA_HUMAN:NEF_HV1Z6:PME17_HUMAN:NCAP_CVHSA:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:TERT_HUMAN:H2RG00_PANTR:K7N5M9_HUMAN:A14_VACCW:AMPD2_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:A0A0B4J277_HUMAN:K7N5M3_HUMAN:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:TVAL2_HUMAN:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:T CELL RECEPTOR ALPHA[115 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:T CELL RECEPTOR ALPHA[190 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:T-cell Receptor alpha chain[194 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:Tax Peptide V7R[9 aa]:PROTEIN (human T-Cell receptor)[200 aa]:TAX PEPTIDE Y8A[9 aa]:HUMAN T-CELL RECEPTOR[200 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:A6-Tcr[200 aa]:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:AHIII TCR ALPHA CHAIN[194 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:A6 TCR alpha chain[200 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:Antibody heavy chain[220 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:T-CELL RECEPTOR, ALPHA CHAIN[194 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1[8 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:Peptidomimetic ELA-2.1[8 aa]:BSLF2/BMLF1 protein[9 aa]:T-CELL RECEPTOR, ALPHA CHAIN[195 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:DMF5 alpha chain[199 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:DMF4 alpha chain[195 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:A6 alpha chain[200 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:High Affinity TCR Alpha Chain[196 aa]:Melanoma peptide L7A[10 aa]:High Affinity TCR Alpha Chain[197 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:Telomerase reverse transcriptase[9 aa]:Uncharacterized protein, T-cell receptor, sp3.4 al..:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:Mel5 TCR chain alpha[194 aa]:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:Protein TRAV22,Human nkt tcr alpha chain[200 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:DMF5 TCR alpha chain[189 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:DMF5 TCR alpha chain[195 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:DMF5 T-cell Receptor Alpha Chain fusion[192 aa]:G1/S-specific cyclin-D2[10 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:302TIL TCR alpha chain[202 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:Alpha chain of engineered high affinity T-cell rec..:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:T-cell receptor alpha chain[189 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:T4H2 T cell receptor alpha chain[201 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:Heavy chain of Fab fragment 11D06[215 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Nucleoprotein peptide[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:T-cell receptor alpha chain[243 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:Mel5 Human TCR, alpha chain[198 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:Human Mel5 T Cell Receptor, Alpha Chain[199 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:Human T Cell Receptor Mel8, Alpha Chain[193 aa]:Human T Cell Receptor Mel8, Alpha Chain[190 aa]:Fab heavy chain[212 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Fab heavy chain[218 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:PN45545 TCR alpha chain[257 aa]:Melanoma-associated antigen 4[10 aa]:PN45428 TCR alpha chain[251 aa]:CMV peptide[9 aa]:REGN6972 Fab heavy chain[214 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] PE8 NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. 1PG:GOL:SO4:FMT:EDO:PEG:IMD:ACT:GLY:PG4 2 1 2 3 9 2 2 4 3 5 4 5 2 6 5 5 3 2 27 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" W->G:LB/B:rs3098019: -; 192 L H b 0.0 6o9c_A 3 1 1 1 2 2 0 5 1 49 0 1 1 1 11 7 1 7 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 193 R H e 39.5 6o9c_A IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:T-cell receptor alpha chain[189 aa]:PA2.1 Fab Heavy Chain[215 aa] IOD:CL:NA GOL:SO4:EPE:EDO:IMD 2 0 3 5 0 1 12 1 10 12 2 4 1 11 22 4 1 6 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 194 R H e 43.1 6o9c_A TCA_HUMAN:MAG1_HUMAN:MAGA1_HUMAN:Q9YYU8_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YYU3_9HIV1:TITIN_HUMAN:NEF_HV1ND:K7N5M3_HUMAN:PHX2B_HUMAN:RDRP_I97A1:SPIKE_SARS2:T CELL RECEPTOR ALPHA[115 aa]:T-CELL RECEPTOR, ALPHA CHAIN[200 aa]:PROTEIN (human T-Cell receptor)[200 aa]:HUMAN T-CELL RECEPTOR[200 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:A6-Tcr[200 aa]:nonameric peptide from Melanoma-associated antigen..:A6 TCR alpha chain[200 aa]:10-mer peptide from Protein Nef[10 aa]:DMF5 alpha chain[199 aa]:A6 alpha chain[200 aa]:Protein Nef[10 aa]:JKF6 alpha chain[201 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[8 aa..:High Affinity TCR Alpha Chain[196 aa]:High Affinity TCR Alpha Chain[197 aa]:8-Mer peptide from Protein Nef[8 aa]:IMMUNOGLOBULIN HEAVY CHAIN[223 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:Human T-cell receptor alpha chain[200 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:H7-25-F[5 aa]:HIV-1 Nef138-10 peptide[10 aa]:V-delta chain of T cell receptor[207 aa]:DMF5 TCR alpha chain[189 aa]:DMF5 alpha chain,DMF5 alpha chain[185 aa]:High Affinity Mel5 TCR, alpha chain[196 aa]:Alpha chain of engineered high affinity T-cell rec..:T-cell receptor alpha chain[189 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:Heavy chain of Fab fragment 11D06[215 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP peptide from influenza, YFSPIRVTF[9 aa]:Paired mesoderm homeobox protein 2B peptide[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:T-cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[198 aa]:10LH single chain fragment variable (scFv)[227 aa]..:PN45545 TCR alpha chain[257 aa]:REGN6972 Fab heavy chain[214 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:Spike protein S1[9 aa]:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa] 1PG:GOL:SO4:EDO:PEG:IMD:ACT:PG4 0 0 6 7 0 12 6 6 6 0 0 15 0 2 30 3 0 0 1 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 195 Y H b 1.7 6o9c_A TAT_HTL1C:ENV_HV1B8:CORA_HBVIL:M1_IAPUE:POL_HV1MA:MAGA4_HUMAN:POL_HV1Z2:MAGA3_HUMAN:ERBB2_HUMAN:NEF_HV1Z6:PME17_HUMAN:MAG1_HUMAN:NCAP_CVHSA:TERT_HUMAN:O11822_9HIV1:CRTC_HUMAN:CTG1B_HUMAN:MAR1_HUMAN:CO024_HUMAN:ENV_HV1MA:PP65_HCMVA:POL_HV1B1:MYPR_HUMAN:KPCD2_HUMAN:LSP1_HUMAN:POF1B_HUMAN:N4BP2_HUMAN:MAGA1_HUMAN:HMHA1_HUMAN:Q9YYH6_9HIV1:WT1_HUMAN:VME1_CVHSA:Q692E0_CVHSA:Q1WDM0_9INFA:Q6SW59_HCMV:EB2_EBVG:POLG_HCVJ1:FETA_HUMAN:Q9DIT6_9HEPC:SO2A1_HUMAN:Q9YYU8_9HIV1:A7UMS0_EBVG:Q9YJW5_HBV:LMP2_EBVB9:Q9YV12_9HIV1:INS_HUMAN:Q9YYU3_9HIV1:Q9WPU2_9HIV1:Q9Q5D4_9HIV1:Q9WPV9_9HIV1:TAX_HTL1F:Q9YXL3_9INFA:Q9YXL6_9INFA:Q9YXY3_9HIV1:O75767_HUMAN:ENV_HV1LW:Q9QAC5_HBV:R4P6M5_9INFA:A14_VACCW:AMPD2_HUMAN:TITIN_HUMAN:E9P5U1_9INFA:M1_I34A1:NEF_HV1ND:Q80817_9DELA:W8FN10_9FLAV:O11793_9HIV1:O11803_9HIV1:W0GUW4_9HIV1:W8EGN4_9HIV1:CCND2_HUMAN:Q9WGX1_9HIV1:RETR2_HUMAN:SYNEM_HUMAN:RTA_EBVG:CTNB1_HUMAN:HAUS3_HUMAN:HHAT_HUMAN:PMEL_HUMAN:P53_HUMAN:NCAP_SARS2:PK3CA_HUMAN:R1AB_SARS2:SPIKE_SARS2:IBPL1_HUMAN:PHX2B_HUMAN:NCAP_INBAC:RASN_HUMAN:MAGAA_HUMAN:TYRO_HUMAN:NCAP_INBSI:M1_INBAC:NS1_INBSJ:I27RA_HUMAN:NCAP_I46A1:RDRP_I97A1:MAGA8_HUMAN:RASK_HUMAN:HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa]:TAX PEPTIDE[9 aa]:PEPTIDE P1049 (ALWGFFPVL)[9 aa]:PROTEIN (INFLUENZA MATRIX PEPTIDE)[7 aa]:HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa]:GP2 PEPTIDE[9 aa]:HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 ..:HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[..:INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a..:HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a..:NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE..:BOUND PEPTIDE FRAGMENT[3 aa]:PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9..:HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 4[10 aa]:9 RESIDUE PEPTIDE[9 aa]:Human T-cell lymphotropic virus type 1 Tax peptide..:decameric peptide ligand from the MART-1/Melan-A[1..:nonameric peptide ligand from the MART-1/Melan-A[9..:self-peptide P1049[9 aa]:GILGFVFTL[9 aa]:POL polyprotein[9 aa]:nonamer reverse transcriptase (AIFQSSMTK)[9 aa]:PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa]:TAX PEPTIDE P6A[9 aa]:Tax Peptide V7R[9 aa]:TAX PEPTIDE Y8A[9 aa]:Negative factor[10 aa]:gag peptide[9 aa]:NY-ESO-1 peptide[9 aa]:NY-ESO-1 peptide analogue S9A[9 aa]:NY-ESO-1 peptide analogue S9S[9 aa]:GAG PEPTIDE[9 aa]:epitope of Melanocyte protein Pmel 17[9 aa]:MELANOMA-ASSOCIATED ANTIGEN 1[9 aa]:SARS NUCLEOCAPSID PEPTIDE[9 aa]:Trans-activating transcriptional regulatory peptid..:Telomerase reverse transcriptase[9 aa]:SYNTHETIC PEPTIDE[9 aa]:GAG PROTEIN[9 aa]:DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa]:Cancer/testis antigen 1B[9 aa]:Transcriptional activator TAX[9 aa]:Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a..:Melan-A/MART-1(26-35) peptide[10 aa]:octapeptide from Melan-A/MART-1[9 aa]:Peptide[9 aa]:DNA polymerase PEPTIDE HOMOLOGUE[10 aa]:SELF-PEPTIDE P1049[9 aa]:P1049[9 aa]:UNCHARACTERIZED PROTEIN C15ORF24[9 aa]:HIV P17[9 aa]:FLU MATRIX PEPTIDE[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a..:ENVELOPE GLYCOPROTEIN GP160[9 aa]:HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a..:65 KDA PHOSPHOPROTEIN[9 aa]:H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa]:REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa]:MYELIN PROTEOLIPID PROTEIN[9 aa]:nonameric peptide from Serine/threonine-protein ki..:decameric peptide from Lymphocyte-specific protein..:decameric peptide from Protein POF1B[10 aa]:decameric peptide from NEDD4-binding protein 2[10 ..:nonameric peptide from Melanoma-associated antigen..:Nonameric peptide from HA-1[9 aa]:Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa]:Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 ..:peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa]:phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G..:peptide 38-46 from cell division cycle 25b (CDC25b..:phospho-peptide 38-46 from cell division cycle 25b..:peptide 1097-1105 from insulin receptor substrate ..:phospho-peptide 1097-1105 from insulin receptor s..:citrulline variant HA-1 peptide[9 aa]:histidine variant HA-1 peptide[9 aa]:arginine variant HA-1 peptide[9 aa]:HIV-1 peptide[10 aa]:NYESO-1 peptide[9 aa]:HCMV pp65 fragment 495-503 (NLVPMVATV)[9 aa]:HCMV pp65 fragment 495-503, variant M5S (NLVPSVATV..:HCMV pp65 fragment 495-503, variant M5V (NLVPVVATV..:HCMV pp65 fragment 495-503, variant M5T (NLVPTVATV..:HCMV pp65 fragment 495-503, variant M5Q (NLVPQVATV..:HCMV pp65 fragment 495-503, variant T8A (NLVPMVAAV..:HCMV pp65 fragment 495-503, variant T8V (NLVPMVAVV..:Tel1p peptide[9 aa]:CANCER/MART-1[10 aa]:WT126 peptide[9 aa]:Membrane protein[9 aa]:Membrane glycoprotein peptide[10 aa]:Nucleoprotein peptide[9 aa]:Tax peptide[9 aa]:NYESO-1 peptide analogue[9 aa]:10-meric peptide from Hemagglutinin[10 aa]:9-meric peptide from Tegument protein pp65[9 aa]:9-meric peptide from mRNA export factor EB2[9 aa]:9-meric peptide from Serine protease/NTPase/helica..:9-meric peptide from Alpha-fetoprotein[9 aa]:10-meric peptide from Genome polyprotein[10 aa]:10-meric peptide from Melanoma antigen recognized ..:10-meric peptide from Solute carrier organic anion..:Wilms tumor protein[9 aa]:10-mer peptide from Protein Nef[10 aa]:Peptidomimetic ELA-1.1[8 aa]:Peptidomimetic ELA-2[8 aa]:BSLF2/BMLF1 protein[9 aa]:10mer peptide from Pre-core-protein[10 aa]:HuD (G2L,I9V) peptide[9 aa]:HuD peptide[9 aa]:HuD (G2L) peptide[9 aa]:Mart-1 (26-35) peptide[10 aa]:MART-1(27-35) peptide[9 aa]:MART-1(27-35) peptide[10 aa]:Mart-1(27-35) peptide[9 aa]:TAX(Y5F) peptide[9 aa]:Latent membrane protein 2[9 aa]:RT313 peptide[9 aa]:Nef73 peptide from Protein Nef[10 aa]:Md3-C9 peptide derived from Membrane glycoprotein[..:Insulin[10 aa]:HIV peptide KVAELVHFL[9 aa]:HIV-based altered-peptide ligand KVAEIVHFL[9 aa]:HIV-based altered-peptide ligand KVAELVWFL[9 aa]:Protein Nef[10 aa]:Protein Tax-1[9 aa]:Melanoma antigen recognized by T-cells 1[9 aa]:PA polymerase subunit[10 aa]:RNA-directed RNA polymerase catalytic subunit[7 aa..:RNA-directed RNA polymerase catalytic subunit[8 aa..:FAT Cognate peptide[10 aa]:FLT Cognate peptide[10 aa]:9-mer peptide from Pol protein[9 aa]:9-mer peptide from Tyrosinase-related protein-2[9 ..:9-mer peptide from Envelope glycoprotein gp160[9 a..:Immunogenic peptide[9 aa]:Melanoma peptide[10 aa]:Melanoma peptide L7A[10 aa]:Melanoma motif[10 aa]:E1A heteroclitic Melanoma peptide[10 aa]:G4A heteroclitic Melanoma peptide[10 aa]:L8A heteroclitic Melanoma peptide[10 aa]:Core protein[9 aa]:NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa]:NY-ESO1 double mutant (1Y, 9V)[9 aa]:Melanoma antigen recognized by T-cells 1[10 aa]:Nucleocapsid protein[11 aa]:peptide from Virion membrane protein A14[9 aa]:Serine/threonine-protein kinase D2[9 aa]:Lymphocyte-specific protein 1[12 aa]:AMP deaminase 2[9 aa]:Nucleoprotein[9 aa]:NP44-S7N mutant peptide, CTELKLNDY[9 aa]:Melanoma antigen recognized by T-cells 1 marker pe..:ALQDA peptide, ALQDAGDSSRKEYFI[10 aa]:FLNKD peptide, FLNKDLEVDGHFVTM[15 aa]:AZOBENZENE-CONTAINING PEPTIDE[7 aa]:AZOBENZENE-CONTAINING PEPTIDE[6 aa]:8-Mer peptide from Protein Nef[8 aa]:ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa]:GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa]:Titin[9 aa]:Marker peptide[10 aa]:ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL[9 aa]:11-mer peptide F11V[11 aa]:12-mer peptide F12K[12 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa]:Matrix protein 1[9 aa]:Melanoma derived Mart-1 peptide[10 aa]:Peptide G9L[9 aa]:Peptide G13E[11 aa]:GP100 peptide YLEPGPVTA[9 aa]:Peptide antigen YLAPGPVTA[9 aa]:Peptide antigen YLEPAPVTA[9 aa]:TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa]:Peptide G11N[10 aa]:Peptide Y9L[9 aa]:G9V[9 aa]:Peptide Y16R[11 aa]:Peptide Y10L[10 aa]:Epstein Barr Virus, Latent membrane protein 2 epit..:Epstein Barr Virus, Latent Membrane Protein 2 epit..:8-mer from Protein Nef[8 aa]:Protein Nef[8 aa]:M1-F5L, GILGLVFTL[9 aa]:M1-G4E, GILEFVFTL[9 aa]:M1-L3W, GIWGFVFTL[9 aa]:ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa]:TAX protein[9 aa]:influenza M1 for peptide[9 aa]:Influenza M1(58-66) peptide[9 aa]:KLV peptide[10 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa]:ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa]:ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa]:MVWGPDPLYV[10 aa]:NS5[9 aa]:Gag protein[9 aa]:NA231 influenza epitope[9 aa]:GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa]:GTS1 peptide[10 aa]:GTS3 peptide[10 aa]:GLY-VAL-TRP-ILE-ARG-THR-PRO-THR-ALA[9 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[11 aa]..:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[6 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-MET-THR-PHE[7 aa]:LEU-TYR-LYS-LYS-LEU-LYS-ARG-GLU-ILE-THR-PHE[11 aa]..:H7-25-F[5 aa]:H7-25-F[7 aa]:H7-25[11 aa]:HIV-1 Nef138-10 peptide[10 aa]:NS3 peptide[10 aa]:LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa]:SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa]:MET-MET-TRP-ASP-ARG-GLY-LEU-GLY-MET-MET[10 aa]:ALK[10 aa]:G1/S-specific cyclin-D2[10 aa]:Polyprotein[9 aa]:Reticulophagy regulator 2[9 aa]:Synemin[9 aa]:MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa]:ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa]:peptide[9 aa]:RT313[9 aa]:ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa]:MTB[9 aa]:NP44[9 aa]:ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa]:ALA-THR-ILE-GLY-THR[5 aa]:NRAS Q61K peptide[10 aa]:Replication and transcription activator[9 aa]:Peptide MM91[9 aa]:MM92[9 aa]:MM90[10 aa]:MM96[10 aa]:Catenin beta-1[9 aa]:Melanoma antigen variant[9 aa]:Neoantigen peptide KQWLVWLFL[9 aa]:influenza A NP145-156 peptide[7 aa]:HAUS augmin-like complex subunit 3[9 aa]:SER-LEU-LEU-MET-TRP-ILE-THR-GLN-VAL[9 aa]:SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa]:Cancer/testis antigen 1[9 aa]:Heteroclitic NY-ESO-1 157-165 peptide[9 aa]:LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa]:LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa]:EAAGIGILTV[10 aa]:MAGE-A4 peptide (amino acids 230-239) variant[10 a..:MAGE-A4 peptide (amino acids 230-239)[10 aa]:Protein-cysteine N-palmitoyltransferase HHAT[9 aa]..:LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa]:Melanocyte protein PMEL[9 aa]:peptide from p53 tumor suppressor[9 aa]:Cellular tumor antigen p53 peptide[9 aa]:PB2-549-557 peptide from Influenza B, TYQWVLKNL[9 ..:ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa]:LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa]:LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa]:Wilms tumor 1 (WT1) derived peptide[9 aa]:9-mer peptide from the HCoV spike protein[9 aa]:SARS-CoV-2 T-cell Epitope S1[9 aa]:SARS-CoV-2 T-cell Epitope pep4[9 aa]:NP-164-173 peptide from influenza B, IYFSPIRVTF[10..:NP peptide from influenza, YFSPIRVTF[9 aa]:PB2 peptide from influenza, TYQWIIRNW[9 aa]:PB2 peptide from Influenza, TYQWIIRNWET[11 aa]:ARG-TYR-PRO-LEU-THR-PHE-GLY-TRP[8 aa]:Nucleoprotein[3 aa]:wild-type PIK3CA peptide[9 aa]:mutant PIK3CA peptide[9 aa]:Mutant PIK3CA peptide[9 aa]:Non-structural protein 8[9 aa]:Non-structural protein 7[9 aa]:Spike protein S1 peptide[10 aa]:Spike protein S1 peptide[9 aa]:Insulin-like growth factor-binding protein-like 1 ..:Paired mesoderm homeobox protein 2B peptide[9 aa]:Spike protein S1[9 aa]:Spike protein S2[9 aa]:GLN-LEU-PRO-ARG-LEU-PHE-PRO-LEU-LEU[9 aa]:Diabetes epitope LWMRLLPLL[9 aa]:KRAS peptide (VVVGAGGVGK)[10 aa]:KRAS peptide (VVVGAGGVGK)[7 aa]:KRAS peptide (VVVGAGGVGK)[6 aa]:KRAS G12D peptide (VVVGADGVGK)[8 aa]:KRAS G12D peptide (VVVGADGVGK)[10 aa]:Spike glycoprotein[9 aa]:TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa]:Melanoma-associated antigen 10[9 aa]:Tumor-associated antigentic peptide gp100[9 aa]:ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa]:GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa]:PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa]:Tyrosinase peptide[9 aa]:Nucleoprotein peptide KTNGNAFIGK[10 aa]:Matrix protein 1 peptide SALEWIKNK[9 aa]:Non-structural protein 1 peptide RVLVNGTFLK[10 aa]..:Spike protein S2' peptide VVFLHVTYV [9 aa]:Spike protein S2' peptide VLNDILSRL [9 aa]:KRAS G12V (7-16)[10 aa]:Interleukin-27 receptor subunit alpha[17 aa]:Interleukin-27 receptor subunit alpha[16 aa]:Spike protein S2' peptide [9 aa]:PGM5 peptide (465-473) (H5Y)[9 aa]:SARS-CoV-2 Spike-derived peptide S417-425 K417T mu..:SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG..:LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa]:PB1 peptide[8 aa]:8-mer model peptide[8 aa]:LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa]:VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa]:HIV-1 RT[9 aa]:Melanoma-associated antigen 4[10 aa]:CMV peptide[9 aa]:Melanoma-associated antigen 4 peptide[10 aa]:Melanoma-associated antigen 4 peptide[9 aa]:TLF: TLFDEPPPL[9 aa]:8-mer peptide from Protein Nef[8 aa]:mutated 8-mer peptide from Protein Nef[8 aa]:SARS-CoV-2 T-cell epitope QYIKWPWYI[9 aa]:peptide KRAS-G12V-9[9 aa]:KRAS-G12wt-9[9 aa]:CYS-TYR-THR-TRP-ASN-GLN-MET-ASN-LEU[9 aa]:Spike protein S2' [10 aa]:SARS-CoV-2 Spike-derived peptide S976-984 S982A mu..:LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE[9 aa]:Sorting nexin 24 (127-135)(P132L) peptide[9 aa]:Sorting nexin 24 (127-135) peptide[9 aa]:KRAS-G12V nonamer peptide[9 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. FMT:GLY:EDO 0 0 0 4 11 3 12 4 0 10 0 6 0 0 0 0 0 6 0 43 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen":TOPO_DOM:/note="Extracellular" Y->H:LB/B:-: -; 196 L H b 9.0 6o9c_A GOL:EDO 1 0 0 8 0 5 0 5 0 52 3 6 0 5 3 1 3 2 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 197 E H e 57.8 6o9c_A Q8BEL5_ADE04:I6LEL9_HUMAN:T CELL RECEPTOR ALPHA[115 aa]:E3 19 kDa protein[103 aa]:KIR3DL1[280 aa]:PA2.1 Fab Heavy Chain[215 aa] IOD GOL:SO4:EDO:EPE:PG4 8 0 7 28 3 1 0 4 5 8 7 2 2 5 2 1 2 8 0 6 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 198 N H e 38.2 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa] GOL:ACT:PEG:EDO 9 3 0 11 0 10 2 6 1 6 1 14 0 3 6 12 2 4 0 9 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 199 G T b 3.6 6o9c_A IOD:MG GOL 8 0 0 6 3 40 0 0 5 8 3 0 0 4 5 8 0 3 3 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 200 K H e 51.4 6o9c_A US02_HCMVA:I6LEL9_HUMAN:cytomegalovirus protein US2[95 aa]:KIR3DL1[280 aa]:PA2.1 Fab Heavy Chain[215 aa] NA EDO:GOL:SO4 1 0 8 6 4 4 0 0 21 6 0 6 8 0 18 9 3 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 201 E H e 68.3 6o9c_A US02_HCMVA:E3GL_ADE06:Q8BEL5_ADE04:I6LEL9_HUMAN:cytomegalovirus protein US2[95 aa]:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:T cell receptor, alpha chain[110 aa]:T cell receptor, beta chain[114 aa]:KIR3DL1[280 aa] NA:CL Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[273 aa]:HLA class I histocompatibility antigen[274 aa] GOL:PGE 6 0 8 11 12 5 4 1 7 6 5 7 4 6 3 8 3 1 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 202 T H e 37.0 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, alpha chain[110 aa] IOD:CL:NA:MG Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa] GOL:FMT:ACT:SO4:PGE:EDO 10 0 6 6 4 3 3 3 2 3 3 6 0 0 3 5 31 8 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 203 L H b 1.7 6o9c_A GOL:IMD:EDO 1 0 1 1 1 1 0 15 1 16 0 1 15 15 1 1 1 15 14 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 204 Q T e 54.1 6o9c_A US02_HCMVA:Q8BEL5_ADE04:cytomegalovirus protein US2[95 aa]:E3 19 kDa protein[103 aa]:PA2.1 Fab Heavy Chain[215 aa] TAM IOD:NA:MG:ZN GOL:SO4:EDO 8 0 8 8 0 8 7 0 8 8 0 7 8 7 8 8 8 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 205 R e 63.6 6o9c_A US02_HCMVA:E3GL_ADE06:Q8BEL5_ADE04:I6LEL9_HUMAN:cytomegalovirus protein US2[95 aa]:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[103 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, beta chain[112 aa]:T cell receptor, alpha chain[110 aa]:T cell receptor, beta chain[114 aa]:KIR3DL1[280 aa] CL:NA Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa] GOL:FMT:EDO:IMD:PG4:ACT:SO4:PGE 0 2 3 0 0 5 3 0 7 3 0 8 4 6 47 0 4 3 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 206 T e 42.9 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa] GOL:EDO:IMD:TRS 7 0 0 0 3 0 2 9 6 4 0 2 0 10 8 3 34 11 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 207 D B e 38.9 6o9c_A US02_HCMVA:E3GL_ADE06:Q8BEL5_ADE04:I6LEL9_HUMAN:cytomegalovirus protein US2[95 aa]:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, beta chain[112 aa]:T cell receptor, alpha chain[110 aa]:T cell receptor, beta chain[114 aa]:KIR3DL1[280 aa] NAG MG Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[274 aa] GOL:EDO:FMT:PG4:SO4:TRS 3 0 17 21 0 5 0 0 3 1 3 0 17 6 3 3 0 17 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 208 P e 47.3 6o9c_A MG EDO:GOL:TRS 5 4 0 13 4 0 4 0 10 0 0 0 33 9 5 5 4 0 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" P->A:LB/B:-: -; 209 P b 7.0 6o9c_A EDO:GOL 0 0 0 17 0 0 0 17 17 0 0 0 17 0 0 0 17 17 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 210 K E e 68.4 6o9c_A E3GL_ADE06:Q8BEL5_ADE04:B2MG_HUMAN:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:Beta-2-microglobulin[100 aa]:T cell receptor, beta chain[112 aa]:T cell receptor, beta chain[114 aa] NAG NA:MG Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa] GOL:PG4:EDO:MES:ACT 0 0 1 14 0 0 0 0 28 6 6 2 0 4 2 10 10 17 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" K->R:LB/B:-: -; 211 T E e 22.1 6o9c_A NA:MG GOL:EDO 16 0 0 0 0 2 0 4 0 2 5 0 0 0 1 0 20 48 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 212 H E e 43.5 6o9c_A B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa] CL:NA:MG GOL:EDO:PEG:PG4:SO4 1 0 0 2 1 0 13 8 6 1 0 3 2 10 12 4 8 9 13 6 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 213 M E b 13.0 6o9c_A PEG:PG4:GOL:SO4 0 0 0 0 5 0 0 6 0 30 2 0 3 0 0 4 2 47 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 214 T E e 22.1 6o9c_A B2MG_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[101 aa] NA:CL GOL:EDO:PG4:SO4:PEG 4 0 0 2 0 0 0 0 5 0 0 3 2 2 4 31 44 0 1 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 215 H E e 28.3 6o9c_A B2MG_HUMAN:Beta-2-microglobulin[100 aa] CD:NA:CO:CL GOL:CIT:SO4:EDO:PEG:MES 5 5 0 0 4 3 21 0 7 2 0 2 4 6 22 12 0 3 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 216 H E e 38.2 6o9c_A B2MG_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[93 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa] ZN:CD:NA GOL:MES:CIT:SO4:EDO:PEG 0 0 0 2 0 9 31 0 7 0 0 0 5 3 16 13 9 1 0 3 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 217 P E e 72.9 6o9c_A LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:leukocyte immunoglobulin-like receptor 1[183 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[169 aa]:LIR-1[188 aa]:LIR-1[184 aa]:LIR-1[176 aa] GOL:CIT:SO4:EDO:PEG:MES 2 0 0 11 0 0 0 0 2 0 0 8 60 4 2 5 0 3 2 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" P->A:LB/B:-: -; 218 I S e 55.0 6o9c_A LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:leukocyte immunoglobulin-like receptor 1[183 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[169 aa]:LIR-1[188 aa]:LIR-1[184 aa]:LIR-1[176 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[222 aa] EDO 17 0 1 4 2 5 0 8 0 12 0 1 3 1 5 9 9 18 0 7 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" I->V:LB/B:-: -; 219 S S e 36.7 6o9c_A LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:leukocyte immunoglobulin-like receptor 1[183 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[169 aa]:LIR-1[188 aa]:LIR-1[184 aa]:LIR-1[176 aa] GOL:EDO:SO4:PEG 4 0 1 11 4 5 0 0 3 7 0 13 19 5 1 23 4 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 220 D S e 95.7 6o9c_A LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:leukocyte immunoglobulin-like receptor 1[183 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[169 aa]:LIR-1[188 aa]:LIR-1[184 aa]:LIR-1[176 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[222 aa] GOL:EDO:IMD:SO4:PEG 4 0 15 10 0 16 2 1 1 6 0 11 13 2 2 10 3 4 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 221 H S e 66.5 6o9c_A B2MG_HUMAN:LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:Beta-2-microglobulin[100 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[188 aa]:LIR-1[184 aa]:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[222 aa] CD:CO:ZN EDO:SO4 1 0 1 1 0 42 18 0 5 0 0 8 2 7 11 1 1 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 222 E E e 39.2 6o9c_A CD8A_HUMAN:LIRB1_HUMAN:B2MG_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:leukocyte immunoglobulin-like receptor 1[183 aa]:Beta-2-microglobulin[100 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:LIR-1[188 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[176 aa]:Immunoglobulin heavy chain H2[222 aa] CD:CO:CA:ZN GOL:SO4:EDO:PEG 1 0 2 15 4 1 14 3 12 0 0 8 7 2 16 7 0 4 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 223 A E b 1.8 6o9c_A SO4 20 0 0 0 0 0 0 5 1 12 0 19 10 0 5 7 7 12 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 224 T E b 13.6 6o9c_A LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:Leukocyte immunoglobulin-like receptor subfamily B..:LIR-1[169 aa]:LIR-1[188 aa]:LIR-1[184 aa]:LIR-1[176 aa] NA MES:GOL:EDO:SO4 1 0 0 5 2 0 0 7 1 16 1 8 0 4 0 4 38 11 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 225 L E b 0.0 6o9c_A GOL 4 0 0 0 4 0 0 0 0 86 0 0 0 0 0 0 0 7 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 226 R E b 18.6 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. MES:GOL:EDO:SO4 4 0 0 0 6 3 1 10 4 5 0 11 0 0 16 1 17 22 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 227 C E b 0.0 6o9c_A 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 228 W E b 17.9 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA:CL Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:EDO:SO4:PG4:PEG:ACT:PO4 3 0 0 2 7 0 14 1 2 9 2 0 0 5 13 14 4 3 11 11 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 229 A E b 0.0 6o9c_A 40 0 0 0 0 0 0 11 0 0 3 0 0 0 0 4 0 43 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 230 L E e 24.7 6o9c_A B2MG_HUMAN:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin[96 aa] NA:MG GOL:EDO:SO4:PG4:MES:ACT:PEG:PO4 1 0 9 0 11 0 4 3 0 14 0 6 0 0 1 29 11 0 2 10 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 231 G E b 16.7 6o9c_A B2MG_HUMAN:E3GL_ADE06:Q8BEL5_ADE04:Beta-2-microglobulin[93 aa]:Early E3 18.5 kDa glycoprotein[99 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:Beta-2-microglobulin[99 aa]:T cell receptor, beta chain[112 aa]:T cell receptor, beta chain[114 aa] MG GOL:PG4:EDO:MES:ACT 0 0 17 0 0 54 0 0 5 0 0 13 0 2 2 7 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" G->S:LB/B:-: -; 232 F E b 0.0 6o9c_A 0 0 0 0 87 0 0 6 0 6 0 0 0 0 0 0 0 0 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 233 Y B b 8.7 6o9c_A T cell receptor, alpha chain[108 aa]:T cell receptor, alpha chain[110 aa] GOL:FMT:PG4:SO4 2 1 0 0 13 0 15 0 0 0 0 0 0 0 0 5 1 0 0 64 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 234 P S e 27.9 6o9c_A GOL:SO4:PGE:PEG 0 0 0 0 0 0 0 0 0 0 0 0 96 0 0 2 2 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 235 A S b 17.0 6o9c_A GOL:MES:SO4:EDO:PG4 14 0 3 5 0 15 0 0 12 1 0 0 27 7 7 5 2 0 1 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 236 E e 80.4 6o9c_A CD:NA GOL:MES:EDO:SO4:PGE:PEG 0 0 11 23 0 0 2 3 4 0 0 11 12 9 7 7 0 12 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 237 I b 9.4 6o9c_A NA GOL:EDO 4 0 0 0 0 2 0 65 0 10 0 0 0 0 0 0 0 19 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 238 T E e 37.7 6o9c_A CD8A_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa.. NA GOL:EDO 0 0 2 11 0 1 2 0 9 0 0 12 0 7 2 11 31 1 9 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 239 L E b 5.6 6o9c_A EDO 0 0 0 0 2 0 0 22 0 28 6 0 0 0 0 0 0 42 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 240 T E e 23.4 6o9c_A EDO 2 0 5 4 0 0 5 1 3 2 11 1 0 2 17 9 37 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 241 W E b 0.0 6o9c_A EDO 0 0 0 0 8 0 0 0 0 9 2 0 0 0 0 0 0 0 81 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 242 Q E b 19.9 6o9c_A CO GOL:EDO:SO4:TRS 0 0 0 2 11 0 0 4 7 39 16 3 0 12 3 1 2 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 243 R E e 39.5 6o9c_A NA 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. SO4 3 1 0 1 0 0 4 0 32 8 0 0 0 9 39 2 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 244 D T e 56.8 6o9c_A 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. FMT:SO4:GOL:ACT:EDO 5 0 31 1 0 4 0 0 0 1 0 47 1 0 0 2 0 0 0 5 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 245 G T e 51.2 6o9c_A EDO:SO4:TRS 1 0 1 1 0 79 0 0 1 0 0 3 0 2 5 4 0 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 246 E E e 66.3 6o9c_A CD8A_HUMAN:T-cell surface glycoprotein CD8 alpha chain[114 aa.. NA:ZN EDO:TRS:ACT 3 0 5 30 0 0 4 0 20 3 0 3 0 19 1 0 4 7 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 247 D E e 59.9 6o9c_A NA GOL:EDO:TRS 5 0 13 22 0 1 0 1 13 6 0 0 15 8 1 8 2 3 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 248 Q b 14.8 6o9c_A NA GOL:EDO 2 0 2 20 0 2 0 7 6 12 6 2 0 17 2 4 0 17 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 249 T T e 66.2 6o9c_A CD8A_HUMAN:TPSN_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Tapasin[364 aa]:Tapasin[348 aa] GOL:EDO 8 0 0 3 1 4 1 5 7 3 3 0 7 11 2 7 30 5 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 250 Q T e 86.7 6o9c_A CD8A_HUMAN:B2MG_HUMAN:TPSN_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:Beta-2-microglobulin[100 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Tapasin[364 aa]:Tapasin[348 aa] GOL:EDO 8 0 3 15 2 5 2 0 10 0 3 0 8 29 1 4 6 4 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 251 D T e 71.0 6o9c_A CD8A_HUMAN:B2MG_HUMAN:A0A0G2JQ44_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:Beta-2-microglobulin[100 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Leukocyte immunoglobulin-like receptor subfamily B.. GOL:SO4:EDO 0 0 23 18 0 33 2 0 9 0 0 2 2 2 3 2 2 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 252 T b 19.5 6o9c_A CD8A_HUMAN:TPSN_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Tapasin[348 aa] GOL:EDO 6 0 1 0 2 1 0 3 0 1 6 2 4 0 2 10 30 30 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 253 E E e 55.8 6o9c_A CD8A_HUMAN:B2MG_HUMAN:TPSN_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:Beta-2-microglobulin[100 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[222 aa]:Tapasin[348 aa]:Beta-2-microglobulin[99 aa] NA GOL:PG4:SO4 3 0 7 33 4 6 2 0 3 0 1 4 2 10 1 11 3 10 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 254 L E e 53.4 6o9c_A CD8A_HUMAN:TPSN_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Tapasin[348 aa] GOL:SO4:EDO 4 4 0 8 5 3 3 1 2 16 5 0 6 10 7 11 1 7 0 5 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 255 V e 22.7 6o9c_A B2MG_HUMAN:CD8A_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:T-CELL CORECEPTOR CD8[114 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] IOD GOL:SO4:EDO:PG4:PEG 2 2 0 2 0 22 1 0 2 5 2 4 2 0 2 13 19 20 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 256 E e 86.9 6o9c_A B2MG_HUMAN:CD8A_HUMAN:B2MG_PANTR:TPSN_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:T-CELL CORECEPTOR CD8[114 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Tapasin[348 aa]:Beta-2-microglobulin[90 aa] NA:CL:IOD Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:MES:SO4:ACT:EDO:PEG 1 0 29 16 2 12 1 0 3 4 0 2 5 3 0 11 6 4 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 257 T e 29.2 6o9c_A B2MG_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:BETA 2-MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:BETA-2 MICROGLOBULIN[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] CL GOL:MES:SO4:EDO:PG4:ACT 2 0 0 0 11 0 0 13 0 17 2 3 1 0 0 7 26 14 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 258 R E e 36.8 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] CL:NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:FMT:EDO:SO4:PG4:PEG:ACT:PO4 0 0 0 0 3 5 1 9 7 36 1 2 2 2 14 9 3 3 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 259 P E e 73.6 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:7PE:MES:EDO:PG4:PEG:SO4 1 0 0 1 8 2 1 1 1 2 0 0 62 5 9 5 2 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 260 A e 37.5 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:7PE:MES:EDO 12 1 4 1 0 1 2 2 3 1 0 35 0 2 7 22 7 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 261 G S e 86.9 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:7PE:EDO:SO4:PG4:PEG 14 1 2 2 2 51 0 0 8 2 0 4 2 0 0 6 3 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 262 D S e 74.7 6o9c_A B2MG_HUMAN:B2MG_PANTR:E3GL_ADE06:Q8BEL5_ADE04:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:Beta-2-microglobulin[99 aa]:BETA 2-MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Early E3 18.5 kDa glycoprotein[99 aa]:Early E3 18.5 kDa glycoprotein[97 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:E3 19 kDa protein[102 aa]:E3 19 kDa protein[103 aa]:Beta-2-microglobulin[101 aa]:T cell receptor, alpha chain[108 aa]:T cell receptor, beta chain[112 aa]:T cell receptor, alpha chain[110 aa]:T cell receptor, beta chain[114 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NAG Q53Z42_HUMAN:Q5S3G3_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p..:HLA class I histocompatibility antigen[275 aa]:HLA class I histocompatibility antigen[273 aa]:HLA class I histocompatibility antigen[274 aa] GOL:SO4:7PE:EDO:MES:PG4:PGE 0 0 82 0 0 0 0 0 0 0 0 12 1 5 0 0 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 263 G S e 54.8 6o9c_A T cell receptor, alpha chain[110 aa] GOL:FMT:7PE:PG4:SO4:EDO 1 0 1 4 0 49 7 0 0 2 0 2 0 0 3 4 0 0 25 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 264 T b 11.7 6o9c_A E3GL_ADE06:Early E3 18.5 kDa glycoprotein[97 aa]:T cell receptor, beta chain[112 aa]:T cell receptor, beta chain[114 aa] NAG Q5S3G3_HUMAN:HLA class I histocompatibility antigen[275 aa] GOL:7PE:EDO:MES:PG4:PGE 0 0 0 0 0 0 0 0 0 4 0 4 0 0 0 19 73 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 265 F E b 14.8 6o9c_A GOL:7PE:MES:SO4:EDO:PEG:PG4 0 0 0 0 58 0 0 0 0 0 0 3 0 0 0 0 0 0 11 29 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 266 Q E e 23.5 6o9c_A B2MG_HUMAN:B2MG_PANTR:BETA 2-MICROGLOBULIN[98 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:BETA-2-MICROGLOBULIN[98 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[97 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[101 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Beta-2-microglobulin[90 aa] NA Q53Z42_HUMAN:Beta-2-microglobulin,HLA class I antigen,MAGE-A4 p..:Beta-2-microglobulin,HLA class I antigen,MAGE-A8 p.. GOL:EDO:SO4:PG4:MES:PEG:ACT:PO4 0 0 0 3 4 0 12 0 3 4 0 3 0 44 4 7 0 0 0 17 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 267 K E b 12.3 6o9c_A CD8A_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa.. CL:MG GOL:MES:SO4:EDO 10 0 0 0 0 2 0 9 21 18 1 0 0 4 4 7 18 3 0 3 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 268 W E b 12.4 6o9c_A B2MG_HUMAN:B2MG_PANTR:TPSN_HUMAN:BETA 2-MICROGLOBULIN[98 aa]:BETA 2-MICROGLOBULIN[100 aa]:PROTEIN (HLA-A*0201)[100 aa]:BETA-2 MICROGLOBULIN[99 aa]:BETA-2 MICROGLOBULIN[100 aa]:BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa]:BETA 2-MICROGLOBULIN[99 aa]:PROTEIN (BETA 2-MICROGLOBULIN)[100 aa]:BETA-2-MICROGLOBULIN[100 aa]:beta-2-microglobulin[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[93 aa]:PROTEIN (BETA-2-MICROGLOBULIN)[100 aa]:PROTEIN (beta-2 microglobulin)[100 aa]:Beta-2-microglobulin[99 aa]:Beta-2-microglobulin, Contains: Beta-2-microglobul..:Beta-2-microglobulin[98 aa]:BETA-2-MICROGLOBULIN[99 aa]:Beta-2-microglobulin[96 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[92 aa]:Beta-2-microglobulin[103 aa]:Beta-2-microglobulin[106 aa]:Human MHC Class I, beta 2 microglobulin[100 aa]:Tapasin[348 aa]:Beta-2-microglobulin[101 aa] CL:NA GOL:FMT:EDO:PG4:PEG:ACT:SO4 3 0 0 0 5 4 0 4 0 21 1 0 0 3 9 3 4 3 39 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 269 A E b 0.0 6o9c_A 26 4 0 1 0 0 5 1 0 3 2 2 0 0 0 21 0 34 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" A->V:LB/B:-: -; 270 A E b 4.5 6o9c_A NA GOL:SO4 12 0 0 3 2 0 6 1 2 4 12 0 0 0 3 20 14 4 0 19 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" A->S:LB/B:-: -; 271 V E b 1.3 6o9c_A GOL 5 0 0 0 1 0 0 8 0 52 0 0 0 0 0 3 7 21 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 272 V E e 44.0 6o9c_A CD8A_HUMAN:LIRB1_HUMAN:D9IDM8_HUMAN:A0A0G2JQ44_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:leukocyte immunoglobulin-like receptor 1[183 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa..:LIR-1[169 aa]:Leukocyte immunoglobulin-like receptor subfamily B..:Immunoglobulin heavy chain H2[223 aa]:Immunoglobulin heavy chain H2[222 aa] GOL:SO4:EDO 9 0 11 25 1 1 0 2 0 3 0 3 3 0 8 2 14 11 2 3 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 273 V E b 0.0 6o9c_A SO4 1 0 0 0 16 0 0 11 0 12 7 0 0 0 0 0 3 49 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 274 P E e 32.6 6o9c_A CD8A_HUMAN:T-CELL CORECEPTOR CD8[114 aa] 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. SO4 9 1 5 1 4 0 0 2 5 12 0 1 29 1 1 6 17 6 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 275 S T e 54.7 6o9c_A IMD:SO4:PEG 14 4 0 2 0 0 0 0 0 7 0 2 48 3 2 13 4 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 276 G T e 47.6 6o9c_A 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. GOL 2 0 0 5 0 38 2 0 1 0 0 4 0 13 7 17 6 3 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 277 E e 36.2 6o9c_A MG 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. GOL:SO4 3 0 16 30 0 1 1 0 4 2 0 6 4 9 5 12 3 3 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" E->K:LB/B:-: -;E->Q:LB/B:-: -; 278 E G b 2.5 6o9c_A GOL 9 0 9 35 0 18 0 2 4 2 0 7 1 4 2 2 3 0 2 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 279 Q G e 38.3 6o9c_A GOL:SO4 11 0 29 9 0 0 8 0 1 0 0 2 5 22 0 5 4 3 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" Q->K:LB/B:-: -; 280 R G e 26.5 6o9c_A 1A02_HUMAN:HLA class I histocompatibility antigen, A-2 alpha .. GOL:FMT:SO4 0 0 1 4 3 11 5 5 5 4 0 6 5 10 14 4 5 17 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 281 Y E b 4.8 6o9c_A GOL 0 0 0 0 16 0 0 0 0 12 0 0 0 0 0 0 0 0 0 72 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 282 T E b 4.5 6o9c_A GOL 8 1 9 1 2 0 0 0 0 0 0 0 0 3 1 26 47 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 283 C E b 0.0 6o9c_A 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 284 H E e 20.9 6o9c_A CO GOL:SO4:EDO 0 0 0 5 0 0 19 1 8 3 0 6 0 19 29 2 0 5 1 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 285 V E b 0.0 6o9c_A MES 0 0 0 0 0 0 0 3 0 6 2 0 0 0 0 0 0 88 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 286 Q E e 51.0 6o9c_A CD8A_HUMAN:T-CELL CORECEPTOR CD8[114 aa]:T-cell surface glycoprotein CD8 alpha chain[114 aa.. NA GOL:MES:EDO:SO4:PEG 1 0 7 38 0 0 0 0 11 0 5 4 0 13 5 8 6 1 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 287 H b 9.4 6o9c_A GOL:MES:EDO:PEG 0 0 0 0 0 0 98 0 0 0 0 0 0 0 0 0 0 0 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 288 E T e 58.3 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa]:Human T Cell Receptor Mel8, Beta Chain[245 aa] GOL:MES:EDO:IMD:SO4:PEG 6 3 2 22 0 1 3 0 2 1 0 0 12 4 4 21 4 6 10 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 289 G T e 28.6 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa] SO4:TRS 6 1 0 0 0 53 0 0 0 0 0 0 0 0 0 30 10 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 290 L b 13.5 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa] MES:EDO:SO4:PEG 1 0 0 0 5 0 0 2 0 75 2 0 1 2 1 0 1 7 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 291 P S e 103.1 6o9c_A US02_HCMVA:cytomegalovirus protein US2[95 aa] EDO:SO4 10 0 21 8 0 5 3 0 7 3 1 3 20 6 0 7 6 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 292 K S e 77.8 6o9c_A EDO 3 0 6 25 0 1 1 0 11 0 4 1 0 31 2 10 2 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" K->E:LB/B:-: -; 293 P e 50.4 6o9c_A NA MES:EDO:SO4 1 0 11 0 0 0 0 0 0 0 0 2 70 1 3 4 0 5 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 294 L E e 32.0 6o9c_A NA EDO:SO4 0 0 0 0 1 2 0 23 7 46 4 0 0 2 2 0 0 11 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 295 T E e 53.9 6o9c_A NA GOL:EDO:SO4 0 0 0 1 0 0 0 15 0 14 1 0 0 4 6 11 36 9 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 296 L E b 18.0 6o9c_A PG4:EDO 4 0 0 0 0 1 0 1 8 25 5 0 0 1 4 3 0 43 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 297 R E e 44.7 6o9c_A GOL:PEG:PG4:EDO:SO4 0 0 5 17 0 0 12 1 16 0 0 1 6 4 18 6 2 0 0 11 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 298 W e 28.7 6o9c_A MG:CL EDO:GOL:PEG:SO4 1 0 0 0 0 0 0 0 0 5 0 0 0 3 1 2 3 3 79 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 299 E e 75.9 6o9c_A SO4:EDO:GOL 0 0 22 41 0 8 0 0 9 0 0 0 1 3 11 1 3 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 300 L e 48.3 6o9c_A SO4 21 3 1 4 6 3 4 1 5 12 0 2 21 4 1 9 2 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" L->P:LB/B:-: -; 301 S e 94.5 6o9c_A SO4 2 0 3 7 0 9 3 1 4 4 0 4 14 19 5 19 2 1 1 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 302 S e 133.6 6o9c_A SO4 15 0 2 6 2 6 0 2 1 7 0 2 7 5 1 39 4 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 303 Q 5 0 1 12 0 2 3 4 11 2 1 2 10 14 4 20 7 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 304 P 2 0 0 4 0 6 0 6 4 2 4 5 33 2 0 19 5 5 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 305 T 7 0 3 7 0 4 0 2 0 11 2 6 6 2 0 18 27 1 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 306 I 1 0 1 4 2 1 0 25 3 19 7 1 1 4 5 7 2 12 5 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" I->V:LB/B:-: -; 307 P 5 0 1 1 1 7 0 7 2 9 2 2 40 2 1 10 5 3 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" P->H:LB/B:-: -; 308 I 12 0 0 0 0 0 3 28 2 12 2 3 0 0 2 4 5 23 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 309 V 3 0 0 0 1 11 0 9 0 20 7 0 4 0 0 7 5 32 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 310 G 8 0 0 3 0 61 0 2 5 3 0 3 0 0 1 5 0 7 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 311 I 4 3 3 0 8 2 1 36 2 18 0 1 0 0 0 0 6 12 2 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 312 I 6 0 0 0 2 1 0 36 0 4 1 0 0 0 0 10 1 38 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" I->L:LB/B:-: -; 313 A 25 0 0 0 2 6 0 5 0 18 0 0 0 0 0 15 4 24 0 0 TRANSMEM:/note="Helical":DISORDER:predicted by DISOPRED:TRANSMEM:/note="Helical" 314 G 3 3 1 0 5 59 0 6 0 7 0 0 3 0 0 2 0 11 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 315 L 14 0 0 0 4 1 0 8 0 46 0 0 1 0 0 4 11 11 0 0 TRANSMEM:/note="Helical":DISORDER:predicted by DISOPRED:TRANSMEM:/note="Helical" 316 V 7 1 0 0 5 1 0 25 0 17 1 0 0 0 0 0 4 40 0 0 TRANSMEM:/note="Helical":DISORDER:predicted by DISOPRED:TRANSMEM:/note="Helical" 317 L 1 2 1 1 12 8 0 12 1 28 3 0 1 0 1 1 3 24 0 2 TRANSMEM:/note="Helical":DISORDER:predicted by DISOPRED:TRANSMEM:/note="Helical" 318 L 4 3 1 1 7 2 0 6 1 52 0 1 1 1 1 1 1 16 0 2 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" L->F:LB/B:-: -; 319 G 15 0 1 1 2 28 0 8 1 5 5 1 5 1 2 2 4 19 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 320 A 23 3 0 1 9 10 0 16 0 15 0 0 0 0 0 5 4 10 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 321 V 9 0 0 0 3 5 0 28 0 16 1 0 0 0 0 0 1 34 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" V->M:LB/B:-: -; 322 I 4 0 0 0 4 1 0 35 0 22 4 0 0 0 0 0 2 24 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" I->F:LB/B:-: -; 323 T 19 6 0 1 5 5 0 9 1 8 3 0 0 0 0 3 11 27 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" T->A:LB/B:-: -; 324 G 4 0 0 1 0 63 0 8 1 8 0 0 0 0 0 2 5 4 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 325 A 31 0 1 1 6 11 0 11 1 9 0 1 1 1 1 3 12 7 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 326 V 3 7 1 1 3 4 0 15 1 7 2 1 1 1 1 4 1 43 0 3 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 327 V 2 0 0 1 9 5 0 12 0 17 2 0 0 0 0 1 3 46 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 328 A 25 0 0 0 6 32 0 14 0 3 2 0 0 0 0 3 3 5 0 3 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 329 A 24 0 0 0 13 0 0 18 5 16 0 0 0 0 2 3 0 13 0 3 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 330 V 2 0 0 0 5 5 0 17 2 21 4 0 0 6 0 0 0 31 8 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 331 M 2 1 0 0 10 7 0 13 0 20 28 0 0 0 6 5 0 7 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" M->R:LB/B:-: -; 332 W 0 5 0 0 0 0 5 0 6 9 5 1 0 0 12 0 0 0 51 6 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 333 R 0 0 0 0 2 2 4 0 14 0 3 2 0 0 70 0 0 2 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 334 R 0 0 0 0 0 0 0 0 17 0 0 0 0 0 71 12 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" R->K:LB/B:-: -; 335 K 3 0 0 0 0 7 3 0 26 0 8 5 0 5 25 8 0 2 8 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" K->N:LB/B:-: -; 336 S 12 0 0 0 0 10 6 0 6 0 0 11 5 3 11 31 0 5 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 337 S 7 0 3 0 0 4 3 1 6 0 0 2 5 0 8 41 12 3 0 5 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 338 D 4 0 9 24 0 29 0 0 0 0 0 0 3 0 5 20 0 4 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" D->V:LB/B:-: -; 339 R 1 0 1 2 0 34 0 0 7 1 0 7 4 14 24 1 1 1 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 340 K 9 0 0 0 0 1 9 0 41 1 0 10 0 0 21 1 5 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 341 G 1 0 0 4 0 56 0 0 0 1 10 7 6 10 1 1 0 1 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 342 G 8 0 3 1 0 62 0 0 5 1 0 0 2 0 4 6 1 6 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 343 S 11 1 19 0 0 10 3 5 0 0 4 3 0 0 1 33 5 5 0 0 MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 344 Y 0 4 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 93 MOD_RES:/note="Phosphotyrosine":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphotyrosine":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 345 T 15 0 0 0 0 0 0 3 0 0 0 8 0 8 0 25 26 17 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" T->S:LB/B:-: -; 346 Q 4 0 0 0 0 0 4 8 3 26 0 0 27 28 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 347 A 74 0 0 0 0 0 0 0 0 15 0 0 0 0 0 0 9 2 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 348 A 33 0 0 3 0 0 0 0 0 2 0 0 37 10 0 11 0 0 0 4 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 349 S 0 6 0 0 0 48 0 0 0 0 0 0 0 4 7 19 0 12 4 0 MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 350 S 0 0 3 0 0 2 0 0 0 0 0 15 0 0 3 77 0 0 0 0 MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 351 D 1 0 33 15 1 1 3 1 3 1 0 25 1 1 1 1 9 1 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 352 S 1 0 1 1 1 12 0 1 1 2 0 1 11 1 3 44 1 1 0 18 MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 353 A 49 0 3 1 3 1 0 1 1 2 0 1 9 1 1 23 1 1 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 354 Q 0 0 0 19 0 0 0 0 0 0 0 0 0 68 0 13 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 355 G 0 0 0 0 0 62 0 0 0 0 0 0 13 0 0 14 11 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 356 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 85 0 0 15 0 MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:24275569":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:24275569":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 357 D 0 0 70 11 0 0 19 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 358 V 0 0 4 7 0 0 0 19 0 11 14 0 0 0 0 0 0 43 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" V->M:LB/B:-: -; 359 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:24275569":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:24275569":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 360 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 361 T 0 0 0 0 0 0 0 9 0 0 0 0 28 0 8 0 54 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 362 A 50 0 36 0 0 0 0 0 0 0 0 0 0 0 0 0 3 11 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 363 C 0 78 0 0 0 4 0 0 0 0 0 0 18 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 364 K 0 0 0 0 0 0 0 0 94 0 0 0 0 0 6 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 365 V 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 90 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic"